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Abstract	  
IRSp53	  (Insulin	  Receptor	  Substrate	  protein	  of	  53	  kDa)	  is	  a	  multidomain	  scaffolding	  protein	  that	  possesses	  an	  inverted	  BAR	  (Bin-­‐Amphiphysin-­‐Rvs167)	  domain	  (responsible	  for	  protein	  dimerization	  and	  membrane	  deformation),	  a	  partial	  CRIB	  motif	  (for	  the	  interaction	  with	  active	  CDC42),	  a	  SH3	  domain	  (through	  it	  binds	  actin-­‐related	  proteins,	  such	  as	  the	  capping	  protein	  EPS8)	  and	  additional	  protein	  interaction	  modules	  at	  the	  C-­‐terminus.	  In	  this	  thesis	  we	  have	  studied	  a	  previously	  unknown	  capping	  role	  of	  IRSp53	  and	  the	  functional	  consequences	  of	  its	  interaction	  with	  VASP	  (Vasodilator-­‐stimulated	  phosphoprotein).	  In	  particular,	  we	  showed	  that	  following	  CDC42	  binding	  and	  activation,	  IRSp53	  is	  able	  to	  recruit	  and	  cluster	  VASP	  both	  in	  vitro	  and	  on	  the	  plasma	  membrane,	  thus	  fostering	  VASP	  processive	  elongation	  activity.	  The	  elongation	  of	  actin	  filaments	  by	  VASP,	  together	  with	  the	  membrane-­‐deforming	  ability	  of	  IRSp53,	  combine	  to	  promote	  filopodia	  initiation	  downstream	  of	  CDC42.	  Thus,	  IRSp53	  is	  essential	  for	  coordinating	  these	  activities	  in	  vitro	  and	  in	  cells	  in	  culture.	  Indeed,	  mouse	  embryonic	  fibroblasts	  (MEFs)	  devoid	  of	  IRSp53	  form	  a	  reduced	  number	  of	  filopodia	  and	  are	  impaired	  in	  directional	  migration	  and	  wound	  healing.	  In	  keeping	  with	  a	  critical	  role	  of	  IRSp53	  in	  these	  processes,	  we	  further	  showed	  that	  IRSp53	  null	  mice	  are	  severely	  impaired	  in	  wound	  healing.	  In	  the	  second	  part	  of	  this	  thesis,	  an	  IRSp53	  role	  in	  the	  polarity	  program	  of	  epithelial	  cells	  was	  investigated.	  Few	  scattered	  reports	  had	  provided	  some	  evidence	  that:	  i)	  IRSp53	  binds	  the	  polarity	  protein	  LIN7;	  ii)	  IRSp53	  knock	  down	  affects	  the	  morphogenesis	  of	  MDCK	  (Madin	  Darby	  canine	  kidney)	  cysts	  by	  acting	  downstream	  of	  the	  polarity-­‐regulating	  kinase	  PAR1b.	  The	  molecular	  and	  cellular	  processes	  controlled	  by	  IRSp53	  in	  polarity	  remain,	  however,	  ill	  defined.	  Here	  we	  showed	  that	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IRSp53	  is	  apically	  localized	  in	  3-­‐D	  cyst	  models	  of	  epithelial	  cells,	  and	  IRSp53	  depletion	  leads	  to	  a	  multilumen	  phenotype	  also	  in	  Caco2	  (human	  colorectal	  adenocarcinoma)	  spheroids.	  The	  correct	  morphogenesis	  of	  Caco2	  spheroids	  depends	  on	  the	  intact	  function	  of	  both	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  of	  IRSp53.	  Moreover,	  using	  MDCK	  cysts	  as	  a	  model	  system,	  we	  noted	  that	  IRSp53	  is	  enriched	  early	  at	  the	  prospective	  lumen	  initiation	  site	  (called	  AMIS,	  apical	  membrane	  initiation	  site),	  even	  before	  the	  apical	  marker	  podocalyxin.	  This	  latter	  protein	  is	  known	  to	  be	  a	  critical	  factor	  in	  lumenogenesis.	  Finally,	  IRSp53	  removal	  affects	  podocalyxin	  localization	  in	  MDCK	  cysts	  at	  the	  early	  stages.	  	  We	  speculate	  that	  IRSp53	  might	  be	  involved	  in	  the	  trafficking	  of	  the	  apical	  protein	  podocalyxin,	  and	  we	  are	  currently	  investigating	  the	  molecular	  mechanism	  responsible	  for	  this	  putative	  role.	  We	  are	  also	  exploring	  whether	  IRSp53	  affects	  additional	  functions	  required	  for	  the	  correct	  execution	  of	  the	  polarity	  program,	  first	  and	  foremost	  the	  correct	  orientation	  of	  the	  spindle.	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Introduction	   	  
The	  plasma	  membrane	  is	  a	  barrier,	  which	  separates	  the	  inside	  of	  the	  cell	  from	  its	  environment.	  But	  it	  has	  not	  only	  a	  passive	  role,	  it	  is	  actually	  involved	  in	  information	  transduction,	  entry	  of	  nutrients,	  receptor	  signalling,	  cell	  shaping	  and	  migration.	  The	  lipid	  bilayer	  is	  draped	  over	  a	  cortical	  network,	  composed	  by	  actin,	  septin,	  spectrin	  and	  microtubules.	  The	  coupling	  of	  the	  lipid	  membrane	  bilayer	  and	  the	  force	  generated	  by	  actin	  polymerization	  is	  essential	  for	  all	  the	  above-­‐mentioned	  cellular	  processes.	  	  Membranes	  are	  composed	  of	  more	  than	  300	  different	  lipid	  species,	  asymmetrically	  distributed	  in	  the	  bilayer	  and	  subjected	  to	  constant	  remodeling,	  their	  distribution	  is	  mediated	  by	  a	  variety	  of	  proteins,	  such	  as	  flippases,	  proteins	  able	  to	  transport	  lipids	  between	  the	  two	  leaflets	  that	  compose	  the	  plasma	  membrane.	  The	  chemical	  properties	  of	  the	  different	  lipids	  acyl	  chains	  can	  favor	  different	  membrane	  topologies,	  on	  the	  other	  hand	  membrane-­‐associated	  proteins	  can	  actively	  change	  membrane	  curvature	  by	  sensing	  it	  and	  applying	  forces.	  For	  example,	  proteins	  can	  apply	  a	  localized	  pulling	  force.	  Alternatively,	  proteins	  can	  bend	  the	  membrane	  through	  scaffold	  mechanisms	  (meaning	  that	  the	  intrinsic	  curvature	  of	  the	  protein	  corresponds	  to	  the	  curvature	  that	  is	  induced	  on	  the	  membrane)	  or	  produce	  local	  deformations	  of	  the	  membrane,	  due	  to	  amphipathic	  moieties	  insertions	  [1]	  [2]	  [3].	  Of	  note,	  actin	  architecture	  can	  modulate	  membrane	  composition.	  Conversely,	  changes	  in	  membrane	  composition	  can	  result	  in	  changes	  of	  cortex	  architecture.	  For	  example,	  membrane	  phospholipids,	  in	  particular	  PIP2	  (phosphatidylinositol-­‐(4,5)-­‐bisphosphate),	  activates	  proteins	  that	  promote	  actin	  assembly	  (e.g.	  vinculin,	  talin,	  ezrin,	  WASP,	  WAVE)	  and	  inhibits	  proteins	  involved	  in	  actin	  disassembly	  (such	  as	  gelsolin	  and	  villin)	  [4].	  It	  is	  also	  important	  to	  consider	  that	  these	  systems	  are	  highly	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dynamic	  and	  undergo	  to	  constant	  assembly	  and	  disassembly	  processes	  that	  are	  regulated	  in	  space	  and	  time.	  	  In	  these	  events,	  of	  membrane	  and	  actin	  remodeling,	  crucial	  are	  the	  members	  of	  the	  Bin-­‐Amphiphysin-­‐Rvs167	  (BAR)	  superfamily	  of	  protein.	  BAR	  proteins	  possess	  a	  multidomain	  structure,	  in	  which	  the	  BAR	  domain	  is	  able	  to	  regulate	  the	  shape	  and	  lipid	  organization	  of	  the	  plasma	  membrane,	  while	  additional	  protein-­‐binding	  modules	  are	  able	  to	  recruit	  a	  plethora	  of	  proteins,	  including	  a	  variety	  of	  different	  actin-­‐binding	  proteins	  [5]	  [6]	  [7]	  [8].	  	  In	  this	  thesis,	  I	  will	  focus	  primarily	  on	  IRSp53	  (Insulin	  Receptor	  Substrate	  protein	  of	  53	  kDa).	  IRSp53	  possesses	  an	  inverted	  BAR	  domain	  (I-­‐BAR)	  that	  deforms	  outward	  the	  plasma	  membrane,	  but	  it	  can	  also	  bind	  actin-­‐binding	  proteins,	  such	  as	  EPS8	  (Epidermal	  growth	  factor	  receptor	  kinase	  substrate	  8)	  and	  VASP	  (Vasodilator-­‐stimulated	  phosphoprotein)	  via	  its	  SH3	  (SRC	  homology	  3)	  domain	  [9].	  These	  multiple	  functions	  are	  critical	  to	  account	  for	  the	  role	  that	  IRSp53	  plays	  in	  filopodia	  formation:	  a	  topic	  that	  will	  be	  examined	  in	  detail	  in	  this	  thesis.	  In	  the	  second	  part	  of	  this	  dissertation,	  I	  will	  also	  highlight	  other	  potential	  roles	  of	  IRSp53,	  in	  particular	  I	  will	  discuss	  about	  its	  involvement	  in	  the	  establishment	  of	  polarity	  in	  the	  early	  steps	  of	  epithelial	  morphogenetic	  process.	  	  Before	  touching	  these	  topics,	  I	  will	  start	  with	  a	  brief	  introduction	  on	  actin	  biochemistry	  and	  actin-­‐binding	  proteins.	  
The	  actin	  cytoskeleton	  
Actin	  is	  one	  of	  the	  most	  abundant	  and	  conserved	  proteins	  in	  eukaryotes:	  in	  many	  cells,	  it	  accounts	  for	  more	  than	  the	  10%	  of	  the	  total	  cellular	  protein	  content.	  Actin	  filaments	  (or	  F-­‐actin)	  are	  composed	  by	  two	  intertwined	  chains,	  in	  which	  single	  units	  of	  globular	  actin	  monomers	  (or	  G-­‐actin)	  are	  aligned.	  The	  two	  ends	  of	  the	  filaments	  are	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very	  different:	  at	  the	  barbed	  or	  plus	  end,	  fast	  and	  active	  polymerization	  of	  ATP-­‐bound	  monomers	  occurs;	  at	  the	  pointed	  or	  minus	  end,	  depolymerization	  is	  favored.	  As	  filaments	  grow,	  ATPase	  activity	  of	  actin	  monomers	  is	  activated,	  subsequently	  ATP	  is	  hydrolyzed	  and	  ADP-­‐bound	  actin	  monomers	  are	  released	  from	  the	  minus	  end.	  Once	  ADP	  actin	  monomers	  are	  free	  in	  the	  cytoplasm,	  the	  ADP/ATP	  exchange	  occurs	  and	  new	  ATP	  actin	  monomers	  can	  be	  reassembled	  into	  the	  filaments.	  The	  two	  processes	  of	  polymerization	  and	  depolymerization	  are	  coordinated,	  so	  that,	  at	  the	  “steady	  state”,	  a	  dynamic	  equilibrium	  exist	  between	  G-­‐actin	  and	  F-­‐actin,	  in	  a	  process	  called	  “actin	  treadmilling”	  (Figure	  1)	  [10].	  	  
	  
Figure	  1.	  Model	  for	  “actin	  treadmilling”.	  	  
ATP-­‐bound	  G-­‐actin	  monomers	  associate	  at	  the	  barbed	  ends,	  while	  ADP-­‐bound	  G-­‐actin	  monomers	  dissociate	  at	  the	  pointed	  ends,	  resulting	  in	  a	  flux	  of	  monomers	  through	  the	  F-­‐actin	  filament.	  Dissociated	  monomers	  are	  then	  loaded	  with	  ATP	  and	  again	  used	  to	  sustain	  filament	  polymerization	  (modified	  from	  Littlefield	  et	  al.,	  2002	  [11]).	  	  From	  a	  cell-­‐perspective,	  it	  can	  be	  imagined	  that	  actin	  filaments	  assemble	  at	  the	  leading	  edge,	  the	  front	  of	  cell	  migration,	  while	  there	  is	  an	  actin	  retrograde	  flow,	  from	  cell	  front	  to	  cell	  rear.	  In	  this	  way,	  barbed	  ends	  are	  directly	  exposed	  to	  the	  plasma	  membrane,	  and	  forces	  generated	  by	  actin	  polymerization	  are	  coupled	  with	  membrane	  deformation.	  Forces	  may	  be	  generated	  not	  only	  by	  polymerization,	  but	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ADP                       ATP
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also	  by	  active	  crosslinking	  of	  actin	  filaments	  through	  myosin	  motor,	  which	  in	  turn	  generate	  contraction.	  	  However,	  actin	  polymerization	  is	  not	  enough	  to	  produce	  forces	  able	  to	  generate	  active	  cell	  movement:	  it	  must	  be	  coupled	  to	  adhesion,	  using	  adhesive	  structures	  (as	  focal	  adhesions,	  that	  connect	  actin	  stress	  fibers	  with	  the	  extracellular	  matrix,	  ECM,	  through	  transmembrane	  proteins	  such	  as	  integrins)	  or	  friction,	  to	  transmit	  forces	  over	  the	  substrate	  [12].	  	  Actin	  filaments,	  and	  the	  other	  components	  of	  the	  cytoskeleton,	  such	  as	  microtubules,	  are	  not	  only	  required	  for	  cell	  movement,	  but	  also,	  on	  a	  smaller	  scale,	  for	  vesicular	  transport	  inside	  the	  cell.	  In	  fact,	  a	  lot	  of	  motor	  proteins	  exist	  that	  mediate	  active	  transport	  of	  vesicles	  along	  cytoskeletal	  filaments	  routes	  (consuming	  energy	  from	  ATP	  hydrolysis).	  It	  was	  also	  suggested	  that	  large	  scale	  actin	  flow	  can	  contribute	  to	  intracellular	  transport	  in	  an	  unspecific	  way,	  particularly	  if	  the	  particle	  can	  at	  least	  transiently	  bind	  to	  actin	  [13].	  Recently,	  for	  example,	  it	  has	  been	  shown	  that	  in	  cell	  migration	  there	  is	  an	  invariable	  coupling	  between	  cell	  velocity	  and	  cell	  persistence,	  which	  critically	  rely	  onto	  the	  polarized	  transport	  of	  actin	  binding	  and	  regulatory	  proteins,	  mediated	  by	  an	  active	  retrograde	  actin	  flow	  [14].	  	  
The	  actin	  monomer	  and	  the	  stages	  of	  actin	  polymerization	  Actin	  is	  a	  42	  kDa	  globular	  protein	  that	  stably	  binds	  an	  atom	  of	  Ca2+	  or	  Mg2+	  and	  a	  molecule	  of	  ATP	  or	  ADP,	  inside	  an	  inner	  hydrophobic	  cleft.	  Four	  subdomains,	  named	  from	  one	  to	  four,	  can	  be	  identified	  in	  the	  G-­‐actin	  structure	  (Figure	  2	  A).	  Actin	  monomers	  can	  assume	  an	  open	  or	  a	  close	  conformation,	  that	  differ	  in	  respect	  to	  the	  localization	  of	  a	  loop	  of	  the	  subdomain	  2,	  called	  D-­‐loop,	  and	  in	  the	  opening	  of	  the	  nucleotide	  binding	  cleft	  [15].	  It	  has	  been	  hypothesized	  that	  the	  switch	  between	  the	  two	  forms	  is	  coupled	  to	  the	  ADP/ATP	  exchange:	  ADP-­‐bound	  actin	  may	  adopt	  an	  open	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conformation,	  that	  would	  be	  permissible	  for	  nucleotide	  exchange,	  while	  when	  bound	  to	  ATP	  the	  nucleotide	  binding	  cleft	  closes,	  allowing	  slow	  hydrolysis	  of	  the	  nucleotide	  [16].	  
	  
Figure	  2.	  Structures	  of	  G-­‐actin	  and	  F-­‐actin.	  
A	  Ribbon	  diagram	  showing	  an	  actin	  monomer	  (Protein	  DataBase	  (PDB)	  code	  2BTF).	  In	  the	  figure	  are	  	  highlighted	  the	  subdomains	  1-­‐4,	  the	  nucleotide	  binding	  cleft	  (where	  ATP	  is	  shown	  as	  a	  ball-­‐and-­‐stick	  model	  and	  the	  metal	  ion	  is	  in	  green)	  and	  the	  D-­‐loop	  (modified	  from	  Aguda	  et	  al.,	  2005	  [15]).	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the	  depolymerization	  at	  the	  minus	  end,	  without	  change	  in	  the	  net	  length	  of	  the	  filament	  (Figure	  3).	  	  At	  the	  steady	  state,	  an	  equilibrium	  between	  F-­‐actin	  and	  G-­‐actin	  is	  reached;	  at	  this	  stage	  the	  concentration	  of	  actin	  monomers	  is	  equal	  to	  the	  actin	  critical	  concentration	  (CC),	  which	  is	  the	  minimal	  G-­‐actin	  concentration	  required	  for	  filaments	  assembly.	  The	  critical	  concentration	  depends	  from	  the	  ratio	  of	  the	  constants	  of	  dissociation	  and	  association	  of	  monomers	  with	  each	  filament	  end,	  under	  typical	  in	  vitro	  conditions	  this	  value	  is	  equal	  to	  0.1	  μM	  at	  the	  plus	  end	  (CC+).	  The	  critical	  concentration	  is	  different	  at	  the	  pointed	  end,	  where	  is	  equal	  to	  0.6	  μM	  (CC-­‐).	  At	  steady	  state	  this	  difference	  determines	  the	  net	  monomer	  association	  at	  the	  plus	  end	  and	  the	  net	  depolymerization	  that	  occurs	  at	  the	  minus	  end	  [10].	  
	  
Figure	  3.	  The	  phases	  of	  actin	  polymerization.	  
Actin	  polymerization	  can	  be	  divided	  in	  the	  following	  phases:	  nucleation	  (monomers	  slowly	  assemble,	  forming	  oligomers	  of	  two	  or	  three	  subunits),	  elongation	  (filament	  rapidly	  elongates)	  and	  steady	  state	  (in	  which	  no	  net	  growth	  of	  filaments	  is	  observed)	  (modified	  from:	  Molecular	  biology	  of	  the	  cell,	  Alberts,	  2001).	  	  Of	  note,	  the	  pool	  of	  actin	  monomers	  is	  constantly	  replenished	  in	  cells,	  it	  is	  thefore	  not-­‐limited,	  and	  there	  is	  no	  competition	  for	  actin	  monomers	  between	  all	  the	  filaments	  in	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active	  growth,	  while	  in	  vitro	  a	  finite	  and	  exhaustible	  pool	  of	  monomers	  is	  available	  [18].	  	  	  
Lamellipodia	  and	  filopodia	  The	  actin	  cytoskeleton	  is	  tightly	  regulated	  in	  term	  of	  localization,	  composition	  and	  architecture.	  Examples	  of	  this	  control	  are	  to	  be	  found	  in	  lamellipodia	  and	  filopodia:	  protrusive	  structures	  that	  are	  assembled	  at	  the	  leading	  edge	  of	  motile	  cells	  (Figure	  4).	  Lamellipodia	  are	  sheet-­‐like	  projections	  containing	  a	  network	  of	  short	  branched	  filaments,	  which	  growth	  is	  terminated	  by	  capping	  proteins.	  WAVE2	  mediated	  activation	  of	  Arp2/3	  (Actin-­‐related	  protein	  2/3),	  downstream	  of	  Rac1-­‐GTPase,	  is	  essential	  for	  the	  formation	  of	  branched	  actin	  filaments	  at	  the	  lamellipodium	  [19].	  Filopodia	  are	  thin	  projections	  8-­‐15	  μm	  long	  and	  0.6-­‐1.2	  μm	  wide,	  with	  uniform	  tubular	  morphology,	  containing	  15-­‐20	  long	  and	  parallel	  actin	  filaments,	  bundled	  together	  by	  crosslinking	  proteins,	  such	  as	  fascin.	  Filopodia	  extend	  and	  retract	  quickly	  (their	  lifetime	  is	  79-­‐142	  seconds	  [20]).	  Filopodia	  are	  sites	  for	  integrating	  signalling	  from	  ECM	  and	  external	  clues:	  they	  are	  involved	  in	  many	  cellular	  processes,	  such	  as	  cell	  migration,	  neuritogenesis,	  axon	  guidance	  in	  neuronal	  growth	  cones,	  receptor-­‐ligand	  endocytosis,	  detection	  of	  pathogen	  targets	  for	  phagocytosis,	  angiogenesis,	  wound	  healing	  [12]	  [21]	  [22].	  A	  lot	  of	  proteins	  are	  associated	  with	  filopodia,	  some	  examples	  are:	  the	  formin	  mDia2	  [23],	  fascin	  (found	  along	  filopodia	  shalf)	  [24],	  Ena/VASP	  (located	  at	  tips)	  [25],	  myosin	  X	  (that	  transport	  Ena/VASP	  and	  other	  proteins	  to	  the	  tips,	  traveling	  towards	  actin	  filament	  barbed	  ends)	  [26].	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Figure	  4.	  Lamellipodia	  and	  filopodia.	  
A	  Cartoon	  representing	  a	  moving	  cell,	  in	  which	  are	  highlighted,	  at	  the	  leading	  edge,	  lamellipodia	  and	  filopodia	  structures	  (modified	  from	  Le	  Clainche	  et	  al.,	  2008	  [27]).	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filaments,	  that	  are	  subsequently	  bundled	  together	  [33].	  Filopodia	  stabilization	  is	  guaranteed	  by	  the	  formation	  of	  focal	  complexes	  and	  by	  the	  adhesion	  to	  the	  substrate.	  	  Filopodia	  extension	  and	  retraction	  are	  dependent	  on	  a	  balance	  between	  the	  actin	  polymerization	  rate	  and	  the	  retrograde	  flow:	  the	  assembly	  rate	  at	  the	  tips	  is	  the	  major	  determinant	  of	  filopodia	  dynamics,	  while	  the	  retrograde	  flow	  remains	  almost	  constant,	  but	  becomes	  the	  main	  force	  during	  retraction.	  Moreover,	  the	  plasma	  membrane	  exerts	  tension,	  inducing	  a	  passive	  inward	  retraction	  force	  [34].	  Actin-­‐binding	  proteins	  can	  modulate	  filopodia	  retraction:	  it	  has	  been	  observed	  that	  cofilin	  accumulates	  along	  filopodia	  shaft	  and	  becomes	  enriched	  at	  filopodia	  tips	  during	  their	  retraction.	  Of	  note,	  cofilin	  severing	  action	  is	  more	  efficient	  in	  presence	  of	  fascin-­‐crosslinked	  actin	  bundles,	  promoting	  actin	  disassembly	  [35].	  	  	  
Note	  on	  GTPases	  Kozma	  et	  al.,	  1995	  [36],	  reported	  for	  the	  first	  time	  that	  CDC42	  was	  able	  to	  regulate	  filopodia	  formation;	  in	  a	  variety	  of	  mammals	  cells	  CDC42	  dominant	  negative	  inhibits	  filopodia	  formation.	  Moreover,	  CDC42	  is	  a	  master	  regulator	  of	  cell	  polarity.	  CDC42	  is	  prenylated,	  and	  in	  this	  way	  is	  tethered	  to	  the	  membrane.	  	  CDC42	  and	  others	  small	  GTPases	  (20-­‐30	  kDa	  in	  weight)	  are	  molecular	  switches	  that	  are	  able	  to	  cycle	  between	  an	  active	  GTP-­‐bound	  form	  (at	  the	  plasma	  membrane),	  to	  an	  inactive	  GDP-­‐bound	  form	  (at	  the	  cytoplasm),	  thus	  regulating	  the	  formation	  and	  disassembly	  of	  protein	  complexes	  at	  the	  plasma	  membrane.	  RHO	  GTPases	  switch	  ability	  makes	  them	  ideal	  molecules	  to	  control	  changes	  in	  the	  cytoskeleton	  dynamics,	  allowing	  a	  spatial	  and	  timing	  restricted	  response	  to	  extracellular	  stimuli	  [37].	  GTPases	  itself	  are	  tightly	  regulated	  by	  guanine	  nucleotide	  exchange	  factors	  (GEFs)	  and	  GTPase	  activating	  proteins	  (GAPs).	  GEFs	  promote	  GDP	  to	  GTP	  transition.	  In	  addition,	  it	  is	  possible	  that	  GEFs	  can	  aid	  in	  selecting	  downstream	  GTPase	  effectors,	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through	  direct	  binding	  or	  scaffolding	  mechanisms,	  and	  to	  organize	  a	  specific	  signalling	  pathway	  downstream	  of	  GTPase	  activation.	  GAPs	  are	  responsible	  for	  controlling	  GTP	  hydrolysis	  activity,	  in	  particular	  favoring	  the	  GDP-­‐loaded	  pool.	  Finally,	  guanine-­‐nucleotide	  dissociation	  inhibitors	  (GDIs)	  inhibit	  the	  dissociation	  of	  GDP	  from	  the	  protein,	  keeping	  the	  GTPases	  soluble	  in	  the	  cytoplasm,	  thus	  acting	  as	  negative	  regulators	  of	  the	  protein	  activity.	  Interestingly,	  RHO	  family	  members	  can	  modify	  the	  local	  distribution	  of	  phospholipids	  in	  the	  plasma	  membrane,	  acting	  on	  the	  regulation	  of	  lipid-­‐modifying	  enzymes,	  thus	  are	  able	  to	  influence	  the	  cytoskeletal	  dynamics	  also	  in	  this	  indirect	  way	  [38].	  	  	  
Actin-­‐binding	  proteins	  Actin	  polymerization	  is	  an	  energy-­‐demanding	  process,	  in	  particular	  the	  nucleation	  of	  filaments	  is	  thermodynamically	  counteracted,	  meaning	  that	  the	  addiction	  of	  the	  first	  two	  or	  three	  monomers	  is	  discouraged.	  A	  class	  of	  proteins,	  called	  “nucleators”	  exists	  
in	  vivo	  to	  overcome	  this	  energetic	  barrier.	  Moreover,	  the	  polymerization	  rate	  of	  actin	  in	  vivo	  differs	  from	  the	  one	  reached	  in	  vitro	  by	  orders	  of	  magnitude:	  in	  vivo	  actin	  treadmilling	  is	  100	  time	  faster	  with	  respect	  to	  pure	  actin	  in	  vitro	  [10].	  This	  is	  due	  to	  the	  fact	  that	  polymerization	  and	  depolymerization	  are	  tightly	  regulated	  in	  cells	  by	  a	  variety	  of	  proteins	  that	  influence	  filament	  dynamics,	  stability	  and	  architecture	  (Figure	  5).	  It	  should	  be	  noted	  that	  actin-­‐binding	  proteins	  work	  in	  tandem,	  binding	  together	  the	  actin	  filament,	  thus	  mutually	  influencing	  their	  affinities	  and	  dissociation	  rates,	  allowing	  a	  tighter	  control	  of	  filament	  polymerization	  [18].	  Some	  examples	  of	  actin-­‐binding	  proteins	  will	  be	  briefly	  reviewed	  in	  this	  section.	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Figure	  5.	  Roles	  of	  actin-­‐binding	  proteins.	  	  
Actin-­‐binding	  proteins	  can	  affect	  actin	  polymerization	  acting	  on	  nucleation,	  elongation	  or	  filament	  stability,	  but	  can	  also	  influence	  filaments	  architecture	  through	  capping,	  branching	  and	  crosslinking	  functions.	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Of	  note,	  profilin	  can	  also	  bind	  a	  variety	  of	  proteins,	  mostly	  related	  with	  cystoskeleton	  dynamics,	  using	  its	  proline-­‐rich	  region:	  some	  examples	  will	  be	  discussed	  later	  and	  include	  WASP,	  formins	  and	  VASP	  family	  proteins.	  
	  
Nucleation	  and	  branching	  of	  actin	  filaments	  The	  Arp2/3	  was	  the	  first	  nucleating	  complex	  to	  be	  identified,	  but	  it	  is	  also	  able	  to	  branch	  actin	  filaments,	  with	  a	  typical	  angle	  of	  70°[42-­‐44].	  It	  is	  a	  complex	  of	  220	  kDa,	  composed	  by	  seven	  proteins	  (Arp2,	  Arp3	  and	  five	  additional	  subunits,	  named	  ARPC1-­‐ARPC5)	  [45,	  46].	  It	  has	  been	  recently	  observed	  that	  Arp3,	  ARPC1	  and	  ARPC5	  are	  actually	  present	  in	  two	  distinct	  isoforms	  inside	  the	  cells.	  Interestingly,	  isoform	  composition	  of	  the	  Arp2/3	  complex	  influences	  its	  actin	  assembly	  properties,	  as	  well	  as	  the	  stability	  of	  the	  formed	  filaments	  [47].	  The	  isolated	  Arp2/3	  complex	  is	  an	  inefficient	  nucleator,	  that	  requires	  the	  action	  of	  activators,	  called	  nucleation-­‐promoting	  factors	  (NPFs).	  Among	  the	  NPFs,	  there	  is	  the	  WASP	  family,	  which	  includes	  WASP,	  N-­‐WASP,	  and	  WAVE.	  All	  of	  them	  have	  a	  C-­‐terminal	  WCA	  (WH2	  Central	  Acidic)	  module,	  necessary	  and	  sufficient	  to	  interact	  with	  the	  Arp2/3	  complex	  and	  to	  stimulate	  actin	  nucleation	  and	  branching	  [48].	  In	  particular,	  WCA	  is	  composed	  by	  a	  WH2	  (WASP	  homology	  domain	  2),	  able	  to	  bind	  G-­‐actin	  and	  deliver	  it	  to	  the	  nascent	  filament	  [49],	  an	  amphipathic	  connector	  region	  (C)	  and	  an	  acidic	  polypeptide	  (A).	  The	  CA	  portion	  is	  able	  to	  contact	  different	  subunits	  of	  the	  Arp2/3	  complex,	  causing	  a	  conformational	  change	  required	  for	  its	  activation	  [50].	  Members	  of	  the	  WASP	  family	  also	  share	  a	  central	  poly-­‐proline	  region.	  The	  N-­‐terminus	  of	  the	  proteins	  diverges:	  WASP	  and	  N-­‐WASP	  have	  a	  WH1	  (WASP	  homology	  domain	  1),	  followed	  by	  a	  short	  basic	  region	  and	  a	  CRIB	  domain.	  WAVE	  (also	  called	  SCAR)	  instead	  possesses	  a	  WHD	  (WAVE	  homology	  domain)	  and	  a	  stretch	  of	  basic	  residues,	  but	  lacks	  the	  ability	  to	  bind	  directly	  small	  RHO	  GTPases.	  WAVE	  exists	  in	  3	  isoforms	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(WAVE1-­‐3),	  WAVE1	  and	  3	  are	  expressed	  mainly	  in	  neural	  tissues,	  while	  WAVE2	  isoform	  is	  ubiquitous.	  All	  WAVE	  proteins	  are	  present	  in	  both	  lamellipodia	  and	  filopodia	  tips.	  WAVE2	  exists	  in	  a	  multiprotein	  complex,	  that	  contain	  Nap1	  (NCK-­‐associated	  protein),	  PIR121/Sra1	  (p53	  inducible	  protein),	  HSCP300,	  ABI1/2	  (Abl-­‐interactor	  1/2).	  The	  assembly	  of	  the	  complex	  is	  required	  for	  WAVE	  to	  correctly	  localize	  and	  interact	  with	  activated	  Rac,	  as	  well	  as	  for	  its	  ability	  to	  activate	  Arp2/3	  [51]	  [52].	  WAVE2	  null	  mice	  show	  embryonic	  lethality,	  fibroblasts	  derived	  from	  them	  show	  defect	  in	  lamellipodia	  formation,	  ruffling	  and	  cell	  migration	  [53].	  Filaments	  branching	  can	  be	  also	  down	  regulated	  in	  cells:	  some	  proteins	  exist	  (such	  as	  Gadkin	  or	  Arpin)	  that	  sequester	  Arp2/3	  into	  a	  non-­‐branching	  complex,	  competing	  with	  WASP	  proteins	  [54]	  [55].	  	  
Formins	  Formins	  can	  nucleate	  and	  polymerize	  linear	  actin	  filaments.	  There	  are	  15	  formins	  in	  mammalian	  cells	  which	  are	  currently	  subject	  of	  intense	  investigation	  [56]	  [57].	  Two	  of	  the	  most	  studied,	  primarily	  for	  historical	  reason,	  are	  mDia1/2	  formins,	  acting	  downstream	  of	  the	  small	  GTPases	  of	  the	  RHO	  family.	  The	  N-­‐terminal	  basic	  domain	  of	  formins	  binds	  phospholipids	  and	  localize	  the	  protein	  to	  the	  plasma	  membrane.	  Formins	  then	  possess	  a	  FH1	  (formin	  homology	  1)	  domain,	  which	  is	  a	  proline-­‐rich	  region,	  able	  also	  to	  recruit	  profilin-­‐actin	  complexes,	  and	  a	  FH2	  (formin	  homology	  2)	  domain,	  a	  donut-­‐shaped	  dimer	  required	  and	  sufficient	  for	  promoting	  actin	  assembly	  
in	  vitro.	  In	  fact,	  FH2	  associates	  with	  the	  barbed	  end	  of	  the	  filament	  and	  it	  is	  assisted,	  in	  its	  nucleation	  function,	  by	  the	  adjacent	  DAD	  (diaphanous	  autoregulatory	  domain),	  able	  to	  bind	  actin	  monomers	  [58].	  Formins	  are	  processive	  nucleators:	  they	  bind	  barbed	  ends	  with	  high	  affinity,	  and	  display	  a	  low	  dissociation	  rate,	  so	  that	  a	  formin	  dimer	  can	  catalyze	  thousands	  cycles	  of	  actin	  polymerization	  in	  vitro	  [59]	  [60].	  An	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intramolecular	  interaction	  between	  the	  N-­‐terminal	  DID	  (diaphanous	  inhibitory	  domain)	  with	  the	  C-­‐terminal	  DAD	  autoregulatory	  domain,	  locks	  the	  protein	  in	  an	  inactive	  conformation;	  the	  transition	  to	  the	  active	  state	  occurs	  upon	  RHO	  GTPase	  binding	  and	  the	  disruption	  of	  this	  intramolecular	  interaction	  [61].	  Of	  note,	  FH2	  itself	  is	  not	  a	  dimer,	  but	  the	  active	  form	  of	  the	  formin	  is:	  a	  coiled	  coil	  and	  additional	  dimerization	  elements	  contribute	  to	  the	  overall	  assembly	  of	  the	  molecule.	  
In	  vivo,	  formin	  activity	  can	  be	  controlled	  influencing	  the	  rate	  of	  processive	  assembly	  or	  enhancing	  formin	  dissociation	  from	  the	  barbed	  ends.	  Some	  formins	  are	  instead	  	  poor	  nucleators	  and	  require	  an	  activator	  for	  their	  function.	  Of	  note,	  formins	  often	  act	  in	  membrane-­‐bound	  sites,	  as	  at	  the	  tips	  of	  filopodia,	  some	  reports	  suggest	  that	  this	  tension	  could	  affect	  formin	  activity	  [62].	  	  
Cappers	  Capping	  proteins	  are	  able	  to	  bind	  barbed	  ends	  with	  nanomolar	  affinity,	  thus	  inhibiting	  further	  addiction	  of	  monomers	  (or	  nucleation).	  In	  the	  cytoplasm,	  stable	  capping	  of	  actin	  filaments	  prevents	  any	  unproductive	  polymerization	  and	  the	  associated	  futile	  ATP	  consumption.	  Different	  families	  of	  cappers	  exist,	  as	  the	  gelsolin	  superfamily,	  whose	  members	  (gelsolin,	  adseverin,	  villin,	  advillin,	  supervillin,	  flightless	  I	  homolog,	  CapG)	  are	  composed	  by	  gelsolin-­‐type	  domains,	  that	  sever	  and	  cap	  actin	  filaments	  with	  high	  affinity	  and	  are	  calcium-­‐dependent.	  Another	  example	  are	  the	  capping	  protein	  (CP)	  and	  the	  homolog	  CapZ	  in	  striated	  muscle:	  CP	  is	  an	  heterodimer	  of	  alpha	  and	  beta	  subunits	  and	  is	  the	  major	  barbed	  ends	  capper.	  It	  binds	  the	  two	  terminal	  actin	  subunits	  with	  high	  affinity	  and	  has	  very	  slow	  dissociation	  rates.	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CP	  has	  a	  “mushroom”	  shape:	  the	  N-­‐terminal	  regions	  of	  the	  two	  subunits	  create	  a	  six-­‐helix	  bundle	  structure	  that	  forms	  its	  “stalk”,	  while	  the	  C-­‐terminal	  part	  forms	  an	  intertwined	  β-­‐sheet	  that	  creates	  the	  “cap”.	  At	  the	  very	  C-­‐terminus	  of	  each	  subunit,	  an	  alpha-­‐helix	  emerge:	  they	  are	  the	  “tentacles”	  that	  extend	  perpendicularly	  from	  the	  “mushroom”	  structure	  and	  bind	  the	  barbed	  end	  of	  the	  filament	  [63].	  	  If	  all	  the	  CP	  present	  in	  the	  cytoplasm	  were	  active,	  barbed	  ends	  will	  be	  permanently	  capped	  in	  cells,	  for	  this	  reason	  CP	  are	  finely	  regulated.	  In	  particular,	  	  *	  V-­‐1	  (or	  myotrophin),	  present	  in	  micromolar	  amounts,	  sequester	  free	  CP.	  V-­‐1	  binds	  CP	  with	  high	  affinity,	  directly	  competing	  with	  barbed	  ends	  binding	  activity,	  due	  to	  a	  steric	  hindrance	  effect	  [64];	  *	  CARMIL	  and	  CPI	  (capping	  protein	  interaction)-­‐motif-­‐containing	  proteins	  (CapZIP,	  FAM21,	  CIN85)	  lower	  the	  affinity	  of	  CP	  for	  the	  barbed	  ends,	  through	  an	  allosteric	  mechanism	  [64].	  They	  can	  bind	  both	  free	  CP	  then	  CP	  bound	  to	  the	  barbed	  ends,	  this	  results	  in	  an	  enhanced	  rate	  of	  dissociation	  of	  CP	  from	  the	  barbed	  ends	  (called	  “uncapping”).	  CARMIL	  can	  also	  bind	  CP:V-­‐1	  complex,	  promoting	  V-­‐1	  release.	  Interestingly,	  proteins	  of	  the	  CPI	  family	  act	  in	  a	  site-­‐specific	  manner,	  as	  CARMIL	  is	  an	  Arp2/3-­‐myosin	  I	  linker	  and	  localizes	  at	  the	  protruding	  cell	  edges.	  Of	  note,	  others	  uncapping	  proteins	  exist,	  that	  upon	  the	  transient	  formation	  of	  the	  ternary	  complex	  barbed	  ends:CP:uncapper,	  result	  in	  CP	  dissociation,	  while	  the	  “uncapper”	  remains	  bound.	  Examples	  are:	  the	  WH2	  domain	  of	  VopF	  and	  the	  FH2	  domain	  in	  formin,	  both	  WH2	  and	  FH2	  domains	  possess	  a	  short	  amphipathic	  α-­‐helix,	  that	  inserts	  in	  the	  hydrophobic	  cleft	  between	  subdomains	  1-­‐3	  of	  actin	  at	  the	  barbed	  ends	  [65]	  [66].	  Another	  family	  of	  capper	  exist:	  the	  EPS8	  family	  [67].	  EPS8	  is	  a	  97	  kDa	  protein	  identified	  as	  a	  substrate	  of	  receptor	  tyrosine	  kinase	  (RTK).	  It	  possesses	  a	  modular	  structure:	  a	  N-­‐terminal	  PTB	  domain	  (phospho-­‐tyrosine	  binding	  domain),	  a	  central	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SH3	  domain,	  two	  proline-­‐rich	  regions	  and	  a	  C-­‐terminal	  region,	  which	  is	  able	  to	  bind	  actin.	  The	  SH3	  domain	  of	  EPS8	  binds	  ABI1/2	  and	  RN-­‐tre,	  indicating	  a	  role	  of	  EPS8	  both	  in	  the	  RHO	  GTPase	  signalling	  cascade	  and	  in	  endocytosis.	  EPS8,	  together	  with	  ABI1	  and	  SOS1	  (Son	  of	  sevenless	  homolog	  1),	  forms	  a	  trimeric	  complex	  that	  possesses	  a	  specific	  Rac	  GEF	  activity	  in	  vitro	  and	  in	  vivo,	  essential	  for	  ruffling	  induced	  by	  oncogenic	  Ras	  [68].	  RN-­‐tre,	  instead,	  is	  a	  GAP	  for	  RAB5,	  RAB33	  and	  RAB4,	  connecting	  EPS8	  with	  RTKs	  internalization	  and	  recycling	  [69].	  	  EPS8	  C-­‐terminal	  region	  instead	  affects	  actin	  cytoskeleton	  remodelling,	  in	  particular	  it	  contains	  an	  amphipathic	  H1	  helix,	  homologous	  to	  WH2	  domains,	  that	  is	  responsible	  for	  EPS8	  interactions	  with	  the	  barbed	  end	  and	  is	  crucial	  for	  its	  capping	  activity.	  EPS8	  C-­‐terminus	  also	  possesses	  a	  four	  helix	  bundle	  (H2-­‐H5),	  that	  represents	  a	  second	  interaction	  surface	  which	  mediates	  EPS8	  contacts	  with	  the	  filament	  side	  and	  is	  responsible	  for	  its	  bundling	  activity	  [70].	  These	  two	  actin	  binding	  surfaces	  are	  spatially	  coordinated	  by	  a	  flexible	  linker,	  that	  ensures	  a	  bimodal	  topological	  arrangement	  of	  EPS8	  around	  the	  actin	  filaments.	  Of	  note,	  EPS8	  capping	  activity	  is	  auto	  inhibited	  in	  the	  full-­‐length	  protein	  and	  can	  only	  be	  induced	  upon	  binding	  to	  ABI1,	  while	  full-­‐length	  EPS8	  remains	  functional	  as	  a	  crosslinker	  [67].	  	  
Crosslinking	  	  Actin	  bundling	  or	  crosslinking	  proteins	  mediate	  the	  interaction	  between	  different	  actin	  filaments,	  thus	  affecting	  their	  three-­‐dimensional	  (3-­‐D)	  organization.	  A	  variety	  of	  crosslinking	  proteins	  exist,	  that	  allow	  a	  fine-­‐tuning	  of	  the	  mechanical	  properties	  of	  the	  actin	  bundles	  they	  generate.	  Crosslinking	  proteins	  need	  at	  least	  two	  F-­‐actin	  binding	  regions	  to	  work,	  or	  alternatively	  dimerization	  of	  the	  protein	  is	  needed	  if	  it	  contains	  just	  one	  actin-­‐binding	  module.	  The	  distance	  and	  the	  orientation	  of	  the	  two	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actin-­‐binding	  sites	  are	  crucial	  in	  determining	  the	  structural	  properties	  of	  the	  actin	  network.	  Fascin	  is	  a	  monomeric	  bundling	  protein	  of	  great	  relevance	  for	  filopodia	  formation:	  it	  organizes	  actin	  in	  very	  tight	  and	  stiff	  bundles	  of	  around	  20	  filaments	  [71],	  exclusively	  oriented	  in	  a	  parallel	  fashion	  [35].	  The	  rigidity	  that	  fascin	  confers	  to	  actin	  filaments	  is	  due	  to	  the	  close	  proximity	  of	  the	  two	  actin-­‐binding	  site	  located	  in	  the	  N-­‐	  and	  in	  the	  C-­‐terminus	  of	  the	  protein.	  Fascin	  is	  specifically	  localized	  along	  the	  filopodia	  shaft,	  supporting	  them	  with	  the	  rigidity	  required	  to	  efficiently	  push	  against	  the	  membrane.	  Interestingly,	  fascin	  rapidly	  associates	  and	  dissociates	  from	  actin	  filaments,	  allowing	  an	  efficient	  coordination	  between	  elongation	  and	  bundling	  inside	  the	  filopodium.	  Fascin	  knock	  down	  (KD)	  in	  B16F1	  mouse	  melanoma	  cells	  cause	  a	  decrease	  in	  filopodia	  number,	  while	  the	  remaining	  ones	  contained	  loosely	  arranged	  actin	  filaments	  [24].	  
	  
Depolymerization	  ADF	  (actin	  depolymerizing	  factor)	  or	  cofilin	  bind	  cooperatively	  to	  the	  side	  of	  ADP-­‐bound	  actin	  filaments,	  it	  alters	  the	  mechanical	  properties	  of	  the	  filament,	  increasing	  its	  helical	  twist,	  thus	  weakening	  the	  contacts	  between	  actin	  monomers	  and	  promoting	  filament	  severing	  and	  depolymerization	  [72].	  This	  mode	  of	  action	  does	  not	  affect	  the	  rate	  of	  actin	  polymerization	  per	  se,	  but	  causes	  an	  increase	  of	  the	  pool	  of	  G-­‐actin,	  indirectly	  sustaining	  the	  growth	  of	  filaments.	  Other	  proteins	  can	  work	  with	  ADF/cofilin	  to	  enhance	  filament	  disassembly,	  such	  as:	  Aip1,	  coronin,	  twinfilin,	  cyclase-­‐associated	  proteins	  [73]	  [74]	  [75]	  [76].	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VASP	  I	  dedicated	  a	  separated	  subchapter	  to	  the	  actin-­‐binding	  protein	  VASP,	  since	  it	  will	  be	  an	  important	  player	  in	  our	  research	  that	  will	  be	  described	  later	  on.	  VASP	  belongs	  to	  the	  Ena/VASP	  family	  proteins,	  that	  includes	  Mena	  (Mammalian	  enabled)	  and	  EVL	  (Ena-­‐VASP-­‐like).	  In	  Drosophila	  just	  one	  member	  of	  the	  family	  is	  present:	  Enabled	  (Ena)	  (Figure	  6)	  [77].	  These	  proteins	  localize	  to	  focal	  adhesions,	  actin	  stress	  fibers,	  tips	  of	  filopodia	  and	  lamellipodia	  at	  the	  leading	  edge;	  interestingly	  VASP	  is	  lost	  from	  the	  leading	  edge	  during	  membrane	  retraction	  [78]	  [79]	  [80].	  From	  in	  vivo	  cell	  imaging,	  it	  has	  been	  observed	  that	  GFP-­‐VASP	  increases	  locally	  in	  sites	  that	  subsequently	  give	  rise	  to	  filopodia	  [32].	  Ena/VASP	  proteins	  are	  implicated	  also	  in	  cell-­‐cell	  contact	  maturation:	  they	  localize	  with	  E-­‐cadherin/catenin	  puncta	  in	  primary	  keratinocytes	  [81]	  and	  Ena/VASP	  distruption	  perturbs	  cadherin-­‐associated	  actin	  bundles	  in	  CHO	  cells	  [82];	  in	  Drosophila	  Ena	  is	  essential	  for	  dorsal	  closure,	  influencing	  epithelial	  zippering	  by	  the	  modulation	  of	  filopodial	  number	  and	  length	  [83].	  Finally,	  VASP	  is	  a	  protein	  kinase	  A	  (PKA)	  substrate	  in	  platelets,	  where	  PKA	  inhibits	  platelet	  activation	  [84].	  The	  multidomain	  structure	  is	  conserved	  in	  Ena/VASP	  family	  and	  comprises	  the	  N-­‐terminus	  EVH1	  (Ena-­‐VASP-­‐homology-­‐1)	  domain,	  a	  central	  proline-­‐rich	  sequence	  and	  a	  C-­‐terminal	  EVH2	  domain	  (Ena-­‐VASP-­‐homology-­‐2)	  (Figure	  6).	  EVH1	  interacts	  with	  proteins	  containing	  the	  consensus	  sequence	  (D/E)FPPPPX(D/E)(D/E);	  through	  EVH1,	  VASP	  binds	  its	  upstream	  regulators,	  palladin	  (an	  organizer	  of	  dorsal	  stress	  fibers)	  [85]	  and	  also	  zyxin	  and	  vinculin,	  responsible	  for	  VASP	  subcellular	  targeting	  on	  focal	  adhesions	  [86]	  [87].	  Other	  EVH1	  interactors	  are	  FYB/SLAP	  (through	  which	  VASP	  goes	  to	  immunological	  synapses	  in	  T-­‐cells	  and	  phagocytic	  cups	  in	  macrophages)	  [88]	  and	  lamellipodin/Mig-­‐10/RIAM	  (involved	  in	  the	  recruitment	  of	  VASP	  to	  filopodia	  tips)	  [89].	  Moreover,	  EVH1	  domain	  interacts,	  with	  lower	  affinity,	  with	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proteins	  containing	  a	  LPPPPP	  motif,	  as	  mDia	  formins	  [90]	  and	  ABI1,	  a	  previously	  cited	  component	  of	  the	  WAVE	  complex	  [91].	  	  VASP	  proline-­‐rich	  domain	  (PRD)	  binds	  proteins	  containing	  SH3	  and	  WW	  domains	  (as	  Abl,	  IRSp53,	  FE65),	  as	  well	  as	  profilin	  and	  actin-­‐profilin	  complex	  [92].	  Monomeric	  VASP	  binds	  two	  molecules	  of	  profilin,	  with	  nanomolar	  affinity	  [93],	  and	  the	  biochemical	  properties	  of	  profilin:actin	  complex	  are	  altered	  when	  bound	  to	  Ena/VASP.	  	  	  EVH2	  is	  required	  for	  Ena/VASP	  tetramerization,	  through	  the	  C-­‐terminal	  coiled-­‐coil	  (COCO)	  motif,	  and	  for	  actin	  binding.	  Actually,	  Ena/VASP	  possess	  both	  a	  G-­‐actin	  binding	  domain	  (GAB),	  related	  to	  the	  WH2	  domain,	  and	  a	  F-­‐actin	  binding	  domain	  (FAB).	  Profilin	  and	  profilin:actin	  complex,	  that	  bind	  the	  central	  PRD	  region,	  can	  be	  directly	  transferred	  to	  GAB	  to	  promote	  actin	  filament	  elongation	  [92]	  [94].	  EVH2	  domain	  is	  sufficient	  to	  direct	  GFP-­‐EVH2	  to	  the	  leading	  edges	  of	  spreading	  cells,	  but	  EVH1	  can	  cooperate	  to	  refine	  VASP	  localization	  to	  the	  very	  tip	  of	  lamellipodia	  and	  filopodia;	  moreover,	  EVH2	  contains	  all	  the	  determinants	  required	  to	  regulate	  fibroblast	  lamellipodia	  dynamics.	  The	  activity	  of	  Ena/VASP	  proteins	  is	  regulated	  by	  phosphorylation:	  they	  are	  targets	  of	  cAMP/cGMP-­‐dependent	  protein	  kinases	  (PKA,	  PKG).	  In	  particular	  VASP	  phosphorylation	  occurs	  at	  Ser-­‐153,	  near	  EVH1-­‐PRD	  junction,	  and	  at	  two	  sites	  in	  EVH2	  (Ser-­‐235,	  Thr-­‐274).	  Mutation	  of	  any	  of	  PKA/PKG	  site	  has	  no	  effect	  on	  Ena/VASP	  localization,	  but	  if	  Mena	  is	  mutated	  in	  the	  serine	  flanking	  PRD	  (into	  alanine),	  fails	  to	  support	  normal	  motility	  [95].	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Figure	  6.	  The	  Ena/VASP	  family.	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to	  antigens,	  while	  in	  macrophages	  impairs	  phagocytosis.	  Filopodia	  fail	  to	  form	  in	  
Dictyostelium	  cells	  lacking	  VASP	  [98]	  and	  are	  severely	  reduced	  in	  neuronal	  cells	  lacking	  all	  the	  Ena/VASP	  family	  members	  [99].	  Also	  in	  fibroblast,	  VASP	  removal	  reduces	  filopodia	  formation,	  promoting	  instead	  lamellipodia	  assembly	  [100].	  In	  vitro	  purified	  Ena/VASP	  proteins	  stimulate	  actin	  nucleation,	  but	  at	  low	  and	  non	  physiological	  salt	  concentrations	  [101],	  however,	  EVL	  can	  reduce	  the	  lag	  phase	  in	  in	  
vitro	  actin	  polymerization	  assays	  at	  physiological	  salt	  concentrations.	  It	  has	  also	  been	  proposed	  that	  VASP	  can	  act	  as	  a	  bundling	  protein	  in	  vitro	  [101].	  Finally,	  EVH1:ABI1	  interaction	  acts	  cooperatively	  with	  Rac1	  to	  promote	  WAVE	  complex	  activation,	  and	  subsequently	  Arp2/3	  stimulation	  in	  vitro	  [91].	  	  In	  apparent	  contrast,	  Ena/VASP	  proteins	  have	  also	  been	  proposed	  to	  have	  a	  negative	  role	  in	  actin-­‐dependent	  processes:	  platelets	  isolated	  from	  VASP-­‐KO	  mice	  show	  an	  increased	  rate	  of	  collagen-­‐dependent	  platelet	  activation	  and	  fibroblast	  devoid	  of	  Ena/VASP	  proteins	  exhibit	  increased	  rates	  of	  cell	  motility	  [102].	  Moreover,	  neutralization	  of	  Ena/VASP	  in	  neurons	  caused	  neurons	  to	  migrate	  farther	  then	  normal	  neurons	  in	  neocortex	  [103].	  Finally,	  Ena/VASP	  deficient	  lamellipodia	  contain	  shorter	  and	  denser	  [100]	  branched	  actin	  filaments,	  that	  protrude	  slower	  but	  persist	  longer,	  causing	  cells	  to	  move	  faster.	  Additionally,	  other	  papers	  suggest	  an	  anti-­‐capping	  role,	  proposing	  that	  VASP	  is	  able	  to	  associate	  near	  the	  barbed	  ends	  of	  actin	  filaments	  and,	  in	  this	  way,	  antagonize	  CP	  [100].	  In	  Trichet	  et	  al.,	  2008	  [104],	  it	  is	  proposed	  that	  Ena/VASP	  could	  detach	  the	  actin	  cytoskeleton	  from	  the	  surface	  in	  which	  active	  actin	  polymerization	  occurs,	  due	  to	  its	  	  anti-­‐branching	  activity,	  which	  reduces	  the	  number	  of	  barbed	  ends	  growing	  towards	  the	  surface.	  Pasic	  et	  al.,	  2008	  [105],	  observed	  VASP-­‐mediated	  barbed	  end	  capture,	  without	  detecting	  acceleration	  of	  filament	  assembly,	  using	  a	  100	  mM	  KCl	  buffer	  (high	  ionic	  strength).	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The	  current	  view	  suggests	  that	  VASP	  is	  a	  processive	  actin	  elongator,	  that	  accelerates	  filament	  polymerization	  by	  delivering	  G-­‐actin	  to	  the	  barbed	  ends,	  if	  clustered	  on	  a	  surface	  [106].	  In	  solution,	  VASP	  accelerates	  F-­‐actin	  elongation	  in	  a	  concentration-­‐dependent	  manner,	  but	  it	  is	  inhibited	  by	  low	  doses	  of	  CP.	  In	  contrast,	  VASP	  clustered	  on	  functionalized	  (carboxylated)	  polystyrene	  beads,	  to	  mimic	  actin	  assembly	  on	  a	  surface,	  promotes	  processive	  filament	  elongation,	  which	  is	  insensitive	  to	  high	  CP	  concentrations.	  This	  suggests	  that	  VASP	  remains	  attached	  to	  the	  barbed	  ends	  and	  sterically	  prevents	  the	  interaction	  with	  CP.	  	  The	  effect	  of	  VASP-­‐coated	  beads	  on	  actin	  polymerization	  was	  analysed	  through	  TIRF	  (total	  internal	  reflection	  fluorescence)	  microscopy:	  fluorescence	  initially	  increases	  around	  the	  beads,	  due	  to	  fluorescent	  actin	  accumulation,	  then	  filaments	  start	  to	  grow.	  Two	  populations	  of	  filaments	  can	  be	  identified:	  one	  population	  growing	  at	  the	  same	  rate	  of	  control	  filaments,	  the	  other	  with	  higher	  elongation	  rate.	  These	  latter	  filaments,	  presumably	  assembled	  by	  VASP,	  also	  show	  buckling,	  meaning	  that	  the	  elongation	  of	  actin	  filaments	  is	  subjected	  to	  resistance,	  in	  other	  words	  barbed	  ends	  stayed	  attached	  to	  a	  fixed	  point,	  indicating	  a	  processive	  behavior	  of	  VASP	  [106].	  Note	  that	  these	  experiments	  were	  not	  made	  at	  the	  physiological	  salt	  concentration	  of	  50	  mM	  KCl.	  Profilin	  had	  not	  effect	  on	  actin	  polymerization	  from	  VASP-­‐coated	  beads,	  moreover,	  extensive	  buckling	  occurs	  only	  when	  VASP	  is	  close	  to	  saturation	  on	  beads	  surface.	  Processive	  filament	  elongation	  is	  seen	  in	  even	  presence	  of	  the	  mutants	  lacking	  (Δ)	  GAB	  or	  the	  tetramerization	  domain	  (only ΔGAB	  mutant	  produces	  less	  buckling	  filaments);	  while	  ΔFAB	  mutant	  is	  not	  able	  to	  perform	  elongation,	  in	  presence	  of	  high	  concentrations	  of	  CP	  short	  filaments	  detach	  from	  the	  beads,	  so	  FAB	  is	  critical	  for	  the	  anchorage	  of	  filaments	  to	  the	  beads	  surface,	  in	  the	  region	  immediately	  flanking	  the	  barbed	  ends.	  In	  cells,	  ΔFAB	  mutant	  fail	  to	  localize	  to	  filopodia	  tips	  and	  to	  trigger	  filopodia	  formation	  in	  VASP	  null	  cells,	  that	  present	  also	  defects	  in	  migration	  [106].	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Profilin-­‐PRD	  interaction	  is	  not	  required	  for	  filament	  elongation,	  in	  fact	  both	  VASP	  wild	  type	  (WT)	  and	  VASP-­‐ΔPRD	  elongate	  actin	  filaments	  at	  comparable	  levels,	  in	  presence	  or	  absence	  of	  profilin,	  even	  if	  VASP	  has	  higher	  affinity	  for	  profilin-­‐actin	  than	  actin	  alone	  [107].	  The	  model	  proposed	  in	  Breitspecher	  et	  al.,	  2008	  [106],	  suggests	  that	  VASP	  oligomers	  cluster	  to	  the	  plasma	  membrane,	  then	  use	  GAB	  and	  FAB	  domains	  to	  tether	  actin	  filaments	  and	  promote	  their	  processive	  elongation.	  In	  particular,	  VASP	  binds	  barbed	  ends	  and	  then	  stays	  attached	  to	  filament	  side	  while	  it	  continues	  to	  growth,	  by	  the	  addiction	  of	  G-­‐actin	  molecules	  delivered	  by	  other	  VASP	  proteins	  (Figure	  7).	  Decoration	  of	  barbed	  ends	  by	  multiple	  VASP	  molecules	  could	  prevent	  CP	  access	  to	  the	  barbed	  ends.	  	  
	  
Figure	  7.	  Model	  for	  VASP	  processive	  elongation	  activity.	  	  
When	  clustered	  on	  a	  surface,	  VASP	  acts	  as	  a	  processive	  elongator	  1)	  VASP	  tetramers	  tethered	  to	  the	  surface	  bind	  actin	  and	  deliver	  monomers	  to	  the	  barbed	  end,	  using	  GAB	  and	  FAB	  domains.	  (2)	  VASP	  remains	  bound	  to	  the	  side	  of	  the	  filament,	  as	  it	  elongates	  by	  other	  VASP	  molecules.	  (3)	  Stretched	  VASP	  molecules	  eventually	  detach	  from	  the	  filament,	  due	  to	  its	  continuous	  elongation,	  and	  are	  then	  available	  for	  a	  new	  cycle	  of	  actin	  addition.	  During	  the	  detachment	  period,	  the	  growing	  filament	  is	  constantly	  tethered	  to	  the	  surface	  by	  other	  VASP	  molecules,	  that	  also	  prevent	  access	  of	  CP	  to	  the	  filament	  barbed	  end	  (modified	  from	  Breitspecher	  et	  al.,	  2008	  [106]).	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Later	  observations,	  reported	  in	  Hansen	  et	  al.,	  2010	  [93],	  describe	  three	  binding	  modes	  for	  VASP	  tetramers:	  1)	  static	  side	  binding,	  2)	  side	  binding	  with	  one-­‐dimensional	  diffusion	  (mainly	  contributed	  by	  FAB)	  and	  3)	  processive	  barbed	  end	  tracking	  (in	  50	  mM	  ionic	  buffer),	  that	  is	  enhanced	  by	  the	  presence	  of	  profilin.	  Contrary	  to	  Breitspecher	  et	  al.,	  2008	  [106],	  using	  TIRF	  microscopy	  they	  rarely	  observe	  VASP	  transition	  from	  barbed	  ends	  to	  lateral	  side:	  VASP	  dissociated	  directly	  from	  barbed	  ends,	  while	  molecules	  from	  solution	  frequently	  bind	  filament	  sides.	  The	  model	  proposed	  [93]	  is	  then	  slightly	  changed:	  GAB	  binds	  actin	  monomer,	  if	  FAB	  allows	  VASP	  binding	  enough	  close	  to	  the	  barbed	  ends,	  actin	  is	  included	  in	  the	  growing	  filament	  and	  GAB	  contributes	  to	  filament	  binding.	  Since	  GAB	  affinity	  for	  G-­‐actin	  is	  higher	  than	  the	  affinity	  for	  filament	  side,	  if	  another	  G-­‐actin	  is	  available	  it	  will	  be	  captured	  by	  GAB	  in	  an	  additional	  cycle	  of	  polymerization.	  In	  a	  VASP	  tetramer,	  multiple	  GAB	  near	  the	  barbed	  ends	  further	  increase	  G-­‐actin	  capture	  and	  consequently	  filament	  elongation	  rate.	  Recently,	  it	  has	  been	  observed	  that	  lamellipodin,	  beside	  recruiting	  Ena/VASP	  proteins	  to	  the	  plasma	  membrane,	  also	  promotes	  VASP	  clustering	  and	  simultaneously	  interacts	  directly	  with	  actin	  filaments.	  The	  combination	  of	  these	  activities,	  in	  turn,	  increases	  the	  delivery	  of	  Ena/VASP	  proteins	  to	  the	  barbed	  ends	  and	  promotes	  VASP	  processive	  elongation	  activity	  [108].	  	  
IRSp53:	  protein	  at	  the	  interface	  between	  
membrane	  and	  actin	  
Proteins	  that	  sit	  at	  the	  membrane-­‐actin	  interface	  are	  in	  a	  critical	  position	  to	  couple	  forces	  generated	  by	  actin	  polymerization	  machinery	  and	  membrane	  deformations.	  The	  I-­‐BAR	  containing	  protein	  IRSp53	  is	  one	  of	  these	  key	  proteins,	  and	  will	  be	  extensively	  analysed	  in	  this	  thesis.	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IRSp53,	  known	  also	  as	  BAIAP2	  (Brain-­‐specific	  angiogenesis	  inhibitor	  1-­‐associated	  protein	  2),	  has	  been	  identified	  in	  a	  screen	  for	  substrates	  of	  insulin	  and	  insulin-­‐like	  growth	  factor	  1,	  that	  are	  capable	  of	  phosphorylating	  it	  on	  tyrosine	  residues.	  IRSp53	  is	  widely	  expressed	  in	  different	  tissues	  in	  mammals,	  as	  spleen,	  lung,	  liver,	  testis,	  but	  is	  enriched	  in	  brain,	  in	  particular	  in	  cortex,	  hippocampus,	  striatum	  and	  cerebellum	  [109]	  [110]	  [111].	  	  IRSp53	  is	  abundant	  in	  postsynaptic	  density	  (PSD,	  multi-­‐protein	  complexes	  in	  the	  postsynaptic	  side	  of	  excitatory	  synapses,	  that	  couple	  receptor	  activation	  with	  downstream	  signalling)	  and	  regulates	  actin-­‐rich	  dendritic	  spines.	  IRSp53	  is	  enriched	  during	  the	  first	  three	  weeks	  of	  postnatal	  brain	  development,	  when	  active	  synaptogenesis	  occur.	  Not	  surprisingly,	  IRSp53	  KO	  mice	  display	  enhanced	  NMDAR	  (N-­‐methyl-­‐D-­‐aspartate	  receptor)	  function,	  defects	  in	  learning,	  memory,	  synaptic	  plasticity,	  social	  and	  cognitive	  defects,	  despite	  no	  obvious	  structural	  defects	  being	  apparent	  in	  dendritic	  spines	  from	  their	  brain	  [110]	  [112].	  	  Actin	  filaments	  in	  IRSp53	  KO	  hippocampal	  neurons	  are	  abnormally	  stable,	  which	  may	  promote	  synaptic	  localization	  of	  NMDAR	  and	  suppress	  their	  activity-­‐dependent	  removal	  (cofilin	  resistance);	  mice	  lacking	  EPS8	  and	  WAVE1,	  two	  IRSp53	  interactors,	  also	  show	  altered	  NMDAR	  function	  [113].	  Moreover,	  lens-­‐retina	  inter-­‐epithelial	  filopodium	  formation	  is	  impaired	  in	  IRSp53	  KO	  mice	  [114].	  In	  humans,	  IRSp53	  has	  been	  implicated	  in	  diverse	  psychiatric	  disorders:	  autism	  spectrum	  disorder,	  schizophrenia,	  attention	  deficit/hyperactivity	  disorder	  [112].	  	  IRSp53	  protein	  contains	  different	  domains,	  that	  will	  be	  reviewed	  in	  the	  next	  subchapters	  (Figure	  8).	  Different	  IRSp53	  isoforms	  exist,	  called	  S-­‐	  L-­‐	  M-­‐	  T-­‐,	  differentiated	  by	  their	  C-­‐termini	  [9].	  Isoform	  S	  is	  the	  sorter,	  it	  contains	  a	  PDZ	  (PSD95-­‐DLG1-­‐ZO-­‐1)-­‐binding	  domain,	  while	  M	  and	  L	  isoforms	  contain	  a	  WH2-­‐like	  motif	  (with	  actin-­‐binding	  function),	  isoform	  T	  role	  is	  unclear,	  it	  lacks	  both	  the	  PDZ-­‐binding	  and	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the	  WH2-­‐like	  domains.	  Isoforms	  S	  and	  L	  are	  phosphorylated	  by	  insulin	  stimulation,	  T	  by	  IGF-­‐1	  stimulation.	  
	  
Figure	  8.	  The	  structure	  of	  IRSp53.	  
IRSp53	  S	  isoform:	  it	  contains	  I-­‐BAR	  domain,	  CRIB-­‐PR	  domain,	  SH3	  domain,	  WW-­‐binding	  domain,	  PDZ-­‐binding	  domain	  (modified	  from	  Kast	  et	  al.,	  2014	  [115]).	  	  
I-­‐BAR	  domain	  The	  I-­‐BAR	  domain,	  at	  IRSp53	  N-­‐terminus,	  has	  been	  reported	  to	  be	  able	  to	  bind	  Kank	  [116],	  Tir	  (required	  for	  pedestral	  formation	  in	  enterohemorragic	  E.	  coli	  infection)	  [117],	  Rac1	  (when	  GTP	  bound,	  with	  a	  Kd	  of 3.2	  μM)	  [118]	  and	  synaptopodin	  [119].	  However,	  the	  most	  relevant	  function	  of	  this	  domain	  is	  linked	  to	  its	  dimeric	  structure	  and	  ability	  to	  bind	  and	  sense	  membrane	  curvature	  [120]	  [121].	  Indeed,	  I-­‐BAR	  domain	  belongs	  to	  the	  bigger	  family	  of	  BAR	  (Bin-­‐Amphiphysin-­‐Rvs167)	  domains.	  More	  then	  50	  types	  of	  BAR	  proteins	  are	  present	  in	  humans	  that	  are	  able	  to	  generate	  membrane	  deformation.	  BAR-­‐containing	  proteins	  also	  possess	  protein-­‐binding	  modules,	  consequently	  they	  can	  work	  as	  platforms	  to	  allow	  a	  unique	  coordination	  of	  complex	  processes,	  such	  as	  endocytosis,	  migratory	  protrusion,	  epithelial	  morphogenesis.	  It	  has	  been	  hypothesized	  that	  different	  BAR	  proteins,	  generating	  a	  variety	  of	  membrane	  deformations,	  can	  adapt	  and	  bind	  to	  all	  the	  different	  membrane	  topologies	  that	  are	  formed	  during	  endocytosis:	  from	  the	  low	  curvature	  membrane	  invaginations	  to	  vesicles	  fission	  [6]	  [122].	  The	  BAR	  domain	  was	  identified	  in	  Bin1	  and	  Aphiphysin,	  it	  can	  induce	  membrane	  tubulation	  in	  vitro	  [123].	  Its	  crystal	  structure	  [124]	  revealed	  a	  banana-­‐shaped	  dimer,	  formed	  by	  three	  kinked	  antiparallel	  alpha	  helices	  for	  each	  monomer,	  creating	  a	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concave	  surface	  able	  to	  bind	  negatively	  charged	  membranes.	  For	  this	  reason,	  it	  induces	  positive	  membrane	  curvature	  and	  is	  usually	  involved	  in	  membrane	  invaginations.	  Moreover,	  the	  BAR	  domain	  induce	  homodimerization	  of	  the	  protein	  [5].	  	  BAR	  family	  comprises	  members	  with	  different	  geometrical	  properties:	  N-­‐BAR,	  F-­‐BAR,	  I-­‐BAR	  domains	  (Figure	  9).	  Less	  common	  are	  BAR-­‐PH,	  in	  which	  BAR	  is	  associated	  with	  a	  PH	  (pleckstrin	  homology)	  domain,	  and	  PX-­‐BAR,	  associated	  with	  PX	  (phox	  homology)	  domain,	  present	  in	  certain	  protein	  of	  the	  sorting	  nexin	  family.	  Both	  PH	  and	  PX	  domains	  can	  bind	  various	  phosphoinositides,	  but	  may	  also	  be	  involved	  in	  protein–protein	  interactions,	  adding	  specificity	  to	  BAR	  protein	  function	  and	  localization.	  	  
	  
Figure	  9.	  Structure	  and	  geometrical	  properties	  of	  selected	  BAR	  family	  proteins.	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first	  to	  be	  solved.	  Amphiphysin	  contains	  also	  a	  SH3	  domain	  able	  to	  bind	  dynamin	  and	  N-­‐WASP,	  it	  has	  been	  hypothesized	  that	  this	  protein	  acts	  in	  the	  later	  stages	  of	  fission	  for	  clathrin-­‐mediated	  endocytosis.	  	  *	  F-­‐BAR	  (FCH-­‐BAR,	  Fes/CIP4	  homology	  BAR,	  or	  also	  EFC,	  extended	  Fes-­‐CIP4	  homology)	  subfamily	  comprises	  Toca-­‐1,	  FBP17,	  CIP4,	  Fes.	  F-­‐BAR	  is	  “banana”-­‐shaped	  dimer,	  but	  more	  extended	  in	  comparison	  to	  the	  others	  BAR	  domains,	  it	  contains	  5	  α	  -­‐helices	  per	  monomer	  and	  induces	  curvature	  with	  larger	  diameter.	  It	  has	  been	  hypothesized	  that	  these	  proteins	  correspond	  to	  the	  curvature	  of	  the	  initial	  stages	  of	  clathrin-­‐coated	  pits.	  F-­‐BAR	  self-­‐assemble	  into	  a	  helical	  coat	  around	  the	  membrane	  tubules,	  for	  F-­‐BAR	  it	  is	  known	  that	  they	  form	  both	  end-­‐to-­‐end	  and	  lateral	  homointeractions	  [125].	  Of	  note,	  in	  mammals	  srGAP	  1-­‐3	  (slit-­‐robo	  GAP)	  exist,	  which	  possess	  F-­‐BAR	  domains	  that	  promote	  plasma	  membrane	  protrusions,	  instead	  of	  invaginations.	  *	  I-­‐BAR	  domain	  (inverse-­‐BAR,	  also	  IMD,	  IRSp53-­‐MIM	  homology	  domain)	  binds	  phosphoinoside-­‐rich	  vesicles	  with	  high	  affinity,	  in	  particular	  binds	  liposomes	  enriched	  in	  PIP2	  (content	  major	  than	  5-­‐10%)	  [120],	  the	  most	  abundant	  phosphoinositol	  in	  the	  cytosolic	  leaflet	  of	  the	  plasma	  membrane.	  I-­‐BAR	  is	  able	  to	  deform	  membrane	  into	  tubular	  structures	  [120],	  binding	  their	  internal	  leaflet	  [126].	  Moreover,	  I-­‐BAR	  domain	  induces	  PIP2	  clustering	  at	  the	  membrane	  [126].	  In	  presence	  of	  artificial	  liposomes,	  I-­‐BAR	  binds	  their	  outer	  leaflet	  and	  generates	  membrane	  invaginations,	  in	  contrast,	  N-­‐BAR	  domain	  induced	  long	  outward	  protrusions	  of	  smaller	  diameter	  [120].	  	  I-­‐BAR,	  and	  IRSp53,	  overexpression	  in	  cells	  induces	  actin	  containing	  filopodia-­‐like	  protrusions,	  requiring	  F-­‐actin	  binding	  and	  PIP2	  binding	  [127]	  [120].	  I-­‐BAR	  induced	  protrusion	  are	  frequently	  characterized	  by	  the	  presence	  of	  aberrant	  actin	  aggregates,	  and	  a	  lifetime	  of	  more	  than	  10	  minutes	  [20],	  but	  are	  positive	  for	  filopodial	  marker,	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such	  as	  fascin,	  VASP	  and	  myosin	  X	  [126].	  The	  substitution	  of	  the	  I-­‐BAR	  terminal	  loop	  residues	  K142,143,146,147	  to	  glutamic	  acid	  (4K	  I-­‐BAR	  mutant)	  does	  not	  really	  affect	  the	  global	  conformation	  of	  the	  dimer,	  but	  the	  overexpression	  of	  this	  mutant	  in	  COS7	  cells	  abrogates	  filopodia	  formation	  (as	  ΔI-­‐BAR	  mutant	  overexpression)	  [128].	  Even	  if	  I-­‐BAR	  was	  proposed	  to	  be	  a	  bundling	  domain	  [127],	  in	  physiological	  salt	  conditions	  it	  does	  not	  possess	  a	  strong	  crosslinking	  activity:	  the	  previously	  reported	  actin	  bundling	  activity	  appears	  to	  result	  from	  protein	  aggregation	  in	  low	  salt	  buffers	  [120].	  	  
I-­‐BAR	  containing	  proteins	  I-­‐BAR	  proteins	  are	  present	  in	  lower	  eukaryotes,	  such	  as	  Dictyostelium,	  but	  not	  in	  yeast.	  In	  mammals,	  I-­‐BAR	  containing	  proteins	  can	  be	  divided	  in	  two	  evolutionary	  diverged	  subfamilies:	  the	  first	  including	  MIM	  (Missing-­‐in-­‐metastasis)	  and	  ABBA	  (Actin-­‐bundling	  protein	  with	  BAIAP2	  homology);	  the	  second	  instead	  comprises	  IRSp53,	  IRTK	  (Insulin	  Receptor	  Tyrosine	  Kinase	  substrate,	  also	  BAIAP2L1,	  BAIAP2-­‐like	  protein	  1)	  and	  PINKBAR	  (Planar	  intestinal	  and	  kidney-­‐specific	  BAR	  domain	  protein,	  or	  BAIAP2L2,	  BAIAP2-­‐like	  protein	  2)	  (Figure	  10).	  Tubules	  induced	  by	  MIM	  and	  ABBA	  are	  thicker	  in	  comparison	  to	  the	  ones	  induced	  by	  the	  other	  group.	  In	  fact,	  MIM	  and	  ABBA	  possess	  a	  critical	  11	  amino	  acids	  N-­‐terminal	  helix,	  that	  inserts	  into	  the	  acyl	  chain	  region	  of	  the	  bilayer,	  absent	  in	  IRSp53	  and	  IRTK.	  MIM	  and	  ABBA	  are	  also	  more	  efficient	  in	  inducing	  filopodia	  in	  cells	  and	  contain	  an	  actin-­‐binding	  WH2	  domain	  [126].	  	  IRTK	  is	  closer	  to	  IRSp53,	  it	  is	  expressed	  at	  low	  levels	  in	  brain,	  but	  present	  in	  liver,	  bladder,	  testes,	  heart,	  lung.	  IRTK	  binds	  the	  small	  GTPase	  Rac	  and	  induces	  clusters	  of	  short	  actin	  bundles	  [129].	  More	  peculiar	  is	  PINKBAR:	  it	  possesses	  a	  shorter	  I-­‐BAR	  domain	  (164	  amino	  acids	  long,	  in	  comparison	  to	  IRSp53	  I-­‐BAR,	  which	  is	  long	  182	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amino	  acids)	  that,	  due	  to	  its	  flat	  arrangement,	  deforms	  membrane	  into	  planar	  structures.	  PINKBAR	  is	  expressed	  predominantly	  in	  intestinal	  and	  kidney	  epithelial	  cells,	  it	  interacts	  with	  PIP2-­‐rich	  vesicles	  through	  electrostatic	  interactions	  [130].	  
	  
Figure	  10.	  The	  I-­‐BAR	  family.	  	  
Domain	  structures	  of	  mammalian	  I-­‐BAR	  containing	  proteins:	  subfamily	  1,	  including	  MIM	  and	  ABBA;	  subfamily	  2,	  including	  IRSp53,	  IRTK,	  PINKBAR	  (I-­‐BAR:	  I-­‐BAR	  domain,	  WH2:	  WH2	  domain,	  SH3:	  SH3	  domain,	  PPPP:	  proline-­‐rich	  region,	  Serine	  rich:	  serine-­‐rich	  region,	  CRIB:	  CRIB	  domain,	  WWB:	  WW	  binding	  domain)	  (modified	  from	  Zhao	  et	  al.,	  2011,	  [131]).	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The	  extreme	  ends	  of	  the	  dimer	  present	  a	  strong	  positive	  charge	  (on	  the	  N-­‐terminal	  side),	  and	  correspond	  to	  PIP2	  binding	  site,	  elsewhere	  charge	  distribution	  is	  even,	  with	  a	  slightly	  prevailing	  positive	  charges.	  	  
	  
Figure	  11.	  Structure	  of	  the	  I-­‐BAR	  domain	  from	  IRSp53.	  	  
A	  Two	  orthogonal	  views	  of	  the	  I-­‐BAR	  dimer	  in	  ribbon	  representation.	  The	  helices	  are	  colour	  ramped	  blue	  to	  green	  (chain	  A)	  and	  yellow	  to	  red	  (chain	  B).	  Vertical	  dashed	  lines	  indicate	  the	  core	  region	  of	  the	  dimer.	  	  
B	  Structure	  of	  amphiphysin	  BAR	  domain,	  indicated	  for	  comparison	  with	  A.	  Note	  that	  I-­‐BAR	  dimer	  is	  flatter	  than	  amphiphysin	  BAR	  domain	  (modified	  from	  Millard	  et	  al.,	  2005	  [128]).	  	  I-­‐BAR	  domain	  possesses	  an	  extensive	  dimer	  interface,	  which	  is	  solvent	  accessible:	  it	  encloses	  a	  cavity	  that	  contains	  several	  water	  molecules.	  Hydrophobic	  and	  polar	  surfaces	  contribute	  to	  nearly	  equally	  to	  the	  contact	  surface,	  which	  involves	  all	  the	  four	  helices	  [128]	  [132].	  Dimerization	  of	  the	  proteins	  has	  been	  also	  confirmed	  by	  sedimentation	  velocity	  experiments	  [128]	  and	  coimmunoprecipitation	  approaches	  [127].	  I-­‐BAR	  signature	  sequence	  [127]	  ALXEE[R/K][R/G]RFCX0-­‐1F[I/L]	  is	  mostly	  buried	  in	  the	  dimer,	  with	  the	  EERRR	  core	  segment	  making	  contacts	  with	  the	  other	  conserved	  parts	  in	  the	  opposite	  monomer.	  The	  I-­‐BAR	  domain	  displays	  a	  convex	  geometry,	  thus	  generating	  negative	  membrane	  curvatures,	  through	  a	  scaffolding	  mechanism:	  the	  protein	  domain	  has	  a	  rigid	  surface	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with	  an	  intrinsic	  curvature	  that	  forces	  membrane	  to	  adopt	  a	  similar	  conformation	  (Figure	  12).	  Moreover,	  positive	  residues	  over	  the	  I-­‐BAR	  surface	  fit	  well	  with	  negatively	  charged	  lipids	  that	  BAR	  selects	  for	  binding.	  	  I-­‐BAR	  domain	  is	  able	  both	  to	  sense	  and	  generate	  membrane	  curvature.	  Using	  proteins	  encapsulated	  in	  GUV	  (giant	  unilamellar	  vesicles),	  from	  which	  membrane	  tubes	  of	  controlled	  radius	  are	  pulled,	  it	  has	  been	  demonstrated	  that	  I-­‐BAR	  dimers	  can	  sense	  membrane	  curvature,	  in	  fact	  I-­‐BAR	  is	  enriched	  on	  membrane	  portions	  with	  an	  induced	  negative	  curvature	  [121].	  Additionally,	  I-­‐BAR	  encapsulated	  in	  GUVs	  can	  generate	  membrane	  tubes,	  if	  concentrated	  enough:	  it	  reduces	  the	  force	  needed	  to	  sustain	  and	  stabilize	  the	  tubules.	  Tubulation	  induced	  by	  I-­‐BAR	  proteins	  seems	  to	  be	  concentration-­‐dependent,	  suggesting	  that	  I-­‐BAR	  dimers	  can	  associate	  into	  high	  order	  oligomers	  [120]	  [133].	  
	  
Figure	  12.	  Model	  of	  I-­‐BAR	  localization	  in	  membrane	  protrusions,	  such	  as	  filopodia.	  	  
I-­‐BAR	  binds	  to	  the	  inner	  surface	  of	  the	  protruding	  membrane,	  a	  spiral	  arrangement	  is	  hypothesized	  for	  the	  domains	  (modified	  from	  Suetsugu	  et	  al.,	  2010	  [5]).	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[134].	  The	  partial	  CRIB-­‐like	  region	  is	  followed	  by	  a	  proline-­‐rich	  region,	  together	  indicated	  as	  CRIB-­‐PR.	  CRIB-­‐PR	  is	  specifically	  adapted	  to	  bind	  active	  CDC42	  and	  not	  Rac,	  probably	  because	  only	  few	  residues	  are	  shared	  with	  canonic	  CRIB	  domains,	  while	  the	  region	  in	  which	  CRIB-­‐PR	  diverge	  from	  canonical	  CRIB	  binds	  the	  portion	  of	  CDC42	  that	  highly	  differs	  from	  Rac.	  Moreover,	  the	  PR	  portion	  of	  the	  domain	  is	  able	  to	  bind	  switchI-­‐switchII	  region	  of	  CDC42,	  that	  undergoes	  conformational	  change	  in	  response	  to	  the	  nucleotide	  binding:	  PR	  is	  thus	  involved	  in	  CDC42	  binding	  and	  is	  important	  for	  nucleotide-­‐state	  sensing	  [115].	  Since	  CDC42	  contains	  prenylated	  residues	  that	  tether	  it	  to	  the	  plasma	  membrane,	  both	  I-­‐BAR	  and	  CRIB	  domain	  are	  involved	  in	  membrane	  localization	  of	  IRSp53.	  IRSp53	  mutant	  in	  the	  CRIB	  region	  is	  no	  longer	  able	  to	  induce	  neuritis	  (extensive	  lamellipodium,	  filopodium	  and	  ruffles)	  in	  N1E115	  mouse	  neuroblastoma	  cells	  [135].	  	  	  
SH3	  IRSp53	  SH3	  domain	  binds	  to	  the	  proline-­‐rich	  sequences	  of	  a	  number	  of	  actin-­‐related	  and	  neuronal	  proteins:	  WAVE2	  [136],	  WAVE1	  [20],	  N-­‐WASP	  [20],	  Mena	  [137],	  EPS8	  (EPS8/ABI1/SOS1)	  [138],	  Shank3	  [111],	  Shank1	  [109]	  [139],	  SH2B1	  [140],	  NESH	  [141],	  espin	  [142],	  SPIN90	  [143],	  DRPLA/atrophin-­‐1	  [144],	  BAI1	  [145],	  EspFU	  [117],	  IQ-­‐ArfGEF/BRAG1	  [146],	  WIRE	  [147],	  huntigtin	  [148],	  cypin	  [149],	  synaptopodin	  [119],	  mDia	  [150]	  [20],	  dynamin1	  [151].	  For	  this	  reason,	  IRSp53	  can	  be	  seen	  as	  an	  adaptor,	  that	  allows	  the	  recruitment	  of	  protein	  complexes	  (using	  its	  SH3	  domain)	  to	  specific	  sites	  along	  the	  membrane	  (bounded	  through	  its	  I-­‐BAR	  domain).	  	  SH3	  interactors	  are	  implicated	  in	  different	  biological	  processes.	  For	  example,	  Mena,	  EPS8	  and	  mDia	  have	  been	  linked	  to	  filopodia	  formation,	  while	  WAVE	  proteins	  are	  connected	  to	  lamellipodia	  extension	  [9].	  Additionally,	  Shank	  proteins	  are	  postsynaptic	  scaffolding	  proteins	  that	  regulate	  spine	  morphogenesis	  [109]	  [111].	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Active	  CDC42	  can	  induce	  filopodia	  even	  alone,	  but	  in	  combination	  with	  IRSp53	  or	  IRSp53	  SH3	  mutant	  (W413R	  or	  F428A/P429A)	  allow	  the	  formation	  of	  even	  longer	  filopodia	  [137].	  The	  region	  between	  CRIB-­‐PR	  and	  SH3	  contains	  several	  phosphorylation	  sites,	  involved	  in	  Tiam1	  and	  14-­‐3-­‐3	  binding.	  When	  14-­‐3-­‐3	  binds	  IRSp53,	  the	  protein	  is	  maintained	  inactive	  in	  the	  cytoplasm	  and	  the	  interaction	  with	  SH3	  binders	  of	  IRSp53	  is	  abrogated	  [152]	  [153].	  	  
	  
C-­‐terminus	  As	  introduced	  previously,	  the	  very	  C-­‐terminal	  portion	  of	  IRSp53	  differs	  among	  the	  different	  isoforms.	  Isoform	  S	  contains	  a	  PDZ-­‐binding	  motif	  that	  binds	  CIPP	  [154],	  LIN7	  (or	  MALS)	  [155],	  PSD-­‐95	  [156],	  PSD-­‐93/Chapsyn-­‐110	  [156],	  SAP97	  [155],	  SAP102	  [155],	  S-­‐SCAM	  [155].	  Through	  its	  PDZ-­‐binding	  domain,	  IRSp53	  can	  participate	  to	  big	  scaffolding/signalling	  complexes	  in	  PSD.	  M	  and	  L	  isoforms	  instead	  possess	  a	  WH2	  domain.	  It	  is	  dissimilar	  to	  canonical	  WH2	  domain	  and	  has	  unclear	  functions.	  The	  C-­‐terminal	  portion	  of	  WH2	  is	  very	  similar	  to	  MIM	  WH2,	  while	  the	  N-­‐terminal	  portion	  possesses	  a	  non-­‐canonical	  sequence	  [9].	  
	  
Conformational	  changes	  of	  IRSp53	  An	  intramolecular	  interaction	  between	  IRSp53	  N-­‐terminus	  and	  C-­‐terminus	  has	  been	  proposed	  since	  2001	  [137],	  through	  a	  co-­‐immunoprecipitation	  approach,	  but	  it	  has	  been	  formally	  demonstrated	  to	  occur	  just	  recently	  using	  a	  FRET	  approach	  in	  Kast	  et	  al.,	  2014	  [115].	  IRSp53	  adopts	  a	  “closed”/inactive	  conformation,	  involving	  the	  reciprocal	  binding	  of	  CRIB-­‐PR	  and	  SH3	  domains;	  IRSp53	  opens	  upon	  active	  CDC42	  binding	  to	  CRIB-­‐PR	  region	  and	  the	  subsequent	  binding	  of	  one	  effector	  to	  the	  SH3	  domain	  (Figure	  13).	  The	  release	  of	  this	  intramolecular	  interaction	  is	  synergistic,	  in	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fact	  the	  conformational	  changes	  induced	  by	  CDC42	  and	  SH3	  binders	  are	  different	  in	  nature	  but	  have	  an	  additive	  character:	  both	  the	  interactors	  can	  bind	  simultaneously	  to	  IRSp53	  and	  additively	  modify	  its	  structure	  to	  full	  activate	  it	  in	  an	  “open”	  conformation	  [115].	  
	  
Figure	  13.	  Model	  for	  IRSp53	  activation.	  	  
In	  the	  autoinhibited	  state,	  IRSp53	  is	  in	  a	  “closed”	  conformation,	  due	  to	  an	  intramolecular	  interaction	  between	  CRIB-­‐PR	  and	  SH3	  domains.	  IRSp53	  activation	  requires	  the	  combinatorial	  binding	  of	  GTP-­‐CDC42	  and	  SH3	  effectors	  (modified	  from	  Kast	  et	  al.,	  2014	  [115]).	  	  In	  Kast	  et	  al.,	  2014,	  the	  crystal	  structure	  of	  CDC42	  bound	  to	  CRIB-­‐PR	  allowed	  also	  the	  description	  of	  IRSp53	  mutants	  in	  the	  CRIB-­‐PR	  region,	  able	  to	  decouple	  its	  interaction	  with	  CDC42	  and	  the	  SH3	  domain,	  in	  particular	  I267A/S268A	  mutant	  failed	  to	  bind	  CDC42	  (constitutively	  inactive	  mutant),	  while	  P278D/P281D	  mutant	  failed	  to	  form	  the	  intramolecular	  interaction	  with	  the	  SH3	  domain	  (“open”	  mutant)	  [115].	  	  
IRSp53	  cellular	  functions	  IRSp53	  is	  a	  scaffolding	  protein	  enriched	  at	  the	  plasma	  membrane.	  It	  participates	  in	  processes	  as	  neurite	  extension,	  dendritic	  spine	  morphogenesis,	  cell	  motility,	  tumor	  invasion,	  cell	  polarity,	  eye	  lens	  formation,	  myogenic	  differentiation	  and	  pathogen	  invasion	  [9].	  IRSp53	  is	  involved	  in	  the	  formation	  of	  lamellipodia	  [135]	  [137]	  [127]	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and	  filopodia	  [157]	  [158],	  and	  localizes	  at	  tips	  of	  both	  these	  structures;	  GFP-­‐IRSp53	  is	  absent	  from	  cell	  edges	  undergo	  retraction	  [159].	  IRSp53	  acts	  in	  filopodia	  formation	  downstream	  of	  CDC42	  signalling,	  working	  synergistically	  with	  Mena	  [137].	  Synaptopodin,	  an	  actin-­‐associated	  protein	  that	  has	  been	  linked	  also	  to	  synaptic	  plasticity,	  binds	  directly	  to	  IRSp53	  and	  suppresses	  CDC42-­‐IRSp53-­‐Mena	  initiated	  formation	  of	  filopodia	  in	  kidney	  podocytes	  [119].	  IRSp53	  failed	  to	  induce	  filopodia	  formation	  in	  N-­‐WASP	  KO	  fibroblasts,	  as	  well	  as	  in	  Ena/Mena/VASP	  KO	  cells	  [20].	  Similarly,	  it	  has	  been	  observed	  that	  IRSp53	  overexpression,	  in	  combination	  with	  the	  sequestering	  of	  VASP	  family	  proteins	  away	  from	  the	  plasma	  membrane,	  causes	  a	  reduction	  of	  filopodia	  formation	  in	  cells	  [160].	  Moreover,	  in	  presence	  of	  an	  excess	  of	  IRSp53,	  VASP	  has	  an	  increased	  capacity	  to	  bundle	  actin	  filaments	  in	  in	  vitro	  bulk	  experiments	  [161].	  Formation	  of	  filopodia	  precedes	  the	  formation	  of	  dendrites	  and	  axons;	  it	  has	  been	  proposed	  that	  IRSp53	  can	  recruit	  SH2B1,	  a	  scaffolding	  protein	  that	  interacts	  with	  several	  neurotrophin	  receptors	  and	  regulates	  signalling	  and	  gene	  expression,	  IRSp53:SH2B1	  complex	  can	  enhance	  the	  formation	  of	  filopodia	  and	  dendrites	  of	  hippocampal	  and	  cortical	  neurons	  [140].	  Primary	  cultured	  neurons	  from	  IRSp53	  null	  mice	  show	  changes	  in	  morphology:	  a	  reduction	  in	  primary	  dendrites	  and	  dendritic	  branches	  and	  a	  delayed	  formation	  of	  post	  synaptic	  clusters.	  IRSp53	  overexpression	  in	  cultured	  hippocampal	  neurons,	  on	  the	  other	  hand,	  increases	  spine	  density	  and	  size	  [111].	  IRSp53	  N-­‐terminus	  binds	  Ras	  (in	  a	  domain	  distinct	  from	  CRIB)	  and,	  through	  the	  SH3	  domain,	  to	  WAVE2	  proline-­‐rich	  region,	  this	  complex	  is	  involved	  in	  membrane	  ruffling	  and	  lamellipodia	  formation	  [157].	  Tiam1	  (a	  Rac-­‐GEF)	  enhances	  the	  signalling	  of	  IRSp53-­‐WAVE2	  axis,	  promoting	  IRSp53:Rac-­‐GTP	  bound:WAVE2	  complex	  [162].	  Moreover,	  IRSp53	  KD	  inhibits	  lamellipodia	  formation	  [163].	  Also	  in	  macrophages,	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IRSp53,	  WAVE2	  and	  ABI1	  are	  required	  for	  CSF-­‐1	  dependent	  actin	  remodeling,	  involved	  in	  cell	  migration	  and	  formation	  of	  protrusions,	  but	  not	  in	  podosome/filopodia	  formation	  nor	  phagocytosis,	  requiring	  a	  mechanism	  more	  complex	  than	  simple	  WAVE2	  relocalization	  to	  the	  membrane	  [164].	  	  IRSp53	  is	  involved,	  as	  IRTK,	  in	  the	  formation	  of	  actin	  pedestals:	  actin-­‐rich	  membrane	  protrusions,	  developed	  during	  enterohemorragic	  E.	  coli	  infections.	  The	  major	  binder	  of	  IRSp53	  in	  fibroblasts	  and	  cancer	  cells	  is	  EPS8;	  IRSp53	  interaction	  with	  EPS8	  enhances	  EPS8-­‐ABI1-­‐SOS1	  signalling	  to	  Rac1,	  promoting	  motility	  and	  invasiveness	  of	  the	  malignant	  tumor	  cells	  [138].	  The	  affinity	  between	  IRSp53	  and	  EPS8	  is	  in	  the	  nanomolar	  range,	  their	  interaction	  is	  mediated	  by	  IRSp53	  SH3	  domain	  and	  two	  distinct	  N-­‐terminal	  proline-­‐rich	  sequences	  in	  EPS8	  [138],	  their	  association	  is	  constitutive	  and	  does	  not	  require	  stimulation	  by	  growth	  factors	  [160].	  	  EPS8:IRSp53	  complex	  localization	  is	  regulated	  by	  CDC42.	  In	  cells,	  the	  concomitant	  expression	  of	  IRSp53	  and	  EPS8	  enhances	  IRSp53	  protrusive	  activity,	  promoting	  the	  formation	  of	  long	  and	  branched	  protrusion,	  which	  were	  not	  observed	  in	  presence	  of	  I-­‐BAR	  only	  or	  EPS8	  alone	  [160].	  In	  vitro,	  EPS8	  bundling	  activity	  is	  synergistically	  enhanced	  by	  the	  presence	  of	  full-­‐length	  IRSp53,	  but	  not	  ΔI-­‐BAR	  IRSp53	  mutant.	  In	  neurons	  Shank	  competes	  with	  EPS8	  for	  IRSp53	  binding,	  abrogating	  the	  bundling	  function	  of	  the	  complex	  [111].	  
Further	  roles	  of	  IRSp53	  in	  junctions	  assembly	  
and	  cell	  polarity	  
In	  the	  second	  part	  of	  this	  thesis,	  the	  role	  of	  IRSp53	  in	  cell	  polarity	  will	  be	  discussed.	  It	  is	  already	  known	  that	  IRSp53	  contributes	  to	  assembly	  and	  maintenance	  of	  cell	  tight	  junctions,	  through	  its	  association	  with	  LIN7	  (Protein	  lin-­‐7	  homolog)	  [155]	  [165],	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small	  protein	  containing	  a	  single	  L27	  (LIN2-­‐LIN7)	  domain	  and	  a	  PDZ	  domain.	  LIN7	  is	  also	  involved	  in	  epithelial	  polarization	  by	  stabilization	  of	  PALS1	  (Protein	  associated	  with	  LIN7,	  or	  stardust).	  Moreover,	  IRSp53	  KD	  causes	  abnormalities	  in	  the	  development	  of	  3-­‐D	  epithelial	  model	  system	  that	  will	  be	  described	  in	  the	  next	  section.	  	  	  
Models	  of	  epithelial	  polarity:	  MDCK	  and	  Caco2	  cells	  Epithelial	  organ	  development	  requires	  cell	  to	  polarize,	  forming	  a	  monolayer	  of	  epithelial	  cells,	  surrounding	  a	  central	  lumen,	  in	  which	  apical	  and	  basal	  layer	  acquire	  different	  properties.	  Polarization	  occurs	  through	  different	  mechanisms:	  differential	  expression	  of	  specific	  markers	  and	  transporters	  of	  nutrient	  and	  fluid;	  creation	  of	  intercellular	  junctions	  and	  sealing	  junctions	  between	  apical	  and	  basal	  layer,	  to	  segregate	  the	  two	  compartments;	  epithelial-­‐specific	  cytoskeletal	  rearrangements	  and	  polarized	  trafficking	  (involving	  endoplasmic	  reticulum	  (ER),	  Golgi	  and	  endosomal	  compartements).	  Polarity	  proteins	  can	  be	  divided	  in	  three	  groups	  [166]:	  *	  PAR	  (partitioning	  defective)	  proteins:	  PAR1,	  PAR4,	  PAR5,	  PAR3,	  PAR6,	  aPKC	  (atypical	  protein	  kinase	  C)	  and	  CDC42,	  identified	  in	  a	  screen	  in	  C.	  elegans	  as	  required	  for	  correct	  partitioning	  between	  anterior	  and	  posterior	  cells	  of	  the	  early	  embryo,	  involved	  also	  in	  proliferation	  and	  differentiation;	  *	  Crumbs:	  CRB	  (Crumbs),	  PALS1	  and	  PATJ	  (PALS1-­‐associated	  tight-­‐junction	  homolog),	  localized	  both	  at	  apical	  membrane	  than	  at	  tight	  junctions;	  *	  Scribble:	  DLG	  (Disks	  large	  homolog),	  Lgl	  (Lethal	  giant	  larvae),	  Scribble,	  at	  lateral	  membrane	  of	  epithelial	  cells.	  RHO	  GTPases	  have	  key	  roles	  in	  defining	  the	  polarity	  program,	  even	  independently	  from	  their	  actin-­‐organizing	  role	  [167].	  Also	  phosphoinosides	  and	  other	  lipids	  are	  implicated	  in	  the	  generation	  of	  polarity	  signals,	  for	  example	  PIP3	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(phosphatidylinositol-­‐(3,4,5)-­‐trisphosphate)	  is	  involved	  in	  basolateral	  plasma	  membrane	  identity	  [168],	  while	  PIP2	  in	  apical	  plasma	  membrane	  identity	  [169].	  One	  important	  mechanism	  in	  polarity	  definition	  is	  the	  mutual	  exclusivity:	  for	  example,	  aPKC	  at	  the	  apical	  cortex	  excludes	  basolateral	  proteins,	  while	  PAR1	  at	  the	  basolateral	  side	  exclude	  apical	  proteins;	  both	  aPKC	  than	  PAR1	  act	  promoting	  phosphorylation	  of	  partner	  proteins.	  	  In	  the	  initial	  phases	  of	  epithelial	  polarization,	  aPKC	  associates	  with	  active	  CDC42	  and	  PAR6,	  causing	  the	  apical	  recruitment	  of	  the	  complex	  and	  aPKC	  activation	  [170].	  aPKC	  then	  phosphorylates	  PAR3,	  PAR1	  and	  LGL,	  to	  exclude	  them	  from	  the	  apical	  domain	  [171].	  When	  aPKC	  positioning	  is	  lost	  in	  epithelium,	  also	  E-­‐cadherin,	  Numb	  (involved	  in	  endocytosis)	  and	  Pins/Lgn	  (involved	  in	  spindle	  orientation)	  are	  mislocalized	  [172]	  [173].	  PAR3	  stays	  at	  tight	  junctions	  in	  epithelial	  cells	  and	  is	  not	  part	  of	  the	  apical	  complex,	  but	  it	  is	  necessary	  for	  aPKC	  apical	  delivery,	  since	  it	  binds	  PAR6.	  Basolateral	  PI3K	  (phosphatidylinositol	  3-­‐kinase)	  is	  recruited	  at	  junctions	  by	  E-­‐cadherin.	  PI3K	  recruits,	  in	  turn,	  DLG	  and	  generates	  PIP3,	  which	  binds	  Scribble	  [166]	  (Figure	  14).	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The	  apical	  polarity	  protein	  Crumbs	  (Crb)	  recruits	  PALS1,	  which	  in	  turn	  recruits	  PAR6	  and	  aPKC	  to	  phosphorylate	  PAR3,	  the	  kinase	  PAR1	  and	  LGL	  and	  exclude	  them	  from	  the	  apical	  domain.	  Conversely,	  PAR1-­‐mediated	  phosphorylation	  prevents	  basal	  localization	  of	  the	  apical	  polarity	  determinants,	  such	  as	  PAR3.	  PTEN	  is	  recruited	  to	  the	  junctional	  area	  through	  interaction	  with	  PAR3	  and	  generates	  PIP2,	  which	  helps	  recruit	  CDC42	  via	  annexin	  2.	  CDC42	  participates	  in	  the	  activation	  of	  aPKC	  via	  PAR6.	  Basolateral	  PI3K	  recruits	  DLG	  and	  generates	  PIP3,	  which	  additionally	  contributes	  to	  basal	  membrane	  identity	  through	  the	  recruitment	  of	  Scribble	  (modified	  from	  Rodriguez-­‐Boulan	  et	  al.,	  2014	  [166]).	  	  Polarity	  program	  proteins	  are	  also	  involved	  in	  tight	  junctions	  assembly	  and	  maintenance,	  tight	  junctions	  are	  essential	  to	  form	  a	  barrier	  that	  separates	  apical	  and	  basolateral	  domains.	  Loss	  of	  CRB3	  or	  PALS1	  causes	  defects	  in	  tight	  junctions	  assembly	  [174]	  [175].	  CDC42	  is	  involved	  in	  adherens	  junction	  assembly,	  through	  PAR3-­‐PAR6-­‐aPKC.	  Also	  cadherin-­‐based	  adhesions	  are	  required	  for	  cell	  polarization.	  Newly	  synthetized	  cargo	  proteins	  may	  traffic	  through	  the	  endosome	  compartment:	  apical	  and	  basolateral	  plasma	  membrane	  proteins	  are	  synthetized	  at	  ER,	  transferred	  to	  Golgi	  and	  trans-­‐Golgi	  network	  to	  be	  sorted	  to	  the	  plasma	  membrane.	  	  Although	  there	  is	  conservation	  among	  the	  key	  players	  of	  polarity	  program,	  considerable	  variations	  exist	  among	  different	  tissues	  and	  developmental	  contexts.	  A	  key	  advantage	  for	  the	  comprehension	  of	  epithelial	  polarity	  program	  has	  been	  the	  development	  of	  3-­‐D	  methods	  of	  cell	  culture:	  MDCK	  (Madin	  Darby	  canine	  kidney)	  and	  Caco2	  (human	  colorectal	  adenocarcinoma)	  cells,	  when	  plated	  on	  an	  appropriate	  ECM	  substrate,	  spontaneously	  growth	  as	  cysts.	  Cysts	  are	  polarized	  spherical	  monolayer,	  with	  an	  apical	  site	  surrounding	  a	  central	  lumen,	  a	  lateral	  and	  a	  basal	  layer	  contacting	  ECM.	  All	  the	  cells	  involved	  in	  MDCK	  and	  Caco2	  cysts	  formation	  require	  a	  coordinated	  acquisition	  of	  apical-­‐basal	  polarity,	  but	  they	  do	  not	  need	  apoptosis.	  One	  of	  the	  first	  protein	  to	  be	  relocalized	  to	  the	  nascent	  lumen	  is	  podocalyxin,	  also	  called	  GP135.	  Podocalyxin	  is	  a	  transmembrane	  glycoprotein.	  It	  is	  heavily	  glycosylated	  in	  its	  extracellular	  portion,	  thus	  acts	  as	  an	  anti-­‐adhesive	  protein,	  inducing	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electrostatic	  repulsion	  that	  favors	  lumen	  formation.	  Podocayxin	  that	  accumulates	  at	  the	  nascent	  apical	  site	  at	  least	  partially	  comes	  from	  transcytosed	  peripheral	  protein	  [176].	  Podocalyxin	  null	  mice	  display	  kidney	  developmental	  defects	  and	  perinatal	  lethality	  [177].	  Here	  after	  are	  described	  the	  key	  steps	  in	  MDCK	  cysts	  formation:	  *	  when	  single	  MDCK	  cells	  are	  plated	  in	  3-­‐D	  basement	  membrane	  culture,	  apical	  and	  basolateral	  proteins	  are	  distributed	  over	  the	  entire	  plasma	  membrane,	  as	  podocalyxin;	  *	  polarity	  inversion	  occurs:	  podocalyxin	  relocalizes	  at	  the	  forming	  lumen,	  while	  β-­‐catenin	  and	  Na/K-­‐ATPase	  localize	  at	  the	  baso-­‐lateral	  side;	  	  *	  a	  central	  patch	  at	  cell-­‐cell	  contact	  at	  two-­‐cells	  stage	  emerges,	  it	  is	  called	  AMIS	  (apical	  membrane	  initiation	  site).	  It	  is	  the	  nascent	  apical	  surface,	  where	  apical	  proteins	  start	  to	  localize,	  as	  podocalyxin	  (while	  aPKC	  stays	  both	  at	  AMIS	  than	  at	  the	  plasma	  membrane);	  *	  opposing	  plasma	  membrane	  start	  to	  separate	  in	  PAP	  (pre	  apical	  patch),	  when	  	  tight	  junctions	  markers	  become	  separated	  from	  podocalyxin,	  but	  podocalyxin	  doesn’t	  give	  an	  optically	  resolvable	  signal;	  *	  cyst	  further	  expand	  by	  the	  action	  of	  pumps	  and	  channels	  [176]	  (Figure	  15).	  
	  
Figure	  15.	  Stages	  of	  MDCK	  cyst	  development.	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Sara	  Bisi	  PhD	  thesis	   55	  
Initially	  the	  apical	  marker	  podocalyxin	  (in	  red)	  is	  located	  at	  the	  ECM-­‐contacting	  region	  of	  early	  aggregates	  (12	  h	  after	  plating),	  while	  β-­‐catenin	  (in	  green)	  is	  at	  cell-­‐cell	  junctions.	  Polarity	  inversion	  then	  occurs	  (24	  h)	  and	  a	  pre	  apical	  patch	  (PAP)	  is	  formed,	  where	  podocalyxin	  stays	  at	  the	  cyst	  interior.	  Finally,	  the	  lumenal	  space	  is	  opened	  (48	  h).	  In	  the	  lower	  panel,	  a	  cartoon	  of	  cyst	  development	  is	  presented	  (modified	  from	  Bryant	  et	  al.,	  2010	  [176]).	  
Molecular	  mechanism	  of	  MDCK	  cyst	  generation	  	  Polarity	  proteins,	  lipids	  and	  RHO	  GTPases	  (CDC42,	  RAC1	  and	  RHOA)	  organize	  trafficking	  and	  generate	  junctions,	  to	  set	  apical-­‐basal	  axis	  in	  the	  developing	  cyst.	  Before	  reorientation	  of	  polarity,	  cells	  are	  really	  motile	  and	  use	  an	  inverted	  front-­‐rear	  polarity	  to	  move.	  Upon	  single	  cells	  plating	  on	  matrigel	  and/or	  collagen,	  collagen-­‐mediated	  activation	  of	  β1	  integrin	  occurs,	  promoting	  the	  activation	  of	  the	  complex	  FAK	  (focal	  adhesion	  kinase)/p190A-­‐RHOA	  GAP,	  followed	  by	  RAC1	  activation.	  	  The	  activation	  of	  RHOA	  and	  its	  effectors	  ROCK1	  (RHO-­‐associated	  protein	  kinase)	  and	  myosin	  2	  light	  chain	  is	  then	  suppressed;	  if	  they	  are	  active,	  as	  before	  the	  induction	  of	  polarization,	  they	  promote	  ezrin	  phosphorylation	  and	  its	  association	  with	  podocalyxin	  and	  NHERF1/EBP50,	  stabilizing	  their	  localization	  at	  the	  cell	  surface.	  Later,	  PKCβII	  (protein	  kinase	  C)	  phosphorylates	  podocalyxin	  and	  NHERF1,	  causing	  the	  dissociation	  of	  the	  complex	  podocalyxin:NHERF1:ezrin,	  podocalyxin	  is	  then	  transcytosed	  to	  the	  AMIS	  through	  RAB11a	  positive	  vescicles	  (while	  NHERF1	  is	  maintained	  cytoplasmic)	  [178].	  RAB11a	  regulates	  apical	  trafficking	  and	  lumen	  formation	  [176]	  together	  with	  RAB8a,	  that	  localizes	  in	  podocalyxin	  containing	  vesicles,	  too.	  RAB8	  is	  recruited	  through	  Rabin8	  (a	  RAB	  GEF).	  Vescicle	  transport	  is	  facilitated	  both	  by	  microtubules	  and	  actin	  motors;	  RAB8a/11a	  cooperatively	  bind	  the	  actin-­‐based	  motor	  protein	  myosin	  Vb	  to	  transport	  these	  vesicles	  to	  the	  AMIS	  [179].	  Also	  annexin2,	  a	  protein	  that	  binds	  PIP2,	  transiently	  associates	  with	  RAB11a	  positive	  vescicles;	  RAB11a	  interacts	  with	  Sec15	  exocyst	  subunit	  (linking	  also	  Sec10	  subunit),	  exocyst	  in	  turn	  interacts	  with	  PAR3	  and	  aPKC,	  driving	  PAR3	  to	  the	  apical	  surface	  and	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allowing	  CDC42	  activation.	  The	  CDC42	  GEF	  tuba	  is	  required	  for	  CDC42	  apical	  targeting.	  The	  initial	  landmark	  for	  the	  formation	  of	  the	  apical	  region	  is	  the	  site	  of	  abscission:	  following	  entry	  into	  mitosis,	  RAB11a	  positive	  vesicles	  are	  accumulated	  at	  the	  cleavage	  furrow.	  Apical	  concentration	  of	  PTEN	  (Phosphatase	  and	  tensin	  homolog	  on	  chromosome	  10,	  phosphatase	  whose	  substrates	  are	  PIP3	  and,	  with	  lower	  affinity,	  PIP2),	  recruited	  at	  junctions	  by	  PAR3,	  causes	  the	  exclusion	  of	  PIP3	  and	  the	  apical	  enrichment	  of	  PIP2,	  followed	  by	  the	  recruitment	  of	  annexin	  and	  CDC42	  [169].	  Apical	  vesicles	  then	  undergo	  fusion,	  which	  is	  mediated,	  for	  example,	  by	  syntaxin	  3,	  SLP4	  (synaptotagmin-­‐like	  protein	  4),	  RAB27/RAB3/RAB8	  [180].	  	  The	  exocyst	  is	  required	  for	  docking	  of	  RAB11a	  positive	  vesicles	  to	  the	  AMIS,	  but	  PAR3	  localization	  and	  Crumbs3-­‐PALS1-­‐PATJ	  complex	  are	  also	  required:	  Crumbs	  may	  function	  to	  restrict	  PAR3	  to	  the	  side	  of	  developing	  lumen.	  At	  the	  nascent	  lumen,	  podocalyxin	  and	  NHERF1	  are	  dephosphorylated	  by	  PP2A	  (protein	  phosphatase),	  so	  podocalyxin	  associates	  back	  with	  NHERF1	  and	  ezrin	  [176]	  (Figure	  16).	  Once	  the	  lumen	  is	  formed,	  RAB11a	  vesicles	  stay	  in	  the	  sub-­‐apical	  region,	  as	  CDC42;	  CDC42	  also	  stays	  partially	  at	  cell-­‐cell	  contact.	  Of	  note,	  CDC42	  also	  regulates	  orientation	  of	  cell	  division	  with	  PAR6	  and	  aPKC.	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Figure	  16.	  Model	  of	  the	  first	  events	  in	  MDCK	  cells	  polarization.	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RAB8,	  RAB11a,	  aPKC	  KD	  also	  cause	  defective	  lumenogenesis	  and	  podocalyxin	  accumulation	  into	  vesicles	  close	  to	  the	  cell	  surface.	  aPKC	  inhibition	  moreover	  partially	  affects	  podocalyxin	  internalization	  from	  the	  plasma	  membrane	  [176].	  Interestingly,	  the	  KO	  of	  RAB8	  or	  RAB11a	  in	  the	  mouse	  intestine	  leads	  to	  defective	  trafficking	  of	  apical	  proteins,	  illustrating	  the	  importance	  of	  the	  RAB11a/RAB8	  recycling	  endosome	  system	  in	  vivo	  [182,	  183].	  PAR3	  KD	  causes	  the	  formation	  of	  multiple	  lumen	  cysts,	  which	  are	  positive	  for	  podocalyxin	  staining	  in	  their	  apical	  region	  [184].	  As	  observed	  before,	  differences	  exist	  among	  polarity	  signalling	  in	  different	  tissues,	  however,	  similar	  events	  also	  occur	  at	  mouse	  dorsal	  aorta,	  where	  podocalyxin	  is	  targeted	  to	  a	  central	  patch	  and	  stabilized	  at	  cell-­‐cell	  contact	  by	  moesin	  (protein	  of	  ERM,	  ezrin-­‐radixin-­‐moesin,	  family)	  to	  initiate	  the	  apical	  region	  [185].	  In	  contrast,	  the	  mechanism	  of	  lumen	  formation	  in	  Caco2	  cysts	  is	  different	  from	  the	  one	  used	  by	  MDCK	  cells:	  it	  does	  not	  involve	  podocalyxin	  trafficking.	  Instead	  the	  lumen	  forms	  through	  a	  process	  of	  internal	  expansion	  due	  to	  fluid	  accumulation,	  driven	  by	  polarized	  ion	  transport.	  However,	  also	  in	  Caco2	  cysts	  the	  relocalization	  of	  apical	  markers	  is	  observed:	  for	  example	  aPKC	  is	  localized	  around	  the	  cell	  periphery	  in	  single	  cells,	  while	  later	  accumulates	  in	  the	  nascent	  apical	  surface	  [181].	  	  
IRSp53	  role	  in	  cyst	  development	  As	  mentioned	  before,	  it	  has	  recently	  been	  shown	  that	  silencing	  of	  IRSp53	  leads	  to	  a	  multiple	  lumen	  phenotype	  in	  MDCK	  spheroids	  and	  other	  defects	  in	  polarity	  establishment,	  including	  disrupted	  laminin	  staining	  around	  the	  cyst	  and	  retention	  of	  podocalyxin	  at	  the	  plasma	  membrane	  (indicative	  of	  an	  inverted	  polarity	  phenotype)	  [152].	  In	  Cohen	  et	  al.,	  2011	  [152],	  they	  observe	  the	  same	  phenotype	  in	  PAR1b	  overexpressing	  MDCK	  cells.	  PAR1B	  is	  a	  serine/threonine	  kinase	  that	  regulates	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epithelial	  lumen	  [186]	  and	  is	  involved	  in	  spindle	  positioning	  together	  with	  LGN	  and	  Numa	  [187].	  Consequently,	  Cohen	  et	  al.,	  2011	  [152]	  propose	  a	  model	  in	  which	  the	  polarity	  protein	  PAR1b	  regulates	  IRSp53.	  In	  particular,	  PAR1b	  directly	  phosphorylates	  IRSp53	  on	  S366,	  and	  indirectly	  phosphorylates	  the	  cluster	  S453,	  S454,	  S455.	  These	  residues,	  when	  phosphorylated,	  are	  able	  to	  recruit	  14-­‐3-­‐3,	  that	  in	  turn	  sequesters	  IRSp53	  and	  impairs	  its	  functions	  by	  masking	  the	  SH3	  domain	  [152].	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Aim	  of	  the	  project	  
IRSp53	  have	  previously	  been	  suggested	  to	  act	  downstream	  of	  CDC42	  in	  the	  regulation	  of	  filopodia	  dynamics.	  However,	  the	  molecular	  mechanisms	  exploited	  by	  this	  axis	  and	  the	  players	  controlling	  actin	  dynamics	  and	  architectural	  organization	  have	  remained,	  by	  and	  large,	  elusive.	  	  Hence,	  we	  set	  out	  to	  investigate	  more	  in	  details	  the	  role	  of	  IRSp53	  on	  actin	  dynamics	  and	  asked	  whether	  IRSp53	  interactors,	  other	  than	  Mena,	  were	  involved	  in	  modulating	  IRSp53	  role	  in	  filopodia	  formation.	  	  To	  this	  end,	  we	  will	  use	  a	  combination	  of	  biochemical	  assays,	  to	  analyse	  the	  effect	  of	  IRSp53	  and	  its	  interactors	  on	  actin	  polymerization,	  and	  cell	  biology	  approaches	  by	  taking	  advantage	  of	  IRSp53	  null	  and	  reconstituted	  cell	  lines,	  to	  explore	  the	  biological	  relevance	  of	  our	  findings.	  In	  the	  second	  part	  of	  this	  thesis,	  an	  additional,	  novel	  role	  of	  IRSp53	  will	  be	  discussed.	  Following	  the	  sparse	  evidences	  in	  literature	  pointing	  to	  the	  involvement	  of	  IRSp53	  in	  the	  polarity	  program,	  we	  decided	  to	  investigate	  the	  role	  of	  this	  protein	  in	  the	  establishment	  of	  3-­‐D	  cysts.	  In	  particular	  we	  will	  exploit	  the	  epithelial	  cell	  lines	  MDCK	  and	  Caco2	  as	  in	  vitro	  models	  that	  recapitulate	  the	  morphogenetic	  program	  of	  gland	  formation:	  both	  these	  cells	  lines	  have	  been	  vastly	  used	  in	  literature	  to	  unveil	  the	  mechanisms	  of	  polarization	  and	  lumenogenesis.	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Materials	  and	  methods	  
1	  Common	  laboratory	  solutions	  
Phosphate-­‐buffered	  saline	  (PBS)	  137	  mM	  NaCl	  2.7	  mM	  KCl	  10	  mM	  Na2HPO4	  2	  mM	  KH2PO4	  The	  solution	  is	  prepared	  by	  dissolving	  8	  g	  of	  NaCl,	  0.2	  g	  of	  KCl,	  1.44	  g	  of	  Na2HPO4,	  and	  0.24	  g	  of	  KH2PO4	  in	  800	  mL	  of	  distilled	  water.	  The	  pH	  is	  adjusted	  to	  7.4	  with	  HCl	  and	  distilled	  H2O	  is	  added	  to	  1	  litre.	  
Tris	  HCl	  (1	  M)	  Prepared	  by	  dissolving	  121.1	  g	  of	  Tris	  base	  in	  800	  mL	  distilled	  H2O.	  The	  pH	  is	  adjusted	  (depending	  on	  the	  case)	  with	  HCl,	  and	  distilled	  H2O	  is	  added	  to	  1	  litre.	   	  
10X	  Tris	  EDTA	  (pH	  7.4-­‐8.0)	  	  100	  mM	  Tris	  HCl	  (pH	  7.4-­‐8.0)	  	   10	  mM	  	  EDTA	  (pH	  8.0)	  
50X	  TAE	  (Tris-­‐Acetate-­‐EDTA)	  242	  g/L	  	  	  	  	  	   Tris	  base	  	  57.1	  mL/L	  	  	  	  	  	   Acetic	  acid	  	  20	  mL/L	  	  	  	  	  	  	   0.5	  M	  EDTA	  pH	  8	  	  The	  pH	  is	  adjusted	  to	  8.5	  with	  HCl	  and	  distilled	  H2O	  is	  added	  to	  1	  litre.	  
Tris-­‐buffered	  saline	  (TBS)	  137	  mM	  NaCl	  2.7	  mM	  KCl	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25	  mM	  Tris	  base	  It	  is	  prepared	  by	  dissolving	  8	  g	  of	  NaCl,	  0.2	  g	  of	  KCl	  and	  3	  g	  of	  Tris	  base	  in	  800	  mL	  of	  distilled	  H2O.	  The	  pH	  is	  adjusted	  to	  7.4	  with	  HCl	  and	  distilled	  H2O	  is	  added	  to	  1	  litre	  final	  volume.	  
1.4X	  JS	  lysis	  buffer	  50	  mM	  HEPES	  pH	  7.5	  50	  mM	  NaCl	  	   1%	  glycerol	  	   1%	  Triton	  X-­‐100	  	   1.5	  mM	  MgCl2	  	   5	  mM	  EGTA	  To	  this	  solution	  phosphatases	  and	  proteases	  inhibitors	  were	  freshly	  added:	  	   Protease	  inhibitor	  cocktail	  (Roche,	  Basel,	  Switzerland)	  1	  mM	  DTT	  20	  mM	  Na	  pyrophosphate	  pH	  7.5	  	   50	  mM	  NaF	  	   0.5	  M	  Na-­‐vanadate	  in	  HEPES	  pH	  7.5	  	  
5X	  (2X)	  SDS-­‐PAGE	  Sample	  Buffer	  10%	  (4%)	  SDS	  500	  mM	  (200mM)	  Tris	  HCl	  pH	  6.8	  30%	  (12%)	  glycerol	  0.03%	  (0.0012%)	  saturated	  bromophenol	  blue	  15%	  (6%)	  (v/v)	  β-­‐mercaptoethanol	  (14M)	  
10X	  SDS-­‐PAGE	  Running	  Buffer	  	  144	  g/L	  Glycine	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30	  g/L	  Tris	  base	  1%	  SDS	  
10X	  Western	  Transfer	  Buffer	  	  144	  g/L	  Glycine	  30	  g/L	  Tris	  base	  Diluted	  at	  1X	  concentration	  in	  10%	  of	  EtOH.	  
Ponceau	  S	  
	   0.1%	  (w/v)	  Ponceau	  (C22H12N4Na4O13S4)	  (Sigma)	  5%	  Acetic	  acid	  
2	  Basic	  cloning	  techniques	  
Agarose	  gel	  electrophoresis	  DNA	  samples	  were	  loaded	  on	  0.8%-­‐2%	  agarose	  gels	  along	  with	  DNA	  markers.	  Gels	  were	  made	  in	  TAE	  buffer	  containing	  0.3	  μg/mL	  ethidium	  bromide	  or	  GelRedTM	  Nucleic	  Acid	  	  1:10000	  (Biotium,	  Italy)	  	  and	  run	  at	  80-­‐100	  V	  until	  desired	  separation	  was	  achieved.	  DNA	  bands	  were	  visualized	  under	  a	  UV	  lamp.	  
Minipreps	  
E.	  coli	  Top10	  Cells	  (Thermo	  Fisher	  Scientific)	  were	  picked	  from	  individual	  transformed	  colonies,	  then	  used	  to	  inoculate	  6	  mL	  LB	  (containing	  the	  appropriate	  antibiotic)	  and	  grown	  overnight	  at	  37°C	  in	  15mL	  Falcon	  tubes.	  Cells	  were	  pelleted	  for	  15	  minutes	  at	  2500	  rpm.	  Minipreps	  were	  performed	  according	  to	  the	  manual	  instructions	  (Promega,	  Wizard	  Plus	  SV	  Minipreps).	  The	  final	  elution	  was	  made	  in	  80µl	  of	  milli-­‐Q	  water.	  DNA	  was	  checked	  performing	  an	  agarose	  gel	  electrophoresis	  using	  5µl	  of	  the	  eluate.	  
LB	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1%	  Bactotryptone	  0.5%	  Yeast	  extract	  1%	  NaCl	  pH	  7.25	  
DNA	  digestion	  
Between	  0.5	  and	  2	  µg	  of	  DNA	  was	  digested	  for	  2	  hours	  at	  37°C	  with	  10	  units	  of	  the	  needed	  restriction	  enzymes	  (NEB).	  Reaction	  volume	  was	  adjusted	  to	  20	  µl	  with	  the	  appropriate	  10X	  NEB	  buffer	  and	  ddH2O.	  
Ligation	  
Ligation	   was	   performed	   with	   Quick	   Ligation	   kit	   (NEB),	   according	   to	   the	   manual	  instructions.	  
Large	  Scale	  Plasmid	  Preparation	  
E.	  coli	  Top10	  Cells	  (Thermo	  Fisher	  Scientific)	  containing	  the	  desired	  DNA	  vector	  were	  expanded	  into	  500	  mL	  cultures	  overnight	  with	  the	  appropriate	  antibiotics.	  Plasmid	  DNA	  was	  isolated	  from	  these	  cells	  using	  the	  Qiagen	  Maxi-­‐prep	  kit	  (Qiagen,Valencia,	  CA)	  according	  to	  the	  manufacturer’s	  instructions	  and	  finally	  resuspended	  in	  Tris	  EDTA	  buffer.	  
Transformation	  of	  competent	  cells	  
E.	  coli	  one	  shot	  Top10	  cells	  (Thermo	  Fisher	  Scientific)	  were	  used	  for	  cloning	  and	  large	  scale	  DNA	  preparation,	  while	  E.	  coli	  BL21	  Rosetta	  (DE3)	  cells	  (Promega)	  were	  used	  for	  proteins	  production.	  The	  transformation	  protocol	  used	  was	  the	  same	  for	  both	  strains.	  50	  μl	  of	  fresh	  competent	  cells	  were	  thawed	  on	  ice	  for	  approximately	  10	  minutes	  prior	  to	  the	  addition	  of	  plasmid	  DNA.	  Cells	  were	  incubated	  with	  DNA	  on	  ice	  for	  20	  minutes	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and	  then	  subjected	  to	  a	  heat	  shock	  for	  45	  seconds	  at	  42°C.	  Cells	  were	  then	  returned	  to	  ice	  for	  2	  minutes.	  Then,	  0.2	  mL	  of	  SOC	  were	  added	  and	  the	  cells	  were	  left	  at	  37°C	  for	  60	  minutes	  (with	  200	  rpm	  shaking)	  before	  plating	  them	  onto	  plates	  with	  the	  appropriate	  antibiotic.	  50	  µl	  of	  the	  transformed	  bacteria	  were	  usually	  plated.	  Plates	  were	  incubated	  overnight	  at	  37°C.	  
SOC	  2%	  Bactotryptone	  0.5%	  Yeast	  extract	  10	  mM	  NaCl	  2.5	  mM	  KCl	  10	  mM	  MgCl2	  10	  mM	  MgSO4	  20	  mM	  glucose	  pH	  7.5	  
DNA	  elution	  from	  agarose	  gel	  DNA	  elution	  from	  agarose	  gel	  was	  performed	  using	  the	  Wizard	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System	  (Promega),	  following	  manufacturer’s	  instructions.	  
PCR	  (Polymerase	  Chain	  Reaction)	  
Sense	  and	  antisense	  oligos,	  of	  20-­‐30	  nucleotides	  each,	  were	  generated,	  one	  annealing	  in	  5’	  (forward)	  and	  the	  other	  in	  3’	  (reverse)	  to	  the	  target	  sequence.	  The	  primers	  were	  designed	  of	  similar	  length	  and	  annealing	  temperature.	  Melting	  temperature	  of	  the	  primers	  was	  calculated	  according	  to	  the	  formula:	  Tm	  =	  81.5+0.41(%GC)	  -­‐	  675\N	  -­‐	  %	  mismatch.	  These	  primers	  were	  used	  in	  a	  PCR	  reaction	  together	  with	  the	  DNA	  template	  and	  the	  Phusion	  High-­‐Fidelity	  DNA	  Polymerase	  (NEB).	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Reaction	  mixture	  5x	  Phusion	  HF	  buffer	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  µl	  DNA	  template	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10-­‐20	  ng	  primer	  forward	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.5	  µM	  primer	  reverse	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.5	  µM	  dNTPs	  mix	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.2	  mM	  Phusion	  Polymerase	  (NEB)	  	  	  	  	  1	  U	  ddH2O	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  to	  a	  final	  volume	  of	  50	  µl	  
Cycling	  parameters:	   	   	   	   	  
Step	   Temperature	   	   	   Time	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  N°	  of	  cycles	  A)	   denaturation	  at	  98°C	  	   30	  seconds	   	   	   	  	  	  	  	  	  	  	  	  	   	  	  	  	   1	  B)	   denaturation	  at	  98°C	  	   10	  seconds	   	   	   	  	  	  	  	  	  	  	  	  	   	  	   annealing	  at	  X°C	   	   30	  seconds	  	   	   	   	   	   25	  	   extension	  at	  72°C	  	   	   (30	  seconds/each	  kb	  of	  target	  length)	  C)	   extension	  at	  72°C	   	   10	  minutes	   	   	   	  	   	   1	  This	  was	  done	  on	  an	  automated	  cycler	  (GeneAmp	  PCR	  system	  9700,	  Applied	  Biosystems).	  
Site	  directed	  mutagenesis	  Site	  directed	  mutagenesis	  was	  performed	  using	  the	  Quick	  Change	  mutagenesis	  kit	  (Stratagene),	  following	  manufacturer’s	  instructions.	  Briefly,	  a	  sense	  and	  an	  antisense	  oligo	  of	  about	  30-­‐45	  nucleotides	  each,	  carrying	  the	  desired	  mutation	  in	  the	  middle	  of	  the	  sequence,	  were	  generated	  and	  used	  in	  a	  PCR	  reaction	  using	  the	  wild	  type	  construct	  as	  template.	  PCR	  was	  performed	  using	  the	  Pfu	  DNA	  Polymerase	  (Promega).	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Reaction	  mixture	  10X	  Pfu	  buffer	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  µl	  DNA	  template	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10-­‐100	  ng	  primer	  forward	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.125	  µM	  primer	  reverse	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.125	  µM	  dNTPs	  mix	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.2	  mM	  Phusion	  Polymerase	  (NEB)	  	  	  	  	  3	  U	  ddH2O	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  to	  a	  final	  volume	  of	  50	  µl	  	  For	  the	  amplification	  step,	  18	  PCR	  cycles	  were	  performed	  with	  a	  denaturation	  step	  of	  30	  seconds	  at	  95°C,	  followed	  by	  an	  annealing	  step	  of	  1	  minute	  at	  55°C	  and	  an	  extension	  step	  at	  68°C	  of	  2	  minutes/each	  kb	  of	  plasmid	  length.	  After	  amplification,	  2	  µl	  of	  DpnI	  restriction	  enzyme	  (NEB),	  which	  selectively	  cuts	  methylated	  DNA	  at	  the	  GATC	  sequence,	  was	  added	  to	  digest	  the	  wild	  type	  parental	  DNA.	  After	  one	  hour	  incubation	  at	  37˚C,	  the	  PCR	  product	  was	  checked	  by	  DNA	  electrophoresis	  and	  used	  to	  transform	  competent	  E.	  coli	  Top10	  cells	  (Thermo	  Fisher	  Scientific).	  Single	  colonies	  were	  sequenced	  for	  the	  presence	  of	  the	  desired	  mutation	  and	  the	  absence	  of	  other,	  unwanted,	  base	  changes.	  	  
Generation	  of	  IRSp53	  constructs	  All	  the	  used	  constructs	  encode	  for	  the	  S	  (short)	  isoform	  of	  IRSp53,	  that	  possesses	  a	  PDZ	  binding	  domain	  at	  the	  C-­‐terminus.	  Flag–IRSp53	  was	  a	  gift	  from	  S.	  Ahmed	  (Neural	  Stem	  Cell	  Laboratory,	  Institute	  of	  Medical	  Biology,	  Singapore)	  and	  it	  was	  used	  to	  subclone	  IRSp53	  in	  pBABE	  vector	  (Cell	  Biolabs).	  pEGFP–IRSp53	  was	  a	  gift	  from	  H.	  Nakagawa	  (Austrian	  Academy	  of	  Sciences,	  Vienna	  Austria)	  and	  used	  to	  subclone	  IRSp53	  in	  pTrcHis-­‐A	  (Thermo	  Fisher	  Scientific)	  or	  pmCherry-­‐C1	  (Clonetech)	  vectors,	  performing	  BamHI-­‐BamHI	  digestions.	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IRSp53	  deletion	  constructs	  were	  generated	  by	  PCR,	  using	  as	  a	  template	  pTrcHisA-­‐IRSp53	  vector.	  To	  clone	  the	  different	  constructs,	  specific	  primers	  were	  designed,	  flanked	  by	  BamHI	  and	  EcoRI	  sites	  (or	  EcoRI	  and	  SalI	  sites).	  DNA	  fragments	  were	  then	  subcloned	  in	  an	  empty	  pGEX-­‐6P-­‐1	  (Amersham)	  vector.	  Used	  primers	  are	  listed	  in	  the	  table	  below:	  	  	  1-­‐250	  aa	   Fwd:	  5’-­‐GCGGATCCTCTTTGTCTCGCTCAGAGGA-­‐3’	  Rev:	  5’-­‐GCGAATTCTCAGTTGCTGGCCACCTGCTG-­‐3’	  1-­‐290	  aa	   Fwd:	  5’-­‐GCGGATCCTCTTTGTCTCGCTCAGAGGA-­‐3’	  Rev:	  5’-­‐GCGAATTCTCACATCCGCCCCACGAACG-­‐3’	  1-­‐309	  aa	   Fwd:	  5’-­‐GCGGATCCTCTCTGTCTCGCTCAGAGGA-­‐3’	  Rev:	  5’-­‐GCGAATTCGTCCTCGCCATCCGGGCC-­‐3’	  1-­‐339	  aa	  	   Fwd:	  5’-­‐GCGGATCCTCTCTGTCTCGCTCAGAGGA-­‐3’	  Rev:	  5’-­‐GCGAATTCGTTGGAGTAGGAGTCGCTGA-­‐3’	  1-­‐374	  aa	   Fwd:	  5’-­‐GCGGATCCTCTCTGTCTCGCTCAGAGGA-­‐3’	   	  Rev:	  5’-­‐GCGAATTCATTGCGCTCCAGGCCGGC-­‐3’	  1-­‐437	  aa	   Fwd:	  5’-­‐GCGGATCCTCTTTGTCTCGCTCAGAGGA-­‐3’	  Rev:	  5’-­‐GCGAATTCTCAACTGCCATCGCTGTCCA-­‐3’	  290-­‐521	  aa	   Fwd:	  5’-­‐GCGGATCCATGTCTGCCCAGGAGAGCAC-­‐3’	  Rev:	  5’-­‐GCGAATTCTCACACTGTGGACACCAGC-­‐3’	  375-­‐437	  aa	   Fwd:	  5’-­‐GCGAATTCGGCCGTATGCGGGTGAAGGC-­‐3’	  Rev:	  5’-­‐GCGTCGACTCAACTGCCATCGCTGTCCA-­‐3’	  	  IRSp53	  W413G	  mutant	  was	  generated	  by	  site	  directed	  mutagenesis	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Other	  constructs	  CDC42	  N17	  and	  L61	  were	  cloned	  in	  pRK5	  vector	  (with	  a	  myc	  tag)	  for	  mammalian	  expression,	  CDC42	  was	  cloned	  in	  pGEX	  vector	  for	  bacterial	  purification.	  VASP	  was	  cloned	  in	  pEGFP	  vector	  for	  mammalian	  expression	  or	  pGEX/pTRCHisA	  for	  bacterial	  purification.	  EPS8	  was	  cloned	  in	  pFL	  vector	  (kindly	  given	  by	  A.	  Musacchio,	  Max	  Planck	  Institute,	  Dortmund)	  carrying	  His	  tag	  motif	  for	  baculovirus	  expression.	  pFUW	  lentiviral	  vectors	  encoding	  GFP,	  GFP-­‐IRSp53	  WT	  and	  GFP-­‐IRSp53	  mutants	  (in	  I-­‐BAR	  domain:	  4KtoE	  on	  positions	  142,	  143,	  146,	  147,	  CRIB	  domain:	  I268N,	  SH3	  domain:	  I403P,	  PDZ	  domain:	  V522G)	  were	  gifts	  from	  Hans-­‐Jurgen	  Kreienkamp	  (University	  of	  Hamburg).	  Apple-­‐RAB11a	  was	  kindly	  given	  by	  K.	  Mostov	  (University	  of	  California,	  San	  Francisco).	  
3	  Reagents	  and	  antibodies	  The	  monoclonal	  anti-­‐IRSp53	  was	  generated	  against	  the	  full-­‐length	  His-­‐tagged	  purified	  protein	  (Disanza	  et	  al.,	  2006	  [160]).	  Others	  antibodies	  used	  were:	  rabbit	  polyclonal	  anti-­‐IRSp53	  (Sigma),	  monoclonal	  anti-­‐EPS8	  (Transduction	  Laboratories),	  anti-­‐vinculin	  (Sigma),	  anti-­‐tubulin	  (Sigma),	  anti-­‐myc	  (Babco),	  anti-­‐VASP	  (Cell	  Signaling),	  rabbit	  polyclonal	  anti-­‐aPKC	  ζ	  (C-­‐20,	  Santa	  Cruz	  Biotechnology),	  anti-­‐ZO-­‐1	  (Thermo	  Fisher	  Scientific),	  anti-­‐podocalyxin	  (3F2/D8,	  DSHB,	  University	  of	  Iowa,	  deposited	  by	  G.	  Ojakian),	  anti-­‐βcatenin	  (Sigma),	  anti-­‐GFP	  (gift	  from	  Jan	  Faix,	  Hannover),	  anti-­‐EEA-­‐1	  (N-­‐19,	  Santa	  Cruz	  Biotechnology),	  anti-­‐Giantin	  (Covenance),	  anti-­‐RAB7	  (Cell	  Signaling),	  anti-­‐Lamp1	  (Sigma).	  Secondary	  antibodies	  conjugated	  to	  horseradish	  peroxidase	  were	  from	  Bio-­‐Rad;	  FITC-­‐	  and	  Cy3-­‐secondary	  antibodies	  from	  Jackson	  ImmunoResearch,	  AlexaFluor	  488	  was	  from	  Molecular	  Probes,	  TRITC-­‐	  and	  FITC-­‐conjugated	  phalloidin	  were	  from	  Sigma.	  Growth	  Factor	  Reduced	  MatrigelTM	  Matrix	  Basement	  Membrane	  and	  Collagen	  I	  were	  from	  BD	  Biosciences.	  Laminin,	  gelatin	  and	  fibronectin	  were	  from	  Sigma.	  
Sara	  Bisi	  PhD	  thesis	  70	  
4	  Biochemical	  procedures	  
SDS	  polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  
Gels	  for	  resolution	  of	  proteins	  were	  made	  from	  a	  30%,	  37.5:1	  mix	  of	  acrylamide:bisacrylamide	  (Sigma).	  As	  polymerisation	  catalysts,	  10%	  ammonium	  persulphate	  (APS)	  and	  TEMED	  (Fluka)	  were	  used.	  
Running	  gel	  mix	  
	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7.5%	   	  	  	  	  	  	  	  	  	  	  	  8%	   	  	  	  	  	  	  	  10%	   	  	  15%	  
acrylamide	  mix	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  5.625	   	  	  	  	  	  	  	  	  	  	  	  	  6	   	  	  	  	  	  	  	  	  7.5	   	  	  11.25	  
1.5M	  Tris	  pH	  8.8	  (ml)	   7.5	   	  	  	  	  	  	  	  	  	  	  	  7.5	   	  	  	  	  	  	  	  	  7.5	   	  	  	  7.5	  
distilled	  water	  (ml)	   	   16.275	  	  	  	  	  	  	  	  	  15.9	   	  	  	  	  	  	  	  14.4	   	  	  10.65	  
10%	  SDS	  (ml)	  	   	   0.3	   	  	  	  	  	  	  	  	  	  	  	  0.3	   	  	  	  	  	  	  	  	  	  0.3	   	  	  	  0.3	  
10%	  APS	  (ml)	   	   0.3	   	  	  	  	  	  	  	  	  	  	  	  0.3	   	  	  	  	  	  	  	  	  	  0.3	   	  	  0.3	  
TEMED	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.03	   	  	  	  	  	  	  	  	  	  	  	  0.03	   	  	  	  	  	  	  	  	  	  0.03	   	  	  0.03	   	  
	  	   Total	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  30	   	  	  	  	  	  	  	  	  	  	  	  30	   	  	  	  	  	  	  	  	  	  	  30	   	  	  	  30	  
Stacking	  gel	  mix	   	  
acrylamide	  mix	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  1.7	  	  
1M	  Tris	  pH	  6.8	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  1.25	  	  
	   distilled	  water	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  6.8	  	  
	   10%	  SDS	  (ml)	  	   	  	  	  	  	  	  	  	  	  	  	  0.1	  	  
	   10%	  APS	  (ml)	   	  	  	  	  	  	  	  	  	  	  	  0.1	  	  
	   TEMED	  (ml)	  	   	   	  	  	  	  	  	  	  	  	  	  	  0.01	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Western	  blot	  
The	  desired	  amounts	  of	  proteins	  were	  added	  with	  5X	  SDS-­‐PAGE	  sample	  buffer	  and	  loaded	  onto	  0.75-­‐1.5	  mm	  thick	  polyacrylamide	  gels	  for	  electrophoresis	  (Bio-­‐Rad).	  Proteins	  were	  transferred	  in	  a	  Western	  transfer	  tanks	  (Bio-­‐Rad)	  to	  Protran	  Nitrocellulose	  Transfer	  membrane	  (Whatman)	  in	  Western	  Transfer	  buffer	  1X	  (diluted	  in	  10%	  ethanol)	  at	  constant	  voltage	  (100	  V	  for	  1	  hour,	  80	  V	  for	  2	  hours	  or	  30	  V	  overnight).	  Ponceau	  S	  was	  used	  to	  reveal	  the	  amount	  of	  proteins	  transferred	  onto	  the	  filters.	  Filters	  were	  blocked	  1	  hour	  (or	  overnight)	  in	  5%	  milk	  in	  TBS	  0.1%	  Tween	  (TBS-­‐T).	  After	  blocking,	  filters	  were	  incubated	  with	  the	  primary	  antibody,	  diluted	  in	  TBS-­‐T	  5%	  milk,	  for	  one	  hour	  at	  room	  temperature,	  or	  overnight	  at	  4˚C;	  followed	  by	  three	  washes	  of	  five	  minutes	  each	  in	  TBS-­‐T	  and	  then	  incubated	  with	  the	  appropriate	  peroxidase-­‐conjugated	  secondary	  antibody	  diluted	  in	  TBS-­‐T	  for	  1	  hour.	  After	  the	  incubation	  with	  the	  secondary	  antibody,	  the	  filter	  was	  washed	  three	  times	  in	  TBS-­‐T	  and	  the	  bound	  secondary	  antibody	  was	  revealed	  using	  the	  ECL	  (Enhanced	  Chemiluminescence)	  method	  (Thermo	  scientific).	  
GST-­‐fusion	  and	  His-­‐fusion	  protein	  production	  
His-­‐tagged	  IRSp53	  WT	  and	  W413G	  	  
E.	  coli	  BL21	  bacteria	  transformed	  with	  pTrcHis-­‐A	  vector	  (Thermo	  Fisher	  Scientific)	  in	  which	  IRSp53	  WT	  or	  W413G	  has	  been	  cloned,	  were	  used	  to	  inoculate	  50	  ml	  LB	  containing	  ampicillin	  25	  µg/ml	  and	  were	  grown	  overnight	  at	  37°C.	  5	  ml	  of	  the	  overnight	  culture	  were	  diluted	  in	  500	  ml	  LB	  and	  grown	  at	  37°C	  (240	  rpm	  shaking)	  till	  it	  reached	  approximately	  OD=0.6,	  then	  induced	  with	  1	  mM	  IPTG	  at	  37°C	  for	  3.5	  hours.	  Bacteria	  were	  then	  pelleted	  down	  at	  2000	  rpm	  for	  25	  minutes	  at	  4°C	  and	  pellets	  were	  resuspended	  in	  His-­‐lysis	  buffer	  (10	  ml	  every	  liter	  of	  culture)	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His-­‐lysis	  buffer	  50	  mM	  Tris	  pH	  8	  300	  mM	  NaCl	  10	  mM	  imidazole	  1	  mM	  β-­‐mercaptoethanol	  protease	  inhibitors	  10%	  glycerol	  Samples	  were	  sonicated	  and	  ultracentrifugated	  (at	  40000	  rpm	  for	  45	  minutes	  at	  4°C,	  using	  a	  50.2	  Ti	  Beckman	  rotor),	  finally	  the	  supernatant	  was	  incubated	  with	  Ni-­‐NTA	  agarose	  beads	  (Qiagen),	  pre-­‐equilibrated	  in	  His-­‐lysis	  buffer	  (600	  μl	  slurry	  every	  liter	  of	  culture),	  for	  1.5	  hours	  at	  4°C,	  rocking.	  Beads	  were	  then	  washed	  two	  times	  in	  buffer	  1	  and	  once	  in	  buffer	  2	  	   Buffer	  1	  	   20	  mM	  imidazole	  	   600	  mM	  NaCl	  50	  mM	  Tris	  pH	  8	  1	  mM	  β-­‐mercaptoethanol	  10%	  glycerol	  
	  
Buffer	  2	  40	  mM	  imidazole	  300	  mM	  NaCl	  50	  mM	  Tris	  pH	  8	  1	  mM	  β-­‐mercaptoethanol	  10%	  glycerol	  
Sara	  Bisi	  PhD	  thesis	   73	  
Beads	  were	  then	  packed	  in	  Poly-­‐Prep	  Chromatography	  columns	  (Bio-­‐Rad),	  His-­‐fusion	  proteins	  were	  eluted	  from	  beads	  in	  elution	  buffer,	  collecting	  8-­‐10	  fractions	  of	  500	  μl	  each,	  in	  clean	  tubes.	  	  	   Elution	  buffer	  	   200	  mM	  imidazole	  	   50	  mM	  Tris	  pH	  8	  	   200	  mM	  NaCl	  	   1	  mM	  β-­‐mercaptoethanol	  10%	  glycerol	  	   (1	  mM	  EDTA	  was	  added	  directly	  to	  the	  tube)	  The	  eluted	  fractions	  were	  evaluated	  through	  SDS-­‐PAGE,	  selected	  fractions	  were	  collected	  together	  and	  their	  buffer	  was	  exchanged	  using	  PD10	  columns	  (GE	  Healthcare).	  	   Exchange	  buffer	  50	  mM	  Tris	  pH	  6.8	  100	  mM	  NaCl	  5%	  glycerol	  1	  mM	  DTT	  0.5	  mM	  EDTA	  The	  sample	  was	  diluted	  in	  dilution	  buffer	  just	  before	  the	  injection	  on	  Resource	  S	  column	  (GE	  Healthcare),	  on	  an	  AKTA	  purifier	  system	  (Amersham	  Bioscience),	  elution	  was	  performed	  following	  a	  0à50%	  B	  gradient	  of	  60	  CV	  (column	  volume)	  length.	  	  	   Dilution	  buffer	  50	  mM	  Tris	  pH	  6.8	  5%	  glycerol	  0.5	  mM	  EDTA	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ResS	  buffer	  A	  50	  mM	  NaCl	  50	  mM	  Tris	  pH	  6.8	  5%	  glycerol	  1	  mM	  EDTA	  1	  mM	  DTT	  	  
ResS	  buffer	  B	  1	  M	  NaCl	  50	  mM	  Tris	  pH	  6.8	  5%	  glycerol	  1	  mM	  EDTA	  1	  mM	  DTT	  Fractions	  (1.2	  ml	  each)	  were	  evaluated	  through	  SDS-­‐PAGE,	  the	  selected	  one	  were	  collected	  and	  concentrated	  with	  Vivaspin	  concentrators	  (Vivaspin	  20	  MWCO	  100000,	  Sartorius	  Stedim	  Biotech).	  Sample	  was	  then	  loaded	  on	  a	  Superdex	  200	  10/300	  gel	  filtration	  column	  (GE	  Healthcare),	  equilibrated	  in	  storage	  buffer,	  on	  an	  AKTA	  purifier	  system	  (Amersham	  Bioscience).	  	   Storage	  buffer	  50	  mM	  Tris	  pH	  7.5	  200	  mM	  NaCl	  1	  mM	  DTT	  10%	  glycerol.	  The	  best	  fraction	  identified	  in	  SDS-­‐PAGE	  gel	  were	  collected	  together,	  concentrated,	  flash	  frozen	  using	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  until	  use.	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GST-­‐VASP	  
E.	  coli	  BL21	  bacteria	  transformed	  with	  pGEX-­‐6P-­‐1	  vector	  in	  which	  VASP	  has	  been	  cloned,	  were	  used	  to	  inoculate	  50	  ml	  LB	  containing	  ampicillin	  25	  µg/ml	  and	  were	  grown	  overnight	  at	  37°C.	  5	  ml	  of	  the	  overnight	  culture	  was	  diluted	  in	  500	  ml	  LB	  and	  grown	  at	  37°C	  (240	  rpm	  shaking)	  till	  it	  reached	  approximately	  OD=0.6,	  then	  induced	  with	  0.5	  mM	  IPTG	  at	  16°C	  overnight.	  Cells	  were	  then	  pelleted	  down	  at	  2000	  rpm	  for	  25	  minutes	  at	  4°C	  and	  pellets	  were	  resuspended	  in	  buffer	  A	  	   Buffer	  A	  50	  mM	  Tris	  pH	  7.4	  500	  mM	  NaCl	  1	  mM	  MgCl2	  1	  mM	  DTT	  0.1%	  Triton	  X-­‐100	  protease	  inhibitors	  Samples	  were	  sonicated	  and	  ultracentrifugated	  (at	  40000	  rpm	  for	  45	  minutes	  at	  4°C,	  using	  a	  50.2	  Ti	  Beckman	  rotor),	  finally	  the	  supernatant	  was	  incubated	  with	  Glutathione	  Sepharose	  4B	  beads	  (GE	  Healthcare),	  pre-­‐equilibrated	  in	  buffer	  A	  without	  Triton	  X-­‐100	  nor	  protease	  inhibitors,	  for	  1	  hour	  at	  4°C,	  rocking.	  Beads	  were	  then	  washed	  with	  the	  same	  buffer.	  Proteins	  were	  cleaved	  from	  the	  GST	  using	  the	  PreScission	  protease	  (Amersham	  Pharmacia	  Biotech)	  according	  to	  the	  manufacturer’s	  instructions,	  otherwise	  eluted	  by	  competition	  with	  glutathione.	  Cleaved	  protein	  was	  then	  loaded	  on	  a	  Superdex	  200	  10/300	  gel	  filtration	  column	  (GE	  healthcare),	  equilibrated	  in	  dyalisis	  buffer,	  on	  an	  AKTA	  purifier	  system	  (Amersham	  Bioscience).	  	   Dialysis	  buffer	  50	  mM	  Tris	  pH	  7.5	  200	  mM	  NaCl	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1	  mM	  DTT	  5%	  glycerol	  The	  best	  fraction	  identified	  in	  SDS-­‐PAGE	  gel	  were	  collected	  together,	  concentrated	  with	  Vivaspin	  concentrators	  (Vivaspin	  20	  MWCO	  100000,	  Sartorius	  Stedim	  Biotech),	  flash	  frozen	  using	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  until	  use.	  	  
GST-­‐IRSp53	  mutants	  and	  GST-­‐SH3	  	  IRSp53	  truncated	  constructs	  were	  cloned	  in	  pGEX-­‐6P-­‐1	  vectors	  and	  purified	  following	  the	  same	  protocol	  as	  indicated	  in	  GST	  VASP,	  with	  the	  only	  exception	  that	  E.	  
coli	  BL21	  bacteria	  were	  induced	  at	  OD=0.6	  with	  1	  mM	  IPTG	  at	  37°C	  for	  3	  hours.	  	  
His-­‐VASP	  and	  His-­‐VASP-­‐DdGAB	  
E.	  coli	  BL21	  bacteria	  transformed	  with	  pTrcHis-­‐A	  vector	  (Thermo	  Fisher	  Scientific)	  in	  which	  VASP	  had	  been	  cloned,	  were	  used	  to	  inoculate	  50	  ml	  LB	  containing	  ampicillin	  25	  µg/ml	  and	  were	  grown	  overnight	  at	  37°C.	  5	  ml	  of	  the	  overnight	  culture	  was	  diluted	  in	  500	  ml	  LB	  and	  grown	  at	  37°C	  (240	  rpm	  shaking)	  till	  it	  reached	  approximately	  OD=0.6,	  then	  induced	  with	  0.5	  mM	  IPTG	  at	  16°C	  overnight.	  Cells	  have	  been	  resuspended	  in	  His-­‐lysis	  buffer,	  sonicated,	  ultracentrifugated,	  and	  supernatant	  was	  incubated	  with	  Ni-­‐NTA	  agarose	  beads	  (Qiagen),	  as	  written	  in	  His-­‐tagged	  IRSp53	  
WT	  purification	  protocol.	  	  Beads	  were	  then	  washed	  in	  washing	  solution	  and	  eluted.	  
Washing	  solution	  20	  mM	  imidazole	  	   1	  M	  NaCl	  50	  mM	  Tris	  pH	  8	  1	  mM	  β-­‐mercaptoethanol	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Elution	  buffer	  200	  mM	  imidazole	  	   150	  mM	  NaCl	  50	  mM	  Tris	  pH	  8	  1	  mM	  β–mercaptoethanol	  (1	  mM	  EDTA	  directly	  added	  to	  the	  tube)	  Eluted	  fractions	  were	  subjected	  to	  SDS-­‐PAGE	  and	  dialyzed	  in	  dialysis	  buffer.	  The	  sample	  was	  then	  concentrated	  using	  Vivaspin	  concentrators	  (Vivaspin	  20	  MWCO	  100000,	  Sartorius	  Stedim	  Biotech)	  before	  loading	  on	  a	  Superdex	  200	  10/300	  gel	  filtration	  column	  (GE	  healthcare),	  equilibrated	  in	  dialysis	  buffer,	  on	  an	  AKTA	  purifier	  system	  (Amersham	  Bioscience).	  The	  best	  fraction	  identified	  in	  SDS-­‐PAGE	  gel	  were	  collected	  together,	  concentrated	  with	  Vivaspin	  concentrators,	  flash	  frozen	  using	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  until	  use.	  	  
GST-­‐CDC42	  purification	  and	  loading	  
E.	  coli	  BL21	  bacteria	  transformed	  with	  pGEX-­‐CDC42	  were	  grown	  and	  induced	  as	  described	  for	  GST-­‐IRSp53	  mutants.	  Purification	  was	  performed	  as	  previously	  described	  for	  GST-­‐VASP;	  GST-­‐CDC42	  was	  detached	  from	  Glutathione	  Sepharose	  4B	  beads	  (GE	  Healthcare)	  by	  competition	  with	  glutathione	  (20	  mM	  Tris	  pH	  8,	  50	  mM	  NaCl,	  GSH	  10	  mM),	  since	  the	  vector	  do	  not	  contain	  a	  PreScission	  protease	  cleavage	  site.	  The	  loading	  was	  performed	  mixing	  	  	  30	  µM	  of	  purified	  protein	  15	  mM	  GTP-­‐γ-­‐S	  or	  GDP	  (Sigma)	  5	  mM	  EDTA	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for	  20	  minutes	  at	  room	  temperature.	  The	  exchange	  reaction	  was	  stopped	  adding	  20	  mM	  MgCl2.	  	  
His-­‐EPS8	  His-­‐EPS8	  protein	  was	  produced	  in	  Baculovirus	  system,	  EPS8	  was	  cloned	  in	  pFL	  vector.	  Transposition	  was	  made	  using	  DH10MultiBac-­‐YFP	  electro	  competent	  cells	  (a	  gift	  from	  A.	  Musacchio)	  that	  were	  electroporated	  in	  presence	  of	  1	  µl	  of	  DNA	  from	  an	  average	  yield	  miniprep.	  Selection	  of	  the	  recombinant	  bacteria	  was	  made	  after	  plating	  on	  LB	  plates	  containing	  50	  µg/mL	  kanamycin,	  7	  µg/mL	  gentamycin,	  10	  µg/mL	  tetracycline,	  200	  µg/mL	  X-­‐gal,	  40	  µg/mL	  IPTG	  at	  least	  48	  hours.	  White	  recombinant	  colonies	  were	  selected	  and	  bacmid	  DNA	  was	  isolate	  using	  the	  Wizard	  Plus	  SV	  Minipreps	  kit	  (Promega)	  with	  a	  slight	  protocol	  modification:	  because	  the	  bacmid	  DNA	  is	  too	  big	  to	  be	  eluted	  with	  the	  kit	  columns,	  DNA	  was	  extracted	  using	  isopropanol	  precipitation.	  	  Bacmid	  DNA	  was	  then	  used	  to	  transfect	  Sf21	  insect	  cells	  (Thermo	  Fisher	  Scientific)	  in	  order	  to	  produce	  the	  virus.	  Sf21	  cells	  were	  plated	  at	  0.5*106/mL	  in	  a	  six	  well	  plate	  and	  transfected	  using	  Insectogene	  reagent	  (Biontex	  Laboratories),	  according	  to	  manufacturer’s	  instruction.	  Cells	  transfection	  was	  monitored	  looking	  at	  the	  appearance	  of	  YFP	  positive	  cells.	  After	  72	  hours	  the	  surnatant	  was	  collected	  (this	  was	  the	  V0,	  primary	  stock	  virus	  production).	  The	  virus	  was	  amplified	  in	  H5	  cells	  (Thermo	  Fisher	  Scientific).	  25	  mL	  of	  H5	  cells	  at	  0.5*106/mL	  were	  infected	  using	  1.5	  mL	  of	  the	  V0	  virus.	  Cells	  infection	  was	  monitored	  looking	  at	  the	  appearance	  of	  YFP	  positive	  cells	  and	  the	  cells	  growth	  arrest,	  that	  is	  caused	  by	  the	  viral	  infection.	  After	  72	  hours	  from	  the	  cell	  growth	  arrest	  the	  surnatant	  was	  collected	  (this	  is	  the	  V1	  generation).	  The	  virus	  was	  amplified	  a	  second	  time	  using	  200	  mL	  of	  H5	  cells	  infected	  with	  2.5	  mL	  of	  the	  V1	  virus.	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Protein	  production	  was	  finally	  began,	  starting	  from	  500	  mL	  of	  H5	  cells	  at	  0.5*106	  cells/mL	  infected	  with	  12.5	  mL	  of	  V2	  virus.	  For	  protein	  purification,	  the	  cells	  were	  harvested	  three	  days	  after	  infection.	  Cells	  pellet	  was	  resuspended	  in	  phosphate	  buffer.	  	   Phosphate	  buffer	  20	  mM	  phosphate	  buffer	  pH	  8	  10	  mM	  imidazole	  500	  mM	  NaCl	  1	  mM	  β–mercaptoethanol	  5%	  glycerol	  	  protease	  inhibitors	  	  After	  sonication	  and	  ultracentrifugation,	  the	  supernatant	  was	  incubated	  with	  Ni-­‐NTA	  agarose	  beads	  (Qiagen)	  (previously	  washed	  twice	  in	  phosphate	  buffer)	  for	  one	  hour.	  Beads	  were	  then	  washed	  in	  washing	  buffer	  and	  eluted	  (as	  described	  for	  His	  IRSp53).	  	   Washing	  buffer	  20	  mM	  phosphate	  buffer	  pH	  8	  20	  mM	  imidazole	  1	  M	  NaCl	  1	  mM	  β–mercaptoethanol	  5%	  glycerol	  	   	  
Elution	  buffer	  20	  mM	  phosphate	  buffer	  pH	  8	  100	  mM	  imidazole	  500	  mM	  NaCl	  1	  mM	  β–mercaptoethanol	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5%	  glycerol	  (1	  mM	  EDTA	  was	  added	  directly	  to	  the	  tube).	  Eluted	  fraction	  were	  evaluated	  through	  SDS-­‐PAGE,	  selected	  fractions	  were	  pulled	  and	  loaded	  on	  a	  Superdex	  200	  10/300	  gel	  filtration	  column	  (GE	  Healthcare),	  equilibrated	  in	  storage	  buffer,	  on	  an	  AKTA	  purifier	  system	  (Amersham	  Bioscience).	  	   Storage	  buffer	  100	  mM	  Tris	  pH	  8	  20	  %	  glycerol	  1	  mM	  DTT	  1	  mM	  EDTA	  500	  mM	  NaCl	  The	  best	  fractions	  identified	  in	  SDS-­‐PAGE	  gel	  were	  collected	  together,	  flash	  frozen	  using	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  until	  use.	  	  
Alexa	  labelling	  Purified	  protein	  was	  concentrated	  until	  at	  least	  2	  mg/ml,	  dyalized	  O/N	  against	  PBS	  pH	  7.	  The	  following	  day,	  protein	  was	  incubated	  for	  1	  hour	  at	  room	  temperature	  in	  the	  dark	  with	  Alexa	  Fluor	  488	  or	  555	  (succinimidyl	  ester,	  that	  reacts	  with	  primary	  amines,	  or	  maleimide,	  that	  reacts	  with	  thiols,	  diluted	  in	  DMSO)	  0.1	  mg	  every	  1	  mg	  of	  total	  protein,	  with	  gentle	  rocking.	  Finally	  the	  labelled	  protein	  was	  gel	  filtered	  and	  treated	  accordingly	  to	  the	  procedures	  described	  before.	  
Other	  proteins	  The	  proteins	  CP,	  profilin	  and	  spectrin-­‐actin	  seeds	  were	  a	  kind	  gift	  from	  Dr.	  Marie-­‐France	  Carlier	  (LEBS-­‐CNRS-­‐Gif	  sur	  Yvette,	  France).	  IRSp53	  mutants	  P278D/P281D	  and	  	  I267A/S268A	  were	  from	  D.	  Kast	  (University	  of	  Pennsylvania,	  Perelman	  school	  of	  medicine,	  Philadelphia,	  USA).	  VASP	  ΔPRD,	  VASP	  Δ(GP5)3,	  VASP	  DdGAB	  were	  from	  J.	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Faix	  (Hannover	  Medical	  School,	  Germany)	  and	  purified	  as	  in	  Breitsprecher	  et	  al.,	  2008	  [106].	  
Co-­‐immunoprecipitation	  assay	  HeLa	  cells	  were	  transfected	  with	  the	  appropriate	  vectors	  using	  lipofectamine,	  lysed	  after	  24	  hours	  in	  JS	  buffer	  with	  the	  indicated	  antibody,	  in	  presence	  of	  sepharose	  beads	  IgA	  or	  IgG	  coupled,	  for	  two	  cycles	  of	  2	  hours	  each	  at	  4°C	  with	  rocking.	  After	  washing	  steps,	  beads	  were	  resuspended	  in	  SDS-­‐PAGE	  sample	  buffer,	  boiled	  for	  10	  min	  at	  95°C	  and	  then	  loaded	  onto	  polyacrylamide	  gels.	  Proteins	  were	  detected	  via	  immunoblotting.	  
In	  vitro	  binding	  assay	  The	  indicated	  proteins	  (tipically	  at	  around	  0.5	  µM)	  were	  mixed	  together	  with	  Ni-­‐NTA	  agarose	  beads	  (Qiagen)	  or	  Glutathione	  sepharose	  beads	  (GE	  Healthcare)	  for	  one	  hour	  at	  4°C,	  in	  mild	  agitation.	  After	  washing	  steps,	  beads	  were	  collected	  and	  eluted	  with	  SDS-­‐PAGE	  Sample	  Buffer.	  Samples	  were	  then	  boiled	  for	  10	  min	  at	  95°C	  and	  loaded	  onto	  polyacrylamide	  gels.	  Proteins	  were	  detected	  using	  Ponceau	  staining	  or	  the	  indicated	  antibodies.	  
IVB	  buffer	  50	  mM	  Tris	  pH	  7.5	  300	  mM	  NaCl	  1	  mM	  DTT	  0.1%	  Triton	  X-­‐100	  (20	  mM	  imidazole	  was	  used	  to	  prevent	  unspecific	  binding	  when	  Ni-­‐NTA	  beads	  were	  used;	  20	  mM	  MgCl2	  was	  used	  to	  preserve	  the	  nucleotide-­‐loaded	  state	  of	  CDC42,	  when	  added)	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Dynamic	  light	  scattering	  (DLS)	  Purified	  proteins	  were	  dialysed	  for	  at	  least	  6	  hours	  in	  DLS	  buffer.	  
DLS	  buffer	  50	  mM	  Tris	  pH	  7.5	  100	  mM	  NaCl	  1mM	  DTT.	  Prior	  to	  the	  experiment,	  mixtures	  of	  proteins	  were	  incubated	  for	  30	  min	  at	  20°C	  to	  allow	  for	  the	  formation	  of	  the	  complexes.	  DLS	  was	  carried	  out	  at	  20°C	  on	  a	  Malvern	  Viscothek	  instrument	  equipped	  with	  a	  633	  nm	  He-­‐Ne	  laser.	  The	  measurement	  duration	  was	  4	  sec,	  and	  100	  measurements	  were	  averaged	  for	  each	  analysis.	  The	  distributions	  of	  the	  mean	  apparent	  translational	  diffusion	  coefficients	  (DT)	  were	  determined	  by	  fitting	  the	  DLS	  autocorrelation	  functions	  using	  nonnegative	  constrained	  least	  squares	  (Hayes	  1995,	  Program	  Sednterp:	  Sedimentation	  Interpretation	  Program	  version	  1.09.	  Alliance	  Protein	  Laboratories,	  Thousand	  Oaks,	  CA,	  USA.).	  The	  distribution	  of	  apparent	  diameters	  Dh	  was	  obtained	  from	  the	  distribution	  of	  mean	  apparent	  translational	  diffusion	  coefficients	  (DT)	  via	  Dh	  =	  2kT/(6πηDT)	  where	  k	  is	  the	  Boltzmann	  constant,	  and	  η	  is	  the	  solvent	  viscosity	  calculated	  from	  the	  buffer	  composition	  using	  SEDNTERP	  (Hayes	  1995,	  Program	  Sednterp:	  Sedimentation	  Interpretation	  Program	  version	  1.09.	  Alliance	  Protein	  Laboratories,	  Thousand	  Oaks,	  CA,	  USA.).	  
Liposomes	  flow	  cytometry	  
Liposome	  preparation.	  A	  plasma	  membrane-­‐like	  mixture	  of	  membrane	  lipids,	  including	  0,	  2.5,	  5	  or	  10%	  PIP2	  (phosphatidylinositol-­‐(4,5)-­‐bisphosphate)	  was	  prepared	  from	  individual	  chloroform	  stock	  solutions	  (Avanti	  Polar	  Lipids).	  The	  mix	  composition	  (in	  mol%)	  was	  the	  following:	  17.5%	  PC	  (phosphatidylcholine),	  5%	  PS	  (phosphatidylserine),	  5%	  PI	  (phosphatidylinositol),	  9%	  PE	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(phosphatidylethanolamine),	  50%	  CL	  (cholesterol),	  12.5%	  SM	  (sphingomyelin),	  1%	  rhodamine-­‐labelled	  PE	  (PE-­‐N-­‐(lissamine	  rhodamine	  B	  sulfonyl),	  rhod-­‐PE),	  and	  0,	  2.5,	  5	  or	  10%	  PIP2.	  The	  PIP2	  content	  was	  increased	  at	  the	  expense	  of	  phosphatidylcholine.	  A	  homogeneous	  lipid	  film	  was	  obtained	  by	  drying	  the	  lipid	  mixture	  in	  a	  round	  bottom	  glass	  flask	  at	  room	  temperature	  under	  nitrogen	  and	  an	  additional	  45	  min	  under	  vacuum.	  The	  lipid	  film	  was	  rehydrated	  in	  reconstitution	  buffer	  (50	  mM	  Tris	  HCl	  pH	  7.4,	  200	  mM	  NaCl)	  containing	  10%	  sucrose.	  The	  obtained	  solution	  was	  subjected	  to	  10	  freeze/thaw	  cycles	  and	  21	  size	  extrusion	  steps	  (mini	  extruder;	  Avanti	  Polar	  Lipids,	  pore	  size	  1000	  nm).	  Liposomes	  were	  checked	  for	  homogeneity	  using	  DLS,	  stored	  at	  4°C	  and	  used	  within	  5	  days.	  
Flow	  Cytometry.	  Liposomes	  were	  incubated	  with	  the	  indicated	  proteins	  and	  analysed	  with	  a	  FACS	  Calibur	  instrument,	  and	  data	  were	  processed	  with	  CellQuest	  Pro	  software	  (Becton	  Dickinson)	  as	  described	  Temmerman	  et	  al.,	  2009	  [188].	  	  
Solid-­‐phase	  binding	  assays	  Solid	  phase	  assays	  to	  probe	  the	  interactions	  between	  VASP,	  GST-­‐IRSp53	  SH3	  and	  profilin	  IIa	  were	  done	  as	  described	  in	  Veniere	  et	  al.,	  2009	  [189].	  Profilin	  IIa	  was	  coated	  in	  microplates,	  ligand	  binding	  was	  monitored	  using	  an	  antibody-­‐based	  method.	  
5	  Biochemical	  actin-­‐based	  assays	  
Common	  buffers	  G	  buffer	  was	  used	  to	  keep	  actin	  in	  the	  monomeric	  state	  (G	  =	  globular)	  
G	  Buffer	  5	  mM	  Tris-­‐HCl	  pH	  7.8	  0.2	  mM	  ATP	  pH	  7.0	  1	  mM	  DTT	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0.1	  mM	  CaCl2	  F	  buffer	  was	  used	  to	  keep	  actin	  in	  the	  polymerized	  state	  (F	  =	  filamentous)	  
F	  Buffer	  	  5	  mM	  Tris-­‐HCl	  pH	  7.8	  0.2	  mM	  ATP	  pH	  7.0	  1	  mM	  DTT	  0.1	  mM	  CaCl2	  1	  mM	  MgCl2	  	  	   0.2	  mM	  EGTA	  0.1	  M	  KCl	  
Actin	  purification	  Actin	  was	  purified	  starting	  from	  Rabbit	  muscle	  acetone	  powder	  (Pel-­‐Frezez	  Biologicals,	  Rogrs,	  Arkansas)	  according	  to	  the	  following	  protocol.	  Nine	  gr	  of	  acetone	  powder	  were	  extracted	  with	  270	  ml	  cold	  buffer	  X	  on	  ice	  in	  a	  500	  ml	  beaker.	  Buffer	  was	  slowly	  added	  with	  gentle	  stirring	  with	  a	  glass	  rod	  to	  thoroughly	  wet	  powder.	  The	  resuspension	  was	  set	  on	  ice	  for	  30	  min	  and	  stirred	  gently	  once	  every	  10	  min.	  The	  preparation	  was	  then	  centrifuged	  at	  25000	  g	  at	  4˚C	  for	  45	  min.	  Supernatant	  was	  filtered	  using	  a	  cotton	  lint	  into	  a	  graduated	  cylinder	  and	  transferred	  into	  a	  beaker.	  Solid	  KCl	  was	  added	  to	  a	  final	  concentration	  of	  3.3	  M	  while	  stirring	  (at	  room	  temperature	  until	  the	  sample	  reaches	  15˚C)	  and	  moved	  back	  on	  ice	  without	  stirring	  until	  temperature	  returned	  to	  5˚C.	  The	  sample	  was	  centrifuged	  at	  25000	  g,	  for	  30	  min	  at	  4˚C.	  Tight	  white	  pellets,	  if	  any,	  is	  actinin.	  Supernatant	  was	  dialyzed	  against	  32	  volumes	  of	  buffer	  D	  overnight.	  Final	  KCl	  concentration	  was	  0.1	  M.	  After	  overnight	  dialysis	  4M	  KCl	  was	  added	  to	  give	  a	  final	  concentration	  of	  0.8	  M	  and	  the	  preparation	  was	  stirred	  for	  1.5	  hours	  at	  4˚C	  in	  order	  to	  solubilize	  tropomyosin.	  The	  preparation	  was	  then	  centrifuged	  at	  100000	  g	  for	  3.5	  hours	  at	  4˚C.	  Supernatant	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was	  discarded.	  Pellets	  were	  homogenized	  with	  a	  potter	  in	  25	  ml	  buffer	  X.	  Once	  added	  0.075	  ml	  MgCl2	  1	  M	  and	  0.375	  ml	  KCl	  4	  M,	  the	  volume	  was	  adjusted	  to	  38.6	  ml	  with	  buffer	  X	  and	  the	  prep	  was	  left	  at	  4˚C	  overnight	  without	  stirring.	  The	  day	  after	  9	  ml	  KCl	  4	  M	  and	  2.37	  ml	  of	  buffer	  X	  were	  added	  and	  the	  preparation	  was	  stirred	  for	  1.5	  hours	  at	  4˚C	  and	  then	  centrifuged	  at	  100000	  g	  for	  3.5	  hours	  at	  4˚C.	  Pellet	  was	  homogenized	  in	  buffer	  X	  (20-­‐30	  ml)	  and	  the	  resuspension	  was	  dialyzed	  against	  1	  liter	  of	  G	  buffer.	  The	  day	  after	  the	  prep	  was	  briefly	  sonicated	  in	  the	  dialysis	  bag,	  1	  x	  10	  seconds	  and	  the	  dialysis	  buffer	  was	  changed.	  After	  two	  days	  of	  dialysis	  in	  G	  buffer	  (with	  daily	  change	  of	  the	  buffer)	  actin	  was	  clarified	  at	  230000	  g	  for	  2	  hours	  at	  4˚C.	  The	  prep	  was	  loaded	  onto	  a	  Superdex	  200	  26/60	  column	  (GE	  Healthcare)	  and	  run	  using	  an	  Amersham	  Biosciences	  AKTA	  Purifier.	  Fractions	  of	  5	  ml	  were	  collected.	  Protein	  concentration	  was	  measured	  using	  UV	  absorbance	  	  (290	  nm	  instead	  of	  280	  nm	  because	  ATP	  interferes	  at	  280	  nm	  wavelength).	  Actin	  concentration	  was	  calculated	  using	  the	  following	  formula:	  [µM]	  =	  (OD	  290	  nm/0.617)	  *	  (1/42)	  where	  0.617	  is	  the	  OD	  of	  actin	  at	  290	  nm	  when	  concentrated	  1mg/ml,	  and	  42	  is	  the	  actin	  molecular	  weight	  (kDa).	  
X	  Buffer	  	  2	  mM	  Tris-­‐HCl	  pH	  7.8	  0.5	  mM	  ATP	  pH	  7.0	  0.1	  mM	  CaCl2	  1	  mM	  DTT	  
	  
D	  Buffer	  	  2	  mM	  Tris-­‐HCl	  pH	  7.8	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1	  mM	  MgCl2	  1	  mM	  DTT	  
Pyrenyl-­‐actin	  labelling	  Actin	  was	  purified	  as	  described	  above	  and	  the	  labelling	  protocol	  was	  started	  at	  the	  end	  of	  the	  third	  day.	  Actin	  is	  labelled	  on	  cysteine	  374.	  After	  centrifugation	  the	  pellet	  was	  resuspended	  in	  buffer	  A	  to	  a	  final	  concentration	  of	  2	  mg/ml.	  1:100	  volume	  of	  N-­‐(1-­‐pyrenyl)iodoacetamide	  (Molecular	  Probes,	  Thermo	  Fisher	  Scientific)	  at	  14	  mg/ml	  in	  DMF	  was	  added	  and	  the	  sample	  was	  gently	  mixed	  until	  it	  became	  white.	  Actin	  was	  then	  incubated	  overnight	  at	  4°C	  rocking.	  From	  this	  moment	  actin	  has	  to	  be	  kept	  always	  in	  the	  dark.	  After	  overnight	  incubation,	  DTT	  was	  added	  to	  1	  mM	  final	  concentration	  and	  the	  sample	  was	  centrifuged	  at	  4000	  g	  for	  15	  min.	  Supernatant	  was	  then	  centrifuged	  again	  at	  100000	  g	  for	  3.5	  hours	  at	  4˚C.	  Pellet	  was	  homogenized	  in	  5	  ml	  of	  buffer	  G	  and	  dialyzed	  against	  one	  liter	  of	  buffer	  G	  overnight	  at	  4˚C.	  The	  day	  after	  the	  prep	  was	  briefly	  sonicated	  in	  dialysis	  bag,	  1	  x	  10	  seconds	  and	  the	  dialysis	  buffer	  was	  changed.	  After	  2	  days	  of	  dialysis	  in	  G	  buffer	  (with	  daily	  change	  of	  the	  buffer)	  actin	  was	  clarified	  at	  230000	  g	  for	  2	  hours	  at	  4˚C.	  The	  prep	  was	  loaded	  onto	  a	  Superdex	  200	  26/60	  column	  (GE	  Healthcare)	  and	  run	  using	  an	  Amersham	  Biosciences	  AKTA	  Purifier.	  Fractions	  of	  5	  ml	  were	  collected.	  Protein	  concentration	  was	  measured	  using	  UV	  absorbance	  	  (290	  nm	  instead	  of	  280	  nm	  because	  ATP	  interferes	  at	  280	  nm	  wavelength).	  Actin	  concentration	  was	  calculated	  using	  the	  following	  formula:	  [µM]	  =	  (OD	  290	  nm/0.617)	  *	  (1/42)	  where	  0.617	  is	  the	  OD	  of	  actin	  at	  290	  nm	  when	  concentrated	  1mg/ml,	  and	  42	  is	  the	  actin	  molecular	  weight	  (kDa).	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To	  evaluate	  the	  actin	  labelling	  OD	  was	  measured	  at	  343	  nm,	  that	  is	  the	  wavelength	  of	  maximum	  absorbance	  for	  pyrene	  (N-­‐(1-­‐pyrenyl)iodoacetamide).	  	  The	  following	  formula	  was	  used	  to	  calculate	  the	  concentration	  of	  the	  labelled	  actin:	  [µM]	  labelled	  actin	  =	  OD	  343	  nm/54000	  where	  54000	  (M-­‐1	  cm-­‐1)	  is	  the	  Pyrene	  ξ	  value	  at	  343	  nm.	  	  To	  evaluate	  the	  percentage	  of	  actin	  labelling	  the	  ratio	  between	  labelled	  and	  total	  actin	  concentration	  was	  then	  calculated.	  
A	  Buffer	  	  5	  mM	  Tris-­‐HCl	  pH	  7.8	  0.5	  mM	  ATP	  pH	  7.0	  1	  mM	  DTT	  0.1	  mM	  CaCl2	  2	  mM	  MgCl2	  0.1	  M	  KCl	  
Atto-­‐488	  labelled	  actin	  	  Atto-­‐488	  actin	  labelling	  was	  essentially	  performed	  as	  described	  in	  Kuhn	  et	  al.,	  2005	  [190].	  Actin	  was	  labelled	  with	  succinimidyl	  ester	  atto-­‐488	  (ATTO-­‐TEC	  GmbH,	  Germany)	  on	  random	  lysine	  residues.	  Actin	  labelling	  was	  performed	  under	  polymerization	  conditions	  (50	  mM	  KCl	  and	  2	  mM	  MgCl2)	  followed	  by	  depolymerization	  and	  gel	  filtration	  in	  G	  buffer.	  	  
Actin	  polymerization	  assays	  	  Initial	  rate	  of	  filament	  growth	  was	  monitored	  by	  the	  increase	  in	  fluorescence	  of	  10%	  pyrenyl-­‐labelled	  actin	  using	  a	  Perkin	  Elmer	  (LS55)	  or	  Safas	  Sfx	  fluorescence	  spectrophotometer.	  Pyrenyl	  fluorescence	  increases	  of	  about	  25	  times	  from	  G-­‐	  to	  F-­‐actin,	  filaments	  growth	  can	  thus	  be	  followed	  looking	  to	  the	  increase	  in	  fluorescence.	  	  The	  used	  wavelengths	  are	  366	  nm	  for	  the	  absorption,	  407	  nm	  for	  the	  emission.	  
Sara	  Bisi	  PhD	  thesis	  88	  
Actin	  polymerization	  was	  induced	  starting	  from	  spectrin-­‐actin	  seeds:	  these	  are	  preformed	  nuclei	  of	  2	  or	  3	  actin	  subunits	  from	  which	  the	  polymerization	  can	  start	  avoiding	  the	  first	  lag	  phase,	  moreover	  they	  have	  only	  free	  barbed	  ends,	  allowing	  actin	  polymerization	  only	  from	  these	  ends.	  	  Seeded	  polymerization	  was	  induced	  by	  addition	  of	  0.05	  M	  KCl,	  1	  mM	  MgCl2	  and	  0.5	  mM	  EGTA	  to	  a	  solution	  of	  Ca-­‐ATP–G-­‐actin	  (1.25	  µM)	  in	  G-­‐buffer	  containing	  0.16	  nM	  spectrin-­‐actin	  seeds,	  5	  µM	  profilin	  and	  the	  desired	  amount	  of	  purified	  protein	  (as	  indicated	  in	  the	  figure	  legends)	  in	  a	  final	  volume	  of	  100	  ml.	  
Total	  Internal	  Reflection	  Fluorescence	  (TIRF)	  Microscopy.	  	  TIRF	  microscopy	  was	  performed	  esentialy	  as	  described	  in	  Breitsprecher	  et	  al.,	  2008	  [106].	  For	  coating	  0.1%	  v/v	  of	  3	  µm	  diameter	  Ni-­‐NTA	  magnetic	  beads	  (Novagen),	  the	  beads	  were	  incubated	  with	  5	  µM	  His-­‐IRSp53	  WT	  or	  W413G	  mutant	  or	  His-­‐tagged	  VASP	  for	  90	  min	  at	  4°	  C	  in	  coating-­‐solution	  (CS)	  (10	  mM	  HEPES	  pH	  7.5,	  50	  mM	  KCl,	  and	  20	  mM	  β-­‐mercaptoethanol).	  Subsequently,	  the	  beads	  were	  washed	  three	  times	  in	  CS	  containing	  1%	  v/v	  BSA	  to	  prevent	  unspecific	  binding.	  	  Coated	  beads	  were	  then	  mixed	  with	  1	  μM	  20%	  Atto-­‐488	  labelled	  actin	  and	  the	  indicated	  proteins	  in	  TIRF	  buffer	  (20	  mM	  imidazole	  pH	  7.4,	  50	  mM	  KCl,	  1	  mM	  MgCl2,	  1	  mM	  EGTA,	  20	  mM	  β-­‐mercaptoethanol,	  0.2	  mM	  ATP,	  15	  mM	  glucose,	  2.5	  mg/ml	  methylcellulose,	  20	  µg/ml	  catalase,	  100	  µg/ml	  glucose-­‐oxidase).	  Analysis	  were	  performed	  in	  flow	  cells,	  as	  described	  in	  Breitsprecher	  et	  al.,	  2008	  [106].	  Fluorescence	  was	  excited	  at	  488	  nm	  with	  a	  Sapphire	  laser,	  and	  images	  from	  an	  Olympus	  IX-­‐81	  inverted	  microscope	  equipped	  with	  an	  Apo	  N	  60x	  TIRF	  objective	  captured	  every	  2	  with	  exposure	  times	  of	  80	  ms	  by	  a	  cooled	  Hamamatsu	  Orca-­‐R2	  CCD	  camera	  (Hamamatsu	  Corp.).	  Using	  2x2	  binning	  mode,	  the	  pixel	  size	  corresponded	  to	  0.21	  μm.	  The	  elongation	  rates	  of	  filaments	  were	  calculated	  by	  manual	  tracking	  of	  growing	  barbed	  ends	  after	  post	  processing	  the	  time	  lapse	  movies	  by	  background	  subtraction	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(30	  px	  rolling	  ball	  radius)	  using	  ImageJ	  software.	  16-­‐24	  filaments	  from	  three	  movies	  per	  condition	  were	  analysed.	  
6	  Cells	  culture	  
Cells	  culture	  HeLa	  cells	  were	  grown	  in	  Minimum	  Essential	  Medium	  (MEM	  Thermo	  Fisher	  Scientific)	  supplemented	  with	  10%	  FBS	  (EuroClone),	  1%	  non	  essential	  ammino	  acids	  and	  1%	  Sodium	  Pyruvate.	  Immortalized	  fibroblasts	  from	  Irsp53	  +/+	  and	  Irsp53	  -­‐/-­‐	  embryos	  were	  generated	  as	  described	  in	  Weiss	  et	  al.,	  2009	  [117].	  Immortalized	  mouse	  embryo	  fibroblasts	  (MEFs)	  were	  grown	  in	  Dulbecco's	  Modified	  Eagle	  Medium	  (DMEM,	  Lonza)	  supplemented	  with	  10%	  FBS	  (EuroClone)	  and	  2	  mM	  L-­‐Glutamine	  (EuroClone).	  MDCK	  cells	  were	  grown	  in	  Dulbecco's	  Modified	  Eagle	  Medium	  (DMEM,	  Lonza)	  supplemented	  with	  5%	  FBS	  (EuroClone)	  and	  2	  mM	  L-­‐Glutamine	  (EuroClone).	  MDCK	  Tet-­‐Off	  cell	  line	  T23	  containing	  IRSp53	  shRNAmir	  (kind	  gift	  of	  A.	  Musch,	  Albert	  Einstein	  College	  of	  Medicine,	  New	  York),	  described	  in	  Cohen	  et	  al.,	  2011	  [152],	  were	  grown	  in	  Dulbecco's	  Modified	  Eagle	  Medium	  (DMEM,	  Lonza)	  supplemented	  with	  10%	  FBS	  (EuroClone)	  and	  2	  mM	  L-­‐Glutamine	  (EuroClone)	  and	  doxycycline	  200	  ng/ml.	  IRSp53	  KD	  was	  induced	  by	  doxycycline	  removal	  (in	  presence	  of	  50	  µM	  enoxacine).	  Caco2	  cells	  were	  grown	  in	  Dulbecco’s	  modified	  Eagle’s	  medium	  (DMEM,	  Thermo	  Fisher	  Scientific)	  supplemented	  with	  20%	  FBS	  (EuroClone)	  and	  1%	  non-­‐essential	  aminoacids.	  HEK-­‐293T	  and	  phoenix	  cells	  were	  grown	  in	  Dulbecco’s	  modified	  Eagle’s	  medium	  (DMEM,	  Lonza)	  supplemented	  with	  10%	  FBS	  (EuroClone)	  and	  2	  mM	  L-­‐Glutamine.	  Cells	  were	  grown	  at	  37°C	  in	  humidified	  atmosphere	  with	  5%	  CO2.	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Transfection	  	  Transfections	  were	  performed	  using	  the	  calcium	  phosphate	  method,	  electroporation,	  Lipofectamine	  (Thermo	  Fisher	  Scientific),	  Lipofectamine2000	  (Thermo	  Fisher	  Scientific)	  or	  FuGENE	  (Thermo	  Fisher	  Scientific).	  HEK-­‐293T	  cells	  were	  transfected	  using	  the	  calcium	  phosphate	  procedure.	  In	  this	  case	  DNA	  (10	  µg	  for	  a	  10	  cm	  plate)	  was	  diluted	  in	  439	  µl	  of	  ddH2O	  and	  61	  µl	  of	  2M	  CaCl2	  were	  added.	  This	  solution	  was	  added,	  drop-­‐wise,	  to	  0.5	  mL	  of	  HBS	  2X.	  Then,	  the	  precipitate	  was	  added	  to	  the	  cells	  and	  removed	  after	  12-­‐16	  hours.	  	  Electroporation	  was	  used	  to	  transfect	  MEF	  cells	  for	  the	  expression	  of	  GFP-­‐VASP,	  myc-­‐CDC42	  or	  mCherry-­‐IRSp53,	  using	  NEONTM	  trasfection	  system	  (Thermo	  Fisher	  Scientific)	  according	  to	  manufacturer’s	  instructions.	  Cells	  were	  microporated	  with	  one	  pulse	  of	  20	  ms	  at	  1650	  V,	  with	  a	  cell	  density	  of	  5*106	  cells.	  Lipofectamine	  (Thermo	  Fisher	  Scientific),	  according	  to	  manufacturer’s	  instruction,	  was	  used	  to	  transfect	  HeLa	  cells.	  Caco-­‐2	  cells	  were	  transfected	  using	  Lipofectamine2000	  (Thermo	  Fisher	  Scientific),	  according	  to	  manufacturer’s	  instructions,	  to	  perform	  CRISPR/Cas9	  genome	  editing.	  MDCK	  were	  transfected	  using	  Lipofectamine2000	  (Thermo	  Fisher	  Scientific),	  according	  to	  manufacturer’s	  instructions,	  for	  Apple-­‐RAB11a	  expression	  and	  selected	  with	  Neomycin.	  MEF	  cells	  were	  transfected	  with	  FuGENE	  for	  the	  expression	  of	  myc-­‐CDC42	  in	  Figure	  34.	  
2X	  HBS	  pH	  7.5	  50	  mM	  HEPES	  pH	  7.5	  10	  mM	  KCl	  12	  mM	  dextrose	  280	  mM	  NaCl	  1.5	  mM	  Na2HPO4	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Retroviral	  infection	  Stable	  MEF	  Irsp53	  -­‐/-­‐	  cells	  were	  subjected	  to	  retroviral	  infection	  with	  pBABE	  control,	  pBABE	  IRSp53	  WT	  and	  pBABE	  IRSp53	  W413G	  vectors.	  Retroviruses	  were	  produced	  by	  transfecting	  Phoenix	  cells	  with	  the	  above	  mentioned	  constructs,	  using	  the	  calcium	  phosphate	  procedure.	  48	  and	  72	  hours	  after	  transfection,	  supernatants	  were	  collected	  and	  passed	  through	  a	  0.45	  µm	  filter.	  Viral	  supernatant	  was	  supplemented	  with	  8	  μg/ml	  Polybrene	  (Sigma)	  and	  added	  to	  cultured	  MEF	  Irsp53	  -­‐/-­‐	  cells.	  Two	  cycles	  of	  infection	  were	  performed,	  of	  four	  hours	  each,	  for	  two	  days.	  Infected	  cells	  were	  selected	  with	  Puromycin.	  Expression	  of	  the	  different	  constructs	  was	  controlled	  by	  Western	  blot	  analysis.	  
Lentiviral	  infection	  	  MDCK	  and	  Caco2	  cells	  were	  subjected	  to	  lentiviral	  infection	  with	  pFUW	  vectors	  encoding	  for	  GFP-­‐IRSp53	  WT	  or	  mutated.	  Lentivirus	  were	  produced	  transfecting	  HEK-­‐293T	  cells	  with	  25	  µg	  of	  the	  vector	  of	  interest,	  9	  µg	  ENV,	  16.25	  µg	  pMDL,	  6.25	  µg	  REV	  (for	  virus	  packaging).	  48	  and	  72	  hours	  after	  transfection,	  supernatants	  containing	  virus	  particles	  were	  collected	  and	  passed	  through	  a	  0.45	  µm	  filter.	  Supernatants	  were	  supplemented	  with	  8	  μg/ml	  Polybrene	  (Sigma)	  and	  added	  to	  cultured	  cells,	  four	  cycles	  of	  infection	  were	  performed.	  GFP-­‐constructs	  expression	  was	  checked	  by	  Western	  blot	  analysis	  and	  immunofluorescence.	  	  
Short	  interfering	  RNA	  (siRNA)	  experiments	  MDCK	  cells	  were	  seeded	  the	  day	  before	  trasfection	  (150000	  cells/well	  in	  6	  well	  format).	  siRNAs	  (small	  interfering	  RNAs)	  delivery	  was	  achieved	  by	  mixing	  10	  nM	  of	  specific	  siRNAs	  with	  Optimem	  and	  Lipofectamine	  RNAiMAX	  Transfection	  Reagent	  (Thermo	  Fisher	  Scientific)	  according	  to	  manufacturer’s	  instruction.	  Negative	  control	  was	  performed	  with	  the	  same	  amount	  of	  scrambled	  siRNA.	  KD	  efficiency	  was	  controlled	  by	  Western	  blot	  analysis.	  Oligoes	  were	  purchased	  from	  Thermo	  Fisher	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Scientific,	  oligos	  details	  as	  follows:	  IRSp53	  (canine):	  CCAAGGAACTCGGAGACGTTCTCTT	  Scrambled:	  TCGAATACGAACATTTATTT	  
Cell	  lysis	  	  After	  washing	  twice	  with	  PBS	  1X,	  cells	  were	  lysed	  in	  JS	  buffer	  directly	  on	  the	  plates	  using	  a	  cell-­‐scraper.	  About	  400	  µl	  of	  JS	  buffer	  for	  10	  cm	  plates	  were	  used.	  Lysates	  were	  incubated	  on	  ice	  for	  10	  minutes	  and	  cleared	  by	  centrifugation	  at	  13200	  rpm	  for	  10	  min	  at	  4°C	  (Eppendorf	  5424	  refrigerated	  tabletop	  centrifuge).	  The	  supernatant	  was	  transferred	  into	  a	  new	  eppendorf	  and	  protein	  concentration	  was	  measured	  by	  the	  Bradford	  assay	  (Bio-­‐Rad),	  following	  manufacturer’s	  instructions.	  	  
CRISPR/Cas9	  KO	  cell	  clones	  CRISPR	  vector	  was	  purchased	  from	  DNA	  2.0,	  containing	  the	  following	  guide	  RNA	  sequence:	  CTGGAGAATTACGTGTCCGA	  	  (selected	  as	  the	  best	  for	  annealing	  vs	  off-­‐target	  probability).	  After	  48	  hours	  transfection	  with	  the	  CRISPR	  vector	  expressing	  both	  Cas9-­‐RFP	  and	  the	  gRNA	  targeting	  IRSp53,	  RFP	  positive	  Caco2	  cells	  were	  selected	  by	  FACS	  (MoFlo	  Astrios,	  Beckman	  Coulter)	  equipped	  with	  405	  nm,	  488	  nm,	  561	  nm	  and	  642	  nm	  lasers.	  To	  obtain	  clones,	  serial	  dilution	  of	  the	  mass	  population	  was	  performed,	  the	  expression	  of	  IRSp53	  was	  finally	  evaluated	  for	  each	  clone	  by	  Western	  blot	  analysis.	  
Caco-­‐2	  cyst	  formation	  assay	  (embedded	  cultures)	  This	  protocol	  was	  adapted	  from	  Jaffe	  et	  al.,	  2008	  [181].	  Growth	  Factor	  Reduced	  MatrigelTM	  Matrix	  Basement	  Membrane	  (BD	  Biosciences)	  should	  be	  thawed	  overnight	  in	  ice	  at	  4°C	  and	  handled	  in	  ice	  with	  cold	  tips.	  Caco2	  cells	  were	  detached	  with	  trypsin	  and	  carefully	  re-­‐suspended	  to	  single	  cells	  by	  pipetting	  and	  flowing	  through	  a	  cell	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strainer	  (size	  40	  μm).	  Cells	  were	  then	  mixed	  to	  60000	  cells/ml	  final	  concentration	  with:	   20	  mM	  Hepes	  	  1	  mg/ml	  Collagen	  I	  (BD)	  50	  %	  MatrigelTM	  (BD)	  The	  mixture	  was	  then	  plated	  250	  μl/well	  in	  one	  μ-­‐slide	  8	  Wells	  chamber	  slide	  (Ibidi).	  After	  30	  minutes	  at	  37°C,	  to	  allow	  matrix	  polymerization,	  each	  well	  was	  overlayed	  with	  250	  μl	  of	  media.	  Media	  was	  replaced	  every	  two	  days.	  At	  day	  6,	  0.1	  μg/ml	  	  cholera	  toxin	  was	  added,	  to	  favour	  lumen	  swelling.	  Cells	  were	  fixed	  approximately	  24	  hours	  later.	  
MDCK	  cyst	  formation	  assay	  (on	  top	  cultures)	  MDCK	  cells	  were	  splitted	  the	  day	  before,	  to	  obtain	  cells	  in	  the	  growing	  state	  the	  day	  of	  the	  experiment.	  Growth	  Factor	  Reduced	  MatrigelTM	  Matrix	  Basement	  Membrane	  (BD	  Biosciences)	  should	  be	  thawed	  overnight	  in	  ice	  at	  4°C	  and	  handled	  in	  ice	  with	  cold	  tips.	  Every	  well	  from	  μ-­‐slide	  8	  Wells	  chamber	  slide	  (Ibidi)	  was	  pre-­‐coated	  with	  15	  μl	  Matrigel	  and	  allowed	  to	  solidify	  for	  30	  minutes	  at	  37°C.	  Cells	  were	  detached	  with	  trypsin	  and	  carefully	  re-­‐suspended	  to	  single	  cells	  by	  pipetting	  and	  flowing	  through	  a	  cell	  strainer	  (size	  40	  μm).	  Cells	  were	  then	  mixed	  to	  40000	  cells/ml	  final	  concentration	  with	  2%	  Matrigel	  and	  plated	  250	  μl/well	  in	  the	  chamber	  slide.	  Media	  was	  replaced	  every	  two	  days.	  Cysts	  were	  fixed	  after	  6	  days	  or	  at	  earlier	  time	  points,	  as	  indicated	  in	  the	  figure	  legends.	  
7	  Imaging	  techniques	  
Microscope	  equipment	  Wide-­‐field	  fluorescence	  images	  were	  taken	  by	  an	  AX70	  (Olympus)	  microscope	  equipped	  with	  a	  12	  bit	  b/w	  camera	  (FviewII,	  Olympus).	  Confocal	  images	  were	  taken	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with	  a	  Leica	  TSC	  SP2	  AOBS	  confocal	  microscope	  controlled	  by	  Leica	  Confocal	  Software	  and	  equipped	  with	  violet	  (405	  nm	  laser	  diode),	  blue	  (argon,	  488	  nm),	  yellow	  (561	  nm	  Solid	  State	  Laser),	  and	  red	  (633	  nm	  HeNe	  Laser)	  excitation	  laser	  lines.	  A	  40x	  oil-­‐immersion	  objective	  lens	  (Leica)	  was	  used	  for	  image	  acquisition	  of	  MDCK	  and	  Caco2	  organoids.	  Timelapses	  analysis	  were	  performed	  as	  indicated	  in	  the	  following	  subchapters.	  
Immunofluorescence	  Cells	  were	  plated	  on	  glass	  coverslips	  (pre-­‐incubated	  with	  0.5%	  gelatin	  in	  PBS	  at	  37˚C	  for	  30	  minutes	  in	  the	  case	  of	  MEFs).	  After	  24	  h,	  cells	  were	  processed	  for	  epifluorescence	  or	  indirect	  immunofluorescence	  microscopy.	  Cells	  were	  fixed	  in	  4%	  paraformaldehyde	  for	  10	  minutes,	  washed	  with	  PBS	  and	  permeabilized	  in	  PBS	  0,1%	  Triton	  X-­‐100	  and	  1%	  BSA	  (to	  prevent	  non-­‐specific	  binding	  of	  the	  antibodies)	  for	  10	  minutes	  at	  room	  temperature	  (RT).	  After	  three	  washes	  in	  PBS,	  the	  coverslips	  were	  gently	  deposited,	  face	  down,	  on	  50	  µl	  of	  primary	  antibody	  diluted	  in	  PBS	  1%	  BSA,	  spotted	  on	  ParafilmTM.	  After	  40	  minutes	  of	  incubation	  at	  room	  temperature,	  coverslips	  were	  washed	  three	  times	  with	  PBS.	  Cells	  were	  then	  incubated	  for	  40	  minutes	  at	  room	  temperature	  with	  the	  appropriate	  secondary	  antibody.	  FITC-­‐	  or	  TRITC-­‐phalloidin	  (Molecular	  Probes)	  was	  added	  in	  the	  secondary	  antibody	  step,	  where	  applicable.	  After	  three	  washes	  in	  PBS,	  coverslips	  were	  incubated	  in	  PBS	  containing	  0.5	  ng/ml	  DAPI	  (1:3000)	  for	  5	  minutes	  at	  RT.	  Coverslips	  were	  washed	  two	  times	  in	  PBS	  and	  then	  in	  deionized	  water,	  finally	  coverslips	  were	  mounted	  in	  mowiol	  (20%	  Mowiol	  (Sigma),	  5%	  Glycerol,	  2.5%	  DABCO	  (Molecular	  Probes),	  0.02%	  NaN3	  in	  PBS)	  and	  examined	  by	  fluorescent	  wide	  field	  microscopy,	  or	  mounted	  in	  Vectashield	  mounting	  medium	  (Vector	  Laboratories)	  for	  confocal	  acquisition.	  Images	  were	  further	  processed	  with	  Image	  J	  software.	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Note	  that	  for	  EEA1	  and	  Lamp1	  antibodies,	  permeabilization	  was	  done	  in	  presence	  of	  0.02%	  saponin,	  saponin	  was	  then	  added	  in	  all	  the	  following	  passages.	  
3-­‐D	  cyst	  staining	  Cysts	  were	  fixed	  in	  2%	  paraformaldehyde	  for	  4	  minutes	  in	  case	  of	  MDCK	  cysts	  or	  30	  minutes	  for	  embedded	  Caco2	  spheroids.	  To	  remove	  paraformaldehyde,	  samples	  were	  washed	  three	  times	  with	  1%	  glycine	  diluted	  in	  1X	  PBS,	  with	  gentle	  agitation.	  Permeabilization	  was	  performed	  in	  1X	  PBS	  containing	  0.5	  %	  Triton	  X-­‐100	  for	  10	  minutes	  at	  room	  temperature,	  then	  cells	  were	  rinsed	  once	  with	  IF	  buffer	  and	  blocked	  in	  IF	  buffer	  plus	  5%	  BSA	  for	  1.5	  hours.	  After	  5	  minutes	  wash	  in	  IF	  buffer,	  samples	  were	  incubated	  with	  primary	  antibodies	  diluted	  in	  IF	  buffer	  for	  few	  hours	  at	  room	  temperature	  or	  overnight	  at	  4°C,	  with	  gentle	  agitation.	  Samples	  were	  rinsed	  three	  times	  with	  IF	  buffer	  and	  incubated	  1.5	  hours	  at	  room	  temperature	  with	  AlexaFluor-­‐secondary	  antibodies	  (and	  eventually	  phalloidin)	  diluted	  in	  IF	  Buffer	  at	  room	  temperature.	  After	  one	  wash	  in	  IF	  buffer	  and	  two	  washes	  in	  1X	  PBS,	  nuclei	  were	  stainined	  with	  0.5	  ng/ml	  DAPI	  diluted	  in	  PBS,	  for	  5	  minutes	  at	  room	  temperature.	  After	  2	  washes	  in	  1X	  PBS,	  images	  were	  acquired	  with	  a	  Leica	  TSC	  SP2	  AOBS	  confocal	  microscope	  and	  a	  HCX	  PL	  APO	  40X/1.25-­‐0.75NA	  oil-­‐immersion	  objective	  lens.	  ImageJ	  software	  was	  used	  for	  image	  analysis.	  
IF buffer 
PBS 
0.2% Triton X-100 
0.05% Tween-20 
0.1% BSA 
Epifluorescence	  time-­‐lapse	  microscopy	  Cells	  electroporated	  with	  various	  expression	  vectors,	  using	  NeonTM	  transfection	  system	  (Thermo	  Fisher	  Scientific)	  according	  to	  the	  manufacturer’s	  instructions,	  were	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seeded	  on	  laminin	  (40	  μg/ml).	  After	  24	  h,	  images	  were	  acquired	  for	  5	  min	  at	  10	  sec	  time	  interval	  using	  an	  Leica	  inverted	  Microscope	  DMI6000B	  with	  adaptive	  focus	  control	  system	  driven	  by	  Leica	  Las	  AF	  software;	  a	  HCX	  PLAPO	  63x	  n.a.	  1.47	  objective	  was	  used	  with	  an	  Andor	  camera	  iXon	  DU-­‐885	  EM	  CCD.	  All	  experiments	  were	  performed	  using	  an	  environmental	  microscope	  incubator	  set	  to	  37°C	  and	  5%	  CO2	  perfusion.	  
Confocal	  spinning-­‐disc	  time-­‐lapse	  microscopy	  Cells	  were	  electroporated	  and	  seeded	  on	  laminin	  as	  described	  above.	  After	  24	  h,	  images	  were	  acquired	  (10	  min,	  0.55	  sec	  time	  interval)	  with	  an	  UltraVIEW	  VoX	  (Perkin	  Elmer)	  spinning	  disk	  confocal	  unit,	  equipped	  with	  an	  EclipseTi	  inverted	  microscope	  (Nikon),	  a	  C9100-­‐50	  emCCD	  camera	  (Hamamatsu)	  and	  driven	  by	  Volocity	  software	  (Improvision,	  Perkin	  Elmer).	  Images	  were	  acquired	  with	  a	  100x	  oil	  immersion	  objectives	  (Nikon	  Apo	  TIRF,	  NA	  1.49).	  All	  the	  experiments	  were	  performed	  using	  an	  environmental	  microscope	  incubator	  (OKOLab)	  set	  to	  37°C	  and	  5%	  CO2	  perfusion.	  
Quantification	  of	  VASP	  at	  filopodia	  tips	  in	  IRSp53	  MEFs	  and	  reconstituted	  cells	  
expressing	  activated	  CDC42	  To	  evaluate	  the	  frequency	  of	  VASP	  localization	  at	  the	  tips	  of	  filopodia,	  GFP-­‐VASP-­‐and	  myc-­‐CDC42	  L61-­‐expressing	  IRSp53	  KO	  and	  reconstituted	  cells	  (with	  either	  WT-­‐IRSp53	  or	  IRSp53W413G	  mutant)	  were	  plated,	  fixed	  and	  stained	  to	  detect	  F-­‐actin	  and	  processed	  for	  epifluorescence	  to	  visualize	  VASP	  foci.	  Filopodia	  were	  scored	  for	  the	  presence	  of	  VASP	  at	  their	  tip.	  Typically,	  >	  80%	  of	  cells	  filopodia	  display	  VASP	  at	  their	  tip	  in	  more	  than	  90%	  of	  filopodia.	  The	  remaining	  ones	  are	  presumably	  also	  positive	  for	  VASP,	  but	  we	  may	  have	  failed	  in	  detecting	  it	  as	  some	  filopodia	  tips	  may	  be	  out	  of	  the	  focal	  plane.	  In	  the	  fewer	  filopodia	  of	  IRSp53	  KO	  MEFs,	  ~	  80%	  of	  cells	  do	  not	  show	  any	  VASP	  at	  filopodia	  tips,	  the	  other	  have	  at	  least	  one	  positive	  filopodia.	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Transwell	  assay	  	  Cells	  were	   seeded	  on	   fibronectin-­‐coated	   chambers	   of	   6.5	  mm	  diameter	   and	  8.5	   µm	  pore	   size	   (Corning	   Incorporated	   Life	   Science,	   Tewksbury,	   MA).	   20%	   Serum	   or	   10	  ng/ml	  PDGF	  were	  added	   in	  the	   lower	  chamber	  as	  chemoattractant.	  Cells	  were	   fixed	  after	  seeding	  with	  4%	  paraformaldehyde,	  stained	  with	  Chrystal	  violet	  and	  visualized	  by	  wide	  field	  microscopy.	  
Invasion	  assay	  Cells	  were	  seeded	  on	  BD	  BioCoat™	  Growth	  Factor	  Reduced	  BD	  Matrigel™	  Invasion	  Chamber,	  8.0	  µm	  PET	  Membranes	  (BD,	  Franklin	  Lakes,	  NJ).	  PDGF	  (10	  ng/ml)	  was	  added	  in	  the	  lower	  chamber	  as	  chemoattractant.	  Cells	  were	  fixed	  16	  h	  after	  seeding	  with	  4%	  paraformaldehyde,	  stained	  with	  DAPI	  to	  detect	  nuclei	  and	  visualized	  by	  confocal	  microscopy.	  	  
Scratch	  assay	  	  Cells	  seeded	  and	  grown	  till	  confluence	  were	  scratched	  with	  a	  pipette	  tip	  and	  carefully	  washed	  with	  1X	  PBS	  to	  remove	  floating	  cells	  and	  create	  a	  cell-­‐free	  wound	  area,	  then	  fresh	  media	  was	  added.	  Cells	  were	  subjected	  to	  DIC	  time-­‐lapse	  analysis	  (20	  h,	  5	  min	  time	  interval)	  using	  an	  Olympus	  IX81	  Inverted	  microscope,	  driven	  by	  an	  "Olympus	  Scan^R"	  software	  and	  equipped	  with	  a	  "Hamamatsu	  Orca-­‐AG"	  CCD	  camera	  12	  bit	  (pixel	  size	  =	  6.45	  µm).	  Objective,	  PlanC	  N	  10X/0.25	  (N.A.),	  Ph1.	  Single	  cell	  migration	  was	  analysed	  using	  Image	  J	  software.	  The	  directional	  migration	  index	  and	  the	  average	  speed	  of	  the	  cells	  were	  calculated.	  The	  directional	  migration	  index	  represents	  the	  ratio	  between	  the	  total	  distance	  covered	  by	  cells	  and	  the	  distance	  covered	  longitudinally	  toward	  the	  center	  of	  the	  wound.	  All	  the	  experiments	  were	  performed	  using	  an	  environmental	  microscope	  incubator	  set	  to	  37°C	  and	  5%	  CO2	  perfusion.	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8	  Other	  techniques	  
Irsp53	  null	  mice	  generation	  
Irsp53	  -­‐/-­‐	  mice	  were	  generated	  by	  a	  transgenic	  insertion	  (“exon	  trap”)	  of	  a	  β-­‐geo	  (β	  -­‐galactosidase–NeoR	  fusion)	  cassette	  between	  exons	  3	  and	  4	  of	  mouse	  Irsp53	  (embryonic	  stem	  cell	  clone	  Accession	  Number	  XG-­‐757,	  BayGenomics,	  S.	  Francisco)	  (described	  in	  Sawallisch	  et	  al.,	  2009	  [111]).	  
Wound	  surgery	  Mice	  were	  treated	  accordingly	  to	  ethical	  procedures.	  Experiments	  were	  performed	  on	  10	  weeks-­‐old	  littermate	  mice	  IRSp53	  WT	  and	  KO	  mice.	  Mice	  were	  anesthetized	  by	  intraperitoneal	  injection	  of	  2.5%	  Avertin	  solution	  and	  their	  back	  skin	  was	  shaved,	  cleaned	  with	  alcohol	  and	  disinfected	  with	  Betadine.	  Using	  a	  sterile	  4-­‐mm	  biopsy	  punch,	  4	  bilateral	  full-­‐thickness	  skin	  wounds	  were	  created	  on	  the	  back	  skin	  without	  injuring	  the	  underlying	  muscle.	  Wounds	  were	  separated	  by	  a	  minimum	  of	  6	  mm	  of	  uninjured	  skin.	  Wounds	  were	  photographed	  at	  0,	  1,	  2,	  4,	  5,	  6,	  7	  days	  after	  wounding	  (0,	  2	  and	  5	  days	  are	  shown	  in	  Figure	  38),	  using	  a	  Canon	  EOS	  D-­‐600	  digital	  camera.	  Wound	  area	  was	  measured	  using	  ImageJ	  software,	  and	  the	  relative	  wound	  closure	  at	  each	  time	  point	  was	  derived	  by	  following	  formula:	  current	  wound	  size/initial	  wound	  size.	  Mice	  were	  sacrificed	  by	  CO2	  euthanasia	  at	  day	  7	  after	  wounding.	  Wound	  tissue	  biopsies	  were	  collected	  for	  histology	  and	  immunohistochemistry.	  
9	  Statistical	  analysis	  In	  case	  of	  re-­‐infection	  with	  GFP	  constructs,	  only	  GFP-­‐positive	  cells	  were	  considered	  for	  the	  analysis.	  All	  data	  are	  presented	  as	  the	  mean±standard	  errors	  of	  mean	  (s.e.m.),	  except	  when	  specified	  in	  figure	  legend,	  from	  at	  least	  three	  independent	  experiments.	  A	  Student’s	  t-­‐test	  was	  used	  to	  calculate	  the	  P-­‐values.	  In	  the	  cyst	  formation	  assay	  at	  least	  30	  cysts	  were	  counted	  for	  each	  sample.	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Results	   	  
Part	  one:	  CDC42:IRSp53:VASP	  axis	  is	  involved	  in	  
filopodia	  formation	  
	  
IRSp53	  possesses	  a	  weak	  capping	  activity,	  in	  seeded	  polymerization	  assay,	  that	  
is	  relieved	  by	  binding	  to	  active	  CDC42	  To	  explore	  the	  role	  of	  IRSp53	  on	  actin	  dynamics,	  we	  employed	  initially	  in	  vitro	  actin	  polymerization	  assays	  reconstituted	  with	  purified	  minimal	  components.	  Actin	  polymerization	  can	  be	  easily	  followed	  using	  pyrenyl-­‐labelled	  G-­‐actin	  (see	  “Material	  and	  methods”).	  Since	  fluorescent	  signal	  from	  pyrenyl-­‐group	  is	  25-­‐fold	  higher	  for	  F-­‐actin	  with	  respect	  to	  G-­‐actin,	  the	  emitted	  fluorescence	  increases	  proportionally	  to	  the	  increase	  of	  actin	  polymerization.	  In	  particular,	  these	  assays	  were	  performed	  in	  the	  presence	  of	  seeds,	  short	  preformed	  actin	  oligomers,	  in	  order	  to	  overcome	  the	  rate-­‐limiting	  step	  of	  actin	  nucleation.	  After	  the	  addition	  of	  seeds,	  actin	  polymerization	  immediately	  starts,	  following	  an	  exponential	  phase	  of	  activity.	  	  We	  observed	  a	  slow	  down	  of	  actin	  barbed	  end	  growth	  by	  around	  10-­‐fold,	  upon	  addition	  of	  increasing	  concentrations	  of	  IRSp53	  (Figure	  17).	  IRSp53	  was	  added	  in	  substoichiometric	  concentration	  with	  respect	  to	  G-­‐actin,	  suggesting	  that	  IRSp53	  effect	  is	  due	  to	  its	  interaction	  with	  barbed	  ends	  and	  not	  with	  G-­‐actin	  itself	  and	  further	  revealing	  a	  potentially	  novel	  and	  unexpected	  role	  for	  IRSp53,	  that	  may	  act	  as	  a	  capping	  protein	  in	  solution.	  IRSp53	  capping	  is	  less	  efficient	  than	  other	  known	  cappers.	  Indeed,	  IRSp53	  calculated	  Kd	  for	  barbed	  ends	  is	  around	  0.29	  μM,	  while	  other	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known	  cappers,	  including	  EPS8	  and	  CP,	  bind	  to	  and	  block	  barbed	  ends	  with	  nanomolar	  affinity.	  
	  
Figure	  17.	  IRSp53	  slows	  down	  barbed	  ends	  growth.	  	  	  
Kinetics	  of	  actin	  polymerization	  in	  presence	  of	  the	  indicated	  concentrations	  of	  IRSp53	  purified	  protein.	  Control	  sample	  contained	  no	  IRSp53.	  Barbed	  end	  growth	  was	  measured	  in	  bulk	  pyrenyl-­‐actin	  polymerization	  assays	  using	  1.25	  μM	  Mg-­‐ATP-­‐G-­‐actin	  (5%	  pyrenyl-­‐labelled),	  5	  μM	  profilin	  and	  0.16	  nM	  spectrin-­‐actin	  seeds	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  IRSp53	  is	  an	  effector	  of	  CDC42.	  Binding	  of	  the	  former	  protein	  to	  the	  GTPase	  has	  been	  shown	  to	  promote	  a	  conformational	  change	  of	  IRSp53,	  opening	  the	  protein	  to	  an	  “active”	  conformation	  [115].	  We	  then	  tested	  the	  effect	  of	  IRSp53	  and	  CDC42	  addition	  in	  our	  seeded	  actin	  polymerization	  assays.	  As	  shown	  in	  Figure	  18,	  in	  the	  presence	  of	  IRSp53	  and	  inactive	  GDP-­‐CDC42,	  IRSp53	  retains	  its	  weak	  capping	  activity.	  However,	  upon	  the	  addition	  of	  active	  GTP-­‐CDC42,	  IRSp53	  capping	  activity	  is	  abrogated.	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Kinetics	  of	  actin	  polymerization	  in	  presence	  of	  0.58	  μM	  IRSp53	  purified	  protein	  alone	  or	  with	  10	  μM	  GTP-­‐CDC42	  or	  GDP-­‐CDC42.	  Control	  sample	  contained	  no	  IRSp53.	  Barbed	  end	  growth	  was	  measured	  in	  bulk	  pyrenyl-­‐actin	  polymerization	  assays	  using	  1.25	  μM	  Mg-­‐ATP-­‐G-­‐actin	  (5%	  pyrenyl-­‐labelled),	  5	  μM	  profilin	  and	  0.16	  nM	  spectrin-­‐actin	  seeds	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  
	  Next,	  we	  performed	  a	  structure-­‐function	  analysis	  to	  identify	  the	  minimal	  region	  or	  domain	  of	  IRSp53	  involved	  in	  capping.	  We	  designed	  and	  purified	  a	  series	  of	  truncated	  or	  mutated	  IRSp53	  constructs,	  and	  tested	  their	  capping	  ability	  in	  seeded	  actin	  polymerization	  assays.	  Results	  are	  summarized	  in	  Figure	  19.	  A	  functional	  SH3	  domain	  is	  not	  required,	  since	  IRSp53	  W413G	  mutant,	  which	  is	  unable	  to	  bind	  SH3	  interactors,	  inhibited	  barbed	  ends	  growth.	  The	  truncated	  protein	  I-­‐BAR-­‐IRSp53	  and	  ΔI-­‐BAR-­‐IRSp53	  displayed	  no	  capping,	  indicating	  that	  the	  I-­‐BAR	  domain	  is	  required	  but	  not	  sufficient	  for	  this	  activity.	  	  The	  activity	  profile	  of	  mutants	  truncated	  between	  CRIB-­‐PR	  and	  SH3	  domains	  revealed	  that	  a	  second	  region	  is	  required	  by	  IRSp53	  to	  perform	  capping:	  this	  region	  comprises	  the	  amino	  acids	  339-­‐374,	  just	  before	  the	  SH3	  domain.	  Of	  note,	  by	  sequence	  alignment,	  we	  observed	  no	  similarities	  between	  339-­‐374	  IRSp53	  region	  and	  any	  other	  known	  actin-­‐binding	  protein,	  suggesting	  that	  IRSp53	  uses	  a	  novel	  mode	  of	  action	  in	  binding	  and	  blocking	  barbed	  ends	  growth.	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Figure	  19.	  Barbed	  end	  growth	  inhibition	  by	  the	  indicated	  IRSp53	  mutants.	  
All	  the	  indicated	  constructs	  were	  tested	  for	  their	  capping	  ability	  in	  bulk	  pyrenyl-­‐actin	  polymerization	  assays	  using	  1.25	  μM	  Mg-­‐ATP-­‐G-­‐actin	  (5%	  pyrenyl-­‐labelled),	  5	  μM	  profilin	  and	  0.16	  nM	  spectrin-­‐actin	  seeds	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  
	  These	  results	  further	  suggest	  that	  IRSp53	  either	  requires	  multiple	  interaction	  surfaces	  to	  act	  as	  a	  capper,	  or	  it	  needs	  to	  adopt	  an	  appropriate	  3-­‐D	  conformation.	  For	  this	  reason,	  we	  also	  tested	  two	  IRSp53	  conformational	  mutants,	  that	  have	  recently	  been	  described	  in	  Kast	  et	  al.,	  2014	  [115].	  IRSp53	  P278D/P281D	  mutant	  is	  no	  longer	  able	  to	  form	  the	  intramolecular	  interaction	  between	  the	  CRIB-­‐PR	  and	  the	  SH3	  domains	  (“open”	  mutant),	  while	  IRSp53	  I267A/S268A	  no	  longer	  binds	  to	  CDC42	  (constitutively	  inactive	  mutant).	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Figure	  20.	  Capping	  activity	  of	  IRSp53	  P278D/P281D	  and	  I267A/S268A	  mutants.	  
Kinetics	  of	  actin	  polymerization	  in	  presence	  of	  the	  indicated	  concentrations	  of	  IRSp53	  WT	  or	  P278D/P281D	  or	  I267A/S26	  mutated,	  alone	  or	  with	  2.5	  μM	  GTP-­‐CDC42.	  Control	  sample	  contained	  no	  IRSp53.	  Barbed	  end	  growth	  was	  measured	  in	  bulk	  pyrenyl-­‐actin	  polymerization	  assays	  using	  1.25	  μM	  Mg-­‐ATP-­‐G-­‐actin	  (5%	  pyrenyl-­‐labelled),	  5	  μM	  profilin	  and	  0.16	  nM	  spectrin-­‐actin	  seeds	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  	  As	  shown	  in	  Figure	  20,	  both	  P278D/P281D	  and	  I267A/S268A	  IRSp53	  mutants	  can	  act	  as	  cappers,	  indicating	  that	  this	  activity	  is	  unlikely	  due	  to	  the	  status	  of	  its	  “open”	  or	  “close”	  conformation.	  The	  finding	  that	  IRSp53	  I267A/S268A	  mutant	  retains	  its	  capping	  proficiency,	  even	  in	  the	  presence	  of	  CDC42-­‐GTP,	  indicates	  that	  their	  interaction	  is	  necessary	  to	  regulate	  barbed	  end	  capping,	  further	  suggesting	  that	  CDC42	  may	  act	  through	  a	  steric	  hindrance	  effect.	  	  	  It	  is	  also	  of	  note	  that	  the	  inhibition	  of	  barbed	  ends	  elongation	  by	  IRSp53	  developed	  slowly	  during	  filament	  growth.	  Interestingly,	  comparing	  actin	  polymerization	  curves	  in	  the	  presence	  of	  IRSp53	  full	  length	  or	  IRSp53	  1-­‐374,	  truncated	  just	  before	  the	  SH3	  domain,	  we	  observed	  that	  the	  two	  proteins	  have	  a	  different	  kinetic	  behavior.	  As	  can	  be	  noticed	  from	  the	  magnification	  of	  the	  firsts	  few	  seconds	  of	  actin	  polymerization,	  in	  Figure	  21,	  IRSp53	  1-­‐374	  inhibited	  instantaneously	  barbed	  end	  growth,	  while	  IRSp53	  displayed	  a	  time	  lag	  delay.	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Figure	  21.	  Comparison	  of	  the	  capping	  activity	  of	  IRSp53	  WT	  or	  1-­‐374	  truncated.	  
Kinetics	  of	  actin	  polymerization	  in	  presence	  of	  the	  indicated	  concentrations	  of	  IRSp53	  WT	  or	  truncated	  (1-­‐374).	  On	  the	  right,	  magnification	  of	  the	  region	  boxed	  in	  the	  left	  graph.	  Control	  sample	  contained	  no	  IRSp53.	  Barbed	  end	  growth	  was	  measured	  in	  bulk	  pyrenyl-­‐actin	  polymerization	  assays	  using	  1.25	  μM	  Mg-­‐ATP-­‐G-­‐actin	  (5%	  pyrenyl-­‐labelled),	  5	  μM	  profilin	  and	  0.16	  nM	  spectrin-­‐actin	  seeds	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  
	  The	  slow	  kinetic	  of	  IRSp53	  association	  to	  the	  barbed	  ends	  again	  suggests	  that	  IRSp53	  may	  need	  a	  slow	  conformational	  change	  to	  efficiently	  cap	  actin	  filaments,	  while	  all	  the	  surfaces	  required	  for	  capping	  are	  presumably	  unmasked	  in	  the	  mutant	  lacking	  the	  SH3	  domain.	  Alternatively,	  these	  small	  conformational	  changes	  might	  follow	  the	  binding	  of	  IRSp53	  to	  the	  actin	  filaments,	  thus	  affecting	  the	  rate	  of	  filament	  growth.	  In	  summary,	  the	  data	  reported	  here	  suggest	  a	  novel	  capping	  function	  for	  IRSp53,	  which	  is	  relieved	  by	  active	  CDC42	  and	  dependent	  on	  two	  regions	  of	  IRSp53:	  the	  I-­‐BAR	  domain	  and	  a	  30	  amino	  acids	  patch	  just	  before	  the	  SH3	  domain.	  	  
IRSp53	  and	  VASP	  directly	  interacts,	  using	  IRSp53	  SH3	  domain	  and	  VASP	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approaches	  suggest	  that	  VASP,	  another	  member	  of	  the	  ENA/VASP	  family,	  is	  also	  able	  to	  bind	  IRSp53[20]	  [161].	  Hence	  we	  next	  tested	  whether	  IRSp53	  and	  VASP	  proteins	  are	  capable	  of	  forming	  a	  complex	  using	  in	  vitro	  purified	  components	  and	  asked	  whether	  their	  interaction	  has	  a	  functional	  role	  in	  cells.	  We	  started	  performing	  simple	  in	  vitro	  binding	  assays.	  As	  shown	  in	  Figure	  22	  A,	  IRSp53,	  as	  well	  as	  its	  isolated	  SH3	  domain,	  bound	  to	  VASP.	  Conversely,	  an	  IRSp53	  point	  mutant	  in	  the	  SH3	  region,	  IRSp53	  W413G,	  was	  no	  longer	  able	  to	  interact	  with	  VASP.	  As	  negative	  control,	  we	  used	  EPS8,	  which	  also	  contains	  a	  SH3	  domain,	  but	  did	  not	  display	  any	  binding	  ability	  to	  VASP	  (Figure	  22	  B).	  	  
	  
Figure	  22.	  IRSp53	  binds	  VASP	  through	  its	  SH3	  domain.	  
A	  Recombinant	  purified	  VASP	  was	  incubated	  with	  glutathione-­‐sepharose	  (GST)	  or	  Ni-­‐NTA	  agarose	  beads	  (His	  beads)	  as	  control,	  or	  in	  presence	  of	  GST,	  GST-­‐IRSp53-­‐SH3	  or	  His-­‐IRSp53.	  Input	  (10%	  of	  total)	  and	  bound	  material	  were	  immunoblotted	  with	  VASP	  antibody.	  Ponceau	  staining	  was	  used	  to	  detect	  recombinant	  GST,	  GST-­‐IRSp53-­‐SH3	  and	  His-­‐IRSp53.	  	  
B	  Recombinant	  purified	  VASP	  was	  incubated	  with	  purified	  His-­‐EPS8,	  His-­‐IRSp53-­‐W413G	  mutant	  or	  His-­‐IRSp53	  WT	  immobilized	  onto	  Ni-­‐NTA	  agarose	  beads.	  Input	  (10%	  of	  total)	  and	  bound	  material	  were	  immunoblotted	  with	  the	  indicated	  antibodies	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	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sequence.	  We,	  therefore,	  took	  advantage	  of	  VASP	  mutant	  in	  which	  the	  central	  PRD	  was	  deleted	  (VASP	  ΔPRD).	  As	  shown	  in	  Figure	  23,	  VASP	  ΔPRD	  was	  no	  longer	  able	  to	  bind	  to	  the	  SH3	  domain	  of	  IRSp53.	  Also	  the	  construct	  lacking	  the	  three	  central	  GP5	  motif	  included	  in	  PRD	  (VASP	  Δ(GP5)3)	  failed	  to	  associate	  with	  the	  SH3	  domain	  of	  IRSp53.	  
	  
Figure	  23.	  VASP	  binds	  IRSp53-­‐SH3	  through	  its	  PRD.	  
A	  Recombinant	  purified	  VASP	  or	  VASP	  ΔPRD	  was	  incubated	  with	  GST,	  as	  control,	  or	  GST-­‐IRSp53-­‐SH3.	  Inputs	  (10%	  of	  total)	  and	  bound	  material	  were	  immunoblotted	  with	  VASP	  antibody.	  Ponceau	  staining	  was	  used	  for	  recombinant	  GST	  and	  GST-­‐IRSp53-­‐SH3.	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Figure	  24.	  IRSp53,	  VASP	  and	  profilin	  may	  form	  a	  ternary	  complex.	  	  
A	  Solid-­‐phase	  binding	  assays.	  His-­‐VASP	  (0.1	  µM)	  pre-­‐incubated	  or	  not	  with	  cleaved	  IRSp53	  SH3	  (0.1	  to	  5	  µM	  SH3)	  was	  added	  to	  profilin	  IIa-­‐coated	  ELISA	  plates	  (0.06	  nmol	  in	  100	  µl).	  After	  blocking	  and	  washing,	  His-­‐VASP	  was	  detected.	  Profilin	  IIa	  without	  VASP	  and	  IRSp53	  SH3	  was	  used	  for	  back	  ground	  correction.	  The	  negative	  control	  was	  the	  highest	  concentration	  of	  IRSp53	  SH3	  (5	  µM)	  in	  the	  absence	  of	  VASP.	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C	  His-­‐VASP	  (0.1	  µM)	  pre-­‐incubated	  or	  not	  with	  GST-­‐IRSp53	  SH3	  (0.1	  to	  5	  µM)	  was	  added	  to	  profilin	  IIa-­‐coated	  ELISA	  plates	  (0.06	  nmol	  in	  100	  µl).	  After	  blocking	  and	  washing,	  GST-­‐IRSp53-­‐SH3	  was	  detected.	  Profilin	  IIa	  without	  VASP	  and	  IRSp53	  SH3	  was	  used	  for	  back	  ground	  correction.	  The	  negative	  controls	  were	  the	  highest	  concentration	  of	  IRSp53-­‐SH3	  in	  the	  absence	  of	  VASP	  and	  VASP	  in	  the	  absence	  of	  GST-­‐IRSp53-­‐SH3.	  Positive	  controls	  were	  concentration	  series	  of	  VASP	  (experiment	  1	  and	  2)	  and	  GST-­‐IRSp53-­‐SH3	  (experiment	  3)	  coated	  directly	  (not	  shown).	  In	  each	  case	  data	  (OD450nm)	  are	  the	  averages	  from	  three	  independent	  experiments	  for	  each	  condition.	  Error	  bars	  are	  SD	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  	  To	  better	  investigate	  the	  molecular	  and	  physical	  property	  of	  the	  IRSp53:VASP	  complex,	  we	  performed	  dynamic	  light	  scattering	  (DLS)	  analysis.	  When	  both	  IRSp53	  than	  VASP	  were	  present,	  species	  with	  high	  hydrodynamic	  radius	  emerged	  (at	  about	  200	  nm),	  indicating	  that	  the	  two	  proteins	  in	  solution	  can	  associate	  and	  form	  large	  clusters.	  When	  IRSp53	  was	  incubated	  in	  the	  presence	  of	  VASP	  ΔPRD	  mutant,	  the	  two	  proteins	  were	  not	  able	  to	  interact	  and	  no	  large	  clusters	  could	  be	  detected	  (Figure	  25).	  	  	  
	  
Figure	  25.	  IRSp53	  and	  VASP	  form	  large	  clusters	  in	  solution.	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B	  Intensity	  weighted	  diameter	  distrubutions	  for	  30	  μM	  IRSp53,	  30	  μM	  VASP	  ΔPRD	  or	  the	  mixture	  of	  10	  μM	  IRSp53	  and	  10	  μM	  VASP	  ΔPRD,	  in	  this	  latter	  condition	  no	  clusters	  were	  observed	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  In	  summary,	  our	  data	  indicate	  that	  IRSp53	  and	  VASP	  interact	  directly.	  The	  SH3	  domain	  of	  IRSp53	  binds	  specifically	  to	  the	  VASP	  PRD	  domain.	  This	  interaction	  leads	  to	  the	  formation	  of	  high-­‐order	  oligomers	  in	  solution.	  
IRSp53	  promotes	  VASP	  processive	  elongation	  activity	  by	  clustering	  VASP	  on	  
surfaces	  Next,	  we	  aimed	  at	  understanding	  whether	  IRSp53:VASP	  interaction	  had	  any	  effect	  on	  their	  biochemical	  functions.	  VASP	  is	  a	  processive	  elongator	  of	  actin	  filaments,	  particularly	  when	  clustered	  on	  functionalized	  beads.	  We	  hypothesized	  that	  if	  IRSp53	  is	  able	  to	  mediate	  VASP	  clustering	  in	  solution	  (as	  emerged	  from	  DLS	  data),	  the	  same	  might	  happen	  when	  IRSp53	  is	  immobilized	  onto	  beads.	  This	  hypothetical	  mode	  of	  action	  is	  schematically	  illustrated	  in	  Figure	  26.	  
	  
Figure	  26.	  Scheme	  of	  the	  experimental	  setup.	  
Magnetic	  Ni-­‐NTA	  beads	  were	  coated	  with	  His-­‐IRSp53,	  then	  added	  to	  TIRF	  buffer	  containing	  Atto-­‐488	  labelled	  monomeric	  actin,	  capping	  protein	  (CP)	  and	  VASP.	  According	  to	  our	  hypothesis,	  if	  IRSp53	  was	  able	  to	  cluster	  VASP	  on	  the	  beads	  surface,	  it	  would	  promote	  VASP	  processive	  elongation	  activity.	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To	  test	  this	  hypothesis,	  we	  performed	  TIRF	  assays	  in	  collaboration	  with	  J.	  Faix	  (Hannover	  Medical	  School,	  Germany).	  Purified	  proteins	  where	  incubated	  in	  TIRF	  buffer,	  in	  the	  presence	  of	  Ni-­‐NTA	  micro	  beads,	  fluorescently	  labelled	  actin	  monomers	  and	  CP.	  The	  addition	  of	  CP	  prevents	  spontaneous	  actin	  polymerization	  in	  solution.	  Recombinant	  and	  purified	  His-­‐VASP	  was	  directly	  recruited	  and	  clustered	  on	  beads:	  a	  step	  that	  led	  to	  the	  activation	  of	  its	  processive	  elongation	  activity.	  Indeed,	  when	  we	  used	  a	  VASP	  tagged	  with	  GST,	  and	  thus	  no	  longer	  able	  to	  bind	  to	  Ni-­‐NTA	  beads,	  no	  enhancement	  of	  filament	  growth	  could	  be	  detected.	  Only	  in	  presence	  of	  Ni-­‐NTA	  beads	  saturated	  with	  IRSp53,	  we	  observed	  GST-­‐VASP	  clustering	  on	  beads	  and,	  subsequently,	  processive	  elongation	  of	  actin	  filaments	  (Figure	  27).	  
	  	  
Figure	  27.	  IRSp53	  recruits	  and	  clusters	  VASP,	  to	  drive	  processive	  actin	  filament	  elongation.	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presence	  of	  50	  nM	  CP	  and	  200	  nM	  VASP	  or	  VASP	  DdGAB.	  Only	  filaments	  that	  were	  attached	  with	  their	  barbed	  ends	  to	  the	  beads	  were	  observed,	  since	  CP	  abolished	  filament	  growth	  in	  solution.	  Time	  is	  indicated	  in	  seconds	  in	  the	  upper	  right	  corner	  of	  each	  frame.	  Scale	  bar:	  10	  μm.	  
B	  Quantification	  of	  actin	  filament	  elongation	  rates	  from	  experiments	  shown	  in	  A.	  Data	  are	  presented	  as	  mean	  ±	  s.d.	  of	  three	  independent	  experiments,	  in	  which	  at	  least	  16	  filaments/experiment	  were	  measured	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  We	  also	  performed	  the	  same	  assay	  in	  the	  presence	  of	  a	  VASP	  chimera,	  in	  which	  the	  human	  GAB	  domain	  was	  substituted	  with	  the	  GAB	  domain	  from	  Dictyostelium	  
discoideum.	  VASP	  DdGAB	  chimera	  promotes	  a	  3-­‐	  to	  4-­‐fold	  higher	  rate	  of	  filament	  elongation	  as	  compared	  	  to	  hVASP,	  due	  to	  its	  higher	  affinity	  for	  G-­‐actin	  [192].	  Even	  under	  these	  conditions,	  IRSp53	  was	  able	  to	  recruit	  and	  to	  cluster	  VASP	  DdGAB	  on	  beads	  and,	  by	  doing	  so,	  to	  promote	  actin	  filament	  elongation.	  The	  IRSp53	  W413G	  mutant,	  instead,	  as	  expected,	  did	  not	  permit	  VASP	  clustering	  on	  beads,	  reinforcing	  the	  functional	  importance	  of	  this	  domain	  in	  mediating	  the	  interaction	  between	  the	  two	  proteins	  and	  the	  activation	  of	  VASP.	  
IRSp53	  is	  able	  to	  recruit	  and	  cluster	  VASP	  on	  membranes	  Our	  TIRF	  data	  support	  the	  hypothesis	  that	  IRSp53	  can	  recruit	  and	  cluster	  VASP	  on	  solid	  supports,	  we	  next	  wandered	  if	  the	  same	  could	  also	  occur	  on	  the	  plasma	  membrane.	  To	  mimic	  the	  plasma	  membrane,	  we	  used	  PIP2-­‐containing	  liposomes	  (since	  IRSp53	  shows	  a	  preference	  for	  PIP2	  lipids	  [120]),	  and	  tested	  their	  ability	  to	  bind	  fluorescently	  labelled	  proteins,	  exploiting	  a	  FACS	  based	  approach,	  in	  collaboration	  with	  W.	  Nickel	  (Heidelberg	  University,	  Germany)	  [188].	  	  As	  shown	  in	  Figure	  28,	  labelled	  IRSp53	  WT	  and	  W413G	  mutant	  were	  both	  recruited	  to	  PIP2	  liposomes,	  that	  in	  fact	  showed	  an	  increased	  associated	  fluorescence	  signal.	  In	  contrast,	  VASP	  did	  not	  directly	  bind	  PIP2	  liposomes.	  Only	  in	  the	  presence	  of	  IRSp53,	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fluorescently	  labelled-­‐VASP	  could	  be	  recruited	  to	  liposomes.	  If	  IRSp53	  was	  mutated	  in	  the	  SH3	  domain,	  VASP	  was	  no	  longer	  recruited	  to	  PIP2	  liposomes.	  
	  
Figure	  28.	  IRSp53	  is	  necessary	  for	  VASP	  recruitment	  to	  PIP2-­‐containing	  liposomes.	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Figure	  29.	  Expression	  levels	  of	  IRSp53	  and	  VASP	  in	  MEFs.	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Figure	  30.	  IRSp53	  is	  required	  for	  VASP	  recruitement	  and	  clustering	  at	  the	  plasma	  membrane.	  
A	  Still	  images	  from	  fluorescence	  time-­‐lapse	  analysis	  of	  migrating	  cells.	  MEF	  cells	  from	  IRSp53	  KO	  mice	  were	  infected	  with	  empty	  vector	  (KO-­‐pBABE),	  KO-­‐pBABE-­‐IRSp53	  WT	  or	  KO-­‐pBABE-­‐IRSp53	  W413G.	  Cells	  were	  then	  electroporated	  with	  GFP-­‐VASP	  and	  plated	  on	  laminin	  (40	  μg/ml).	  Twenty	  hours	  after	  electroporation,	  cells	  were	  analysed	  by	  time-­‐lapse	  imaging	  (5	  minuts,	  time	  interval	  5	  seconds).	  Arrows	  indicate	  VASP	  puncta.	  
B	  Quantification	  of	  the	  number	  of	  clusters	  (mean	  ±	  s.e.m.)	  formed	  by	  GFP-­‐VASP	  for	  all	  the	  conditions	  tested	  in	  A.	  20	  cells	  for	  each	  conditions	  were	  analysed	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  Next	  we	  also	  electroporated	  IRSp53-­‐KO	  MEF	  cells	  with	  GFP-­‐VASP	  and	  mCherry-­‐IRSp53,	  plated	  them	  on	  laminin	  and	  subjected	  to	  time	  lapse	  analysis.	  We	  observed	  that	  also	  IRSp53	  accumulated	  in	  discrete	  foci,	  that	  were	  also	  positive	  for	  VASP	  and	  fascin	  (not	  shown)	  and	  were	  preluding	  the	  formation	  of	  filopodia.	  To	  get	  more	  
t = 0min t = 1min t = 2min t = 3min t = 4min t = 5min
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insights	  into	  the	  timing	  of	  IRSp53	  and	  VASP	  recruitment	  at	  the	  plasma	  membrane,	  we	  performed	  a	  careful,	  fast-­‐acquisition	  time	  lapse	  analysis	  to	  follow	  the	  accumulation	  of	  the	  two	  fluorescent	  proteins	  over	  time.	  We	  observed	  that	  IRSp53	  accumulation	  in	  foci	  slightly,	  but	  reproducibly,	  preceded	  (1.4	  seconds	  on	  average)	  VASP	  accumulation	  (Figure	  31).	  
	  
Figure	  31.	  IRSp53	  accumulation	  into	  foci	  at	  the	  plasma	  membrane	  slightly	  precedes	  VASP	  
recruitment.	  
Still	  images	  from	  fluorescence	  spinning-­‐disk	  confocal	  analysis	  of	  migrating	  cells.	  MEF	  cells	  were	  electroporated	  with	  GFP-­‐VASP	  and	  mCherry-­‐IRSp53	  and	  plated	  on	  laminin	  (40	  μg/ml).	  24	  hour	  after	  electroporation,	  cells	  were	  subjected	  to	  time	  lapse	  analysis	  (time	  interval	  0.55	  sec).	  Upper	  panels	  represent	  GFP-­‐VASP	  and	  mCherry-­‐IRSp53	  signal	  as	  grew	  colours,	  lower	  panels	  represent	  the	  same	  images	  elaborated	  with	  the	  spectrum	  colour	  filter	  from	  ImageJ	  software,	  used	  to	  highlight	  local	  accumulation	  of	  fluorescent	  signals	  (highest	  intensities	  are	  in	  red,	  the	  lowest	  one	  in	  blue).	  White	  and	  yellow	  arrowheads	  indicate	  IRSp53	  and	  VASP	  accumulation.	  Bar	  is	  5	  μm	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  
	  Summing	  up	  this	  section,	  we	  found	  that	  IRSp53	  is	  required	  for	  VASP	  accumulation	  at	  the	  plasma	  membrane	  in	  small	  foci,	  which	  are	  markers	  of	  filopodia	  initiation.	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CDC42	  increases	  the	  apparent	  affinity	  between	  IRSp53	  and	  VASP	  and	  this	  axis	  
promotes	  efficient	  filopodia	  formation	  Since	  CDC42	  is	  a	  known	  IRSp53	  interactor,	  we	  next	  investigated	  whether	  CDC42	  influences	  IRSp53:VASP	  interaction	  and	  modulates	  their	  biological	  activity.	  We	  started	  by	  performing	  in	  vitro	  binding	  assays	  using	  purified	  IRSp53,	  VASP	  and	  CDC42	  proteins.	  We	  observed	  that	  in	  presence	  of	  100	  nM	  or	  250	  nM	  IRSp53,	  the	  amount	  of	  VASP	  that	  IRSp53	  could	  bind	  increased	  in	  the	  presence	  of	  saturating	  concentrations	  of	  GTP-­‐bound	  CDC42.	  At	  500	  nM	  these	  difference	  was	  lost,	  probably	  because	  saturation	  was	  achieved	  (Figure	  32).	  
	  
Figure	  32.	  CDC42	  modulates	  the	  interaction	  between	  purified	  IRSp53	  and	  VASP.	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immunoprecipitating	  with	  VASP	  was	  higher	  than	  the	  amount	  of	  IRSp53	  co-­‐immunoprecipitated	  in	  presence	  of	  CDC42N17	  or	  an	  empty	  vector	  (Figure	  33).	  
	  
Figure	  33.	  CDC42	  favours	  the	  formation	  of	  an	  IRSp53:VASP	  complex	  in	  HeLa	  cells.	  
Lysates	  (2	  mg)	  of	  HeLa	  cells,	  transfected	  with	  an	  empty	  vector	  as	  control	  or	  CDC42	  N17	  (dominant	  negative)	  or	  CDC42	  L61	  (constitutively	  active),	  were	  immunoprecipitated	  with	  an	  anti-­‐VASP	  or	  a	  control	  antibody.	  Input	  lysates	  (40	  μg)	  and	  immunoprecipitates	  (IPs)	  were	  immunoblotted	  with	  the	  indicated	  antibodies	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	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Figure	  34.	  IRSp53	  is	  required	  for	  CDC42-­‐induced	  filopodia	  formation.	  



































































Sara	  Bisi	  PhD	  thesis	   119	  
B	  Quantification	  of	  the	  number	  of	  filopodia	  induced	  per	  cell,	  in	  MEF	  cells	  IRSp53	  KO-­‐pBABE	  and	  IRSp53	  KO-­‐pBABE-­‐IRSp53,	  transfected	  with	  myc-­‐CDC42	  L61.	  At	  least,	  100	  cells	  were	  analysed	  in	  each	  experiment	  and	  three	  independent	  experiments	  were	  performed.	  Data	  are	  mean	  ±	  s.e.m.	  
C	  Expression	  levels	  of	  IRSp53,	  myc-­‐CDC42	  L61	  and	  vinculin	  were	  analysed	  by	  immunoblotting	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  These	  data	  support	  the	  hypothesis	  that	  CDC42:IRSp53	  (and	  possibly	  VASP)	  axis	  is	  important	  in	  filopodia	  formation.	  IRSp53	  is	  also	  required	  for	  VASP	  localization	  at	  filopodia	  tips.	  As	  shown	  in	  Figure	  35,	  VASP	  localized	  at	  filopodia	  tips	  only	  in	  IRSp53	  null	  MEFs	  reconstituted	  with	  pBABE-­‐IRSp53	  WT.	  This	  localization	  of	  VASP	  was	  lost	  in	  MEFs	  infected	  with	  pBABE	  empty	  vector	  or	  pBABE-­‐IRSp53	  W413G	  mutant.	  Of	  note,	  IRSp53	  localized	  along	  the	  shafts	  of	  protruding	  filopodia	  (see	  Figure	  35).	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Figure	  35.	  IRSp53	  removal	  impairs	  VASP	  localization	  at	  filopodia	  tips.	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B	  Expression	  levels	  of	  myc-­‐CDC42	  L61,	  GFP-­‐VASP,	  IRSp53	  and	  vinculin	  were	  analysed	  by	  immunoblotting	  in	  IRSp53	  null	  MEFs	  infected	  with	  pBABE	  empty	  vector,	  pBABE-­‐IRSp53	  WT	  and	  pBABE-­‐IRSp53-­‐W413G.	  
C	  The	  number	  of	  cells	  expressing	  CDC42	  L61	  and	  presenting	  VASP	  at	  tips	  of	  filopodia	  was	  counted.	  Data	  are	  mean	  ±	  s.e.m.	  from	  three	  independent	  experiments	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	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Figure	  36.	  IRSp53	  removal	  affects	  wound	  healing	  closure	  in	  MEFs.	  
A	  IRSp53	  null	  MEF	  cells,	  infected	  with	  pBABE	  empty	  vector	  of	  pBABE-­‐IRSp53	  WT	  vector	  were	  seeded	  and	  grown	  to	  confluence.	  Cells	  were	  then	  scratched	  with	  a	  tip	  and	  analysed	  by	  DIC	  time-­‐lapse	  imaging	  (20	  hours,	  5	  minutes	  time	  interval).	  In	  the	  panels	  are	  represented	  still	  images	  taken	  at	  the	  indicated	  time	  points.	  White-­‐dashed	  lines	  mark	  the	  front	  of	  migrating	  cells,	  bar	  is	  50	  μm.	  
B	  Single-­‐cell	  migration	  was	  analysed	  from	  time-­‐lapse	  data	  presented	  in	  A,	  using	  the	  ImageJ	  software.	  Upper	  panel:	  the	  directional	  migration	  index	  was	  calculated,	  it	  represents	  the	  ratio	  between	  the	  total	  distance	  covered	  by	  the	  cells	  and	  the	  distance	  covered	  longitudinally	  towards	  the	  centre	  of	  the	  wound.	  Lower	  panel:	  calculated	  average	  speed.	  At	  least	  20	  cells	  were	  analysed	  for	  each	  condition,	  in	  three	  independent	  experiments	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  
	  We	  also	  subjected	  IRSp53	  null	  MEFs	  to	  different	  trans-­‐well	  migration	  and	  invasion	  assays:	  we	  observed	  that	  these	  cells	  were	  defective	  in	  migration	  (both	  in	  serum	  or	  PDGF	  chemotactic	  conditions,	  shown	  in	  Disanza	  et	  al.,	  2013	  [191])	  and	  matrigel	  invasion	  (Figure	  37),	  with	  respect	  to	  MEF	  cells	  infected	  with	  pBABE-­‐IRSp53.	  	  
	  
Figure	  37.	  IRSp53	  removal	  affects	  MEFs	  invasion.	  
A	  KO-­‐pBABE	  and	  KO-­‐pBABE-­‐IRSp53	  MEF	  cells	  were	  subjected	  to	  invasion	  assay	  and	  plated	  on	  Matrigel-­‐coated	  chambers.	  PDGF	  was	  added	  in	  the	  lower	  chamber	  to	  generate	  a	  chemo-­‐attractive	  gradient.	  Cells	  were	  fixed	  after	  16	  hours	  and	  stained	  with	  DAPI	  to	  detect	  nuclei.	  Bar	  is	  10	  μm.	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Finally,	  we	  took	  advantage	  of	  Irsp53	  null	  mice,	  and	  subjected	  them	  to	  dermal	  punch	  wound	  as	  model	  of	  wound	  healing.	  During	  tissue	  repair,	  cells	  migrate	  to	  the	  wound	  area,	  including	  keratinocytes,	  endothelial	  cells,	  macrophages	  and	  mesenchymal	  cells.	  We	  observed	  that	  Irsp53	  null	  mice	  displayed	  a	  delayed	  wound	  closure	  when	  compared	  to	  WT	  mice	  (Figure	  38).	  	  
	  
Figure	  38.	  Genetic	  removal	  of	  IRSp53	  in	  mice	  impairs	  wound	  repair.	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Part	  two:	  IRSp53	  is	  involved	  in	  the	  early	  steps	  
of	  lumenogenesis	  
	  
IRSp53	  is	  apical	  and	  junctional	  localized	  in	  MDCK	  cells	  monolayer,	  but	  it	  stays	  
at	  the	  lumen	  in	  MDCK	  cysts	  Scattered	  set	  of	  evidence	  suggest	  an	  involvement	  of	  IRSp53	  in	  polarity	  establishment.	  To	  explore	  further	  this	  possibility,	  we	  initially	  selected	  MDCK	  cells	  as	  model	  system,	  since	  these	  cells	  can	  be	  easily	  grown	  as	  cysts,	  with	  clearly	  defined	  apical	  and	  basal	  surfaces,	  able	  to	  recapitulate	  in	  vitro	  the	  polarity	  morphogenetic	  program.	  Noteworthy,	  a	  lot	  of	  information	  are	  available	  in	  literature	  about	  the	  molecular	  mechanism	  of	  lumenogenesis	  in	  MDCK	  cells	  [176]	  [178].	  	  MDCK	  cells	  were	  infected	  with	  lentiviral	  vectors	  encoding	  for	  GFP-­‐IRSp53,	  or	  GFP	  as	  control.	  Cells	  were	  grown	  at	  confluence	  to	  allow	  the	  formation	  of	  a	  mature	  and	  polarized	  monolayer.	  Under	  these	  conditions,	  we	  assessed	  the	  localization	  of	  GFP-­‐IRSp53:	  it	  was	  enriched	  on	  both	  the	  apical	  and	  junctional	  lateral	  area,	  and	  partially	  co-­‐localized	  with	  β-­‐catenin	  and	  podocalyxin	  (Figure	  39).	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Figure	  39.	  IRSp53	  localizes	  to	  apical	  and	  junctional	  areas	  in	  MDCK	  monolayer.	  
A	  MDCK	  cells	  were	  infected	  with	  GFP-­‐IRSp53	  and	  grown	  at	  confluency.	  Cells	  were	  then	  fixed	  and	  stained	  with	  anti-­‐β-­‐catenin	  antibody,	  DAPI	  was	  used	  to	  detect	  nuclei.	  Z	  and	  X-­‐Y	  sections	  were	  taken	  using	  a	  confocal	  microscope.	  Scale	  bar	  is	  10	  μm.	  
B	  MDCK	  cells	  were	  infected	  with	  GFP-­‐IRSp53	  and	  grown	  at	  confluency.	  Cells	  were	  then	  fixed	  and	  stained	  with	  anti-­‐podocalyxin	  antibody,	  DAPI	  was	  used	  to	  detect	  nuclei.	  Z	  and	  X-­‐Y	  sections	  were	  taken	  using	  a	  confocal	  microscope.	  Scale	  bar	  is	  10	  μm.	  
	  When	  MDCK	  cells	  were	  plated	  on	  top	  of	  a	  Matrigel	  layer,	  to	  form	  a	  polarized	  cyst,	  GFP-­‐IRSp53	  was	  restricted	  to	  the	  apical/lumenal	  side,	  co-­‐localizing	  with	  the	  apical	  marker	  phalloidin,	  but	  not	  with	  β-­‐catenin.	  Importantly,	  endogenous	  IRSp53	  also	  displayed	  a	  pattern	  similar	  to	  the	  ectopically	  expressed	  GFP-­‐tagged	  protein,	  validating	  the	  relevance	  of	  the	  latter	  approach	  to	  gain	  clues	  about	  the	  distribution	  of	  IRSp53	  in	  epithelial	  cells	  and	  tissues.	  Of	  note,	  GFP	  alone	  was	  diffused	  in	  the	  cytoplasm,	  as	  expected	  (Figure	  40).	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Figure	  40.	  IRSp53	  localizes	  at	  the	  lumenal	  region	  in	  MDCK	  cysts.	  
MDCK	  cells	  WT	  or	  infected	  with	  GFP	  or	  GFP-­‐IRSp53	  were	  resuspended	  as	  single	  cells	  and	  plated	  on	  a	  Matrigel	  layer	  for	  6	  days,	  to	  form	  a	  polarized	  cyst.	  Cysts	  were	  then	  fixed	  and	  stained	  with	  phalloidin,	  anti-­‐β-­‐catenin	  or	  anti-­‐IRSp53	  antibody,	  DAPI	  was	  used	  to	  detect	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  18	  μm.	  
	  	  To	  validate	  these	  findings,	  we	  selected	  another	  cell	  line,	  of	  human	  origin,	  that	  forms	  spheroids	  when	  embedded	  in	  a	  Matrigel-­‐collagen	  matrix:	  Caco2.	  We	  again	  tested	  GFP-­‐IRSp53	  localization	  in	  Caco2	  spheroids:	  as	  seen	  in	  MDCK,	  we	  found	  that	  IRSp53	  was	  prominently	  enriched	  in	  the	  apical	  region	  of	  the	  organoids	  (Figure	  41).	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Figure	  41.	  IRSp53	  localizes	  at	  the	  lumenal	  region	  in	  Caco2	  cysts.	  
Caco2	  cells	  have	  been	  infected	  with	  GFP	  or	  GFP-­‐IRSp53	  encoding	  vectors.	  Single	  cells	  were	  then	  embedded	  in	  Matrigel-­‐collagen	  mixture	  to	  form	  Caco2	  spheroids.	  Spheroids	  were	  then	  fixed,	  stained	  with	  DAPI	  to	  detect	  nuclei	  and	  analysed	  by	  confocal	  microscopy.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  70	  μm.	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Figure	  42.	  IRSp53	  KD	  causes	  multilumen	  phenotype	  in	  MDCK	  cysts.	  
A	  MDCK	  IRSp53	  Tet-­‐off	  cells	  were	  treated	  with	  or	  without	  doxycycline,	  to	  induce	  IRSp53	  depletion.	  Single	  cells	  were	  plated	  on	  Matrigel	  to	  form	  cysts	  and	  fixed	  at	  day	  6.	  Cysts	  were	  then	  incubated	  with	  TRIC-­‐phalloidin	  to	  highlight	  the	  lumen	  and	  DAPI	  to	  stain	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  18	  μm.	  
B	  Levels	  of	  IRSp53	  expression	  in	  MDCK	  IRSp53	  Tet-­‐off	  cells	  treated	  with	  or	  without	  doxycycline,	  to	  induce	  IRSp53	  depletion.	  
C	  Percentage	  of	  cyst	  presenting	  a	  multilumen	  phenotype,	  formed	  by	  MDCK	  IRSp53	  Tet-­‐off	  cells	  treated	  with	  or	  without	  doxycycline,	  to	  induce	  IRSp53	  depletion.	  Experiments	  were	  performed	  in	  triplicate,	  counting	  at	  least	  30	  cysts	  for	  each	  condition.	  Data	  are	  mean	  ±	  s.d.	  	  We	  then	  checked	  the	  effect	  of	  IRSp53	  depletion	  also	  in	  Caco2	  cysts.	  We	  decided	  to	  use	  the	  CRISPR/Cas9	  genome	  editing	  approach	  to	  permanently	  KO	  IRSp53	  in	  Caco2	  cells.	  Two	  clones	  were	  derived	  (#3,	  #12)	  and	  used	  to	  form	  organoids:	  again,	  we	  observed	  a	  multilumen	  phenotype	  in	  the	  cysts	  originated	  from	  IRSp53	  KO	  Caco2	  cells	  (with	  a	  frequency	  of	  55%	  and	  35%	  of	  multilumen	  cysts,	  respectively,	  in	  the	  two	  derived	  clones,	  in	  comparison	  with	  WT	  cells	  that	  form	  ~17%	  of	  aberrant	  cysts)	  (Figure	  43).	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Noteworthy,	  both	  in	  control	  and	  KO	  cysts,	  the	  lumens	  were	  stained	  for	  the	  apical	  marker	  aPKC,	  suggesting	  that	  IRSp53	  removal	  does	  not	  affect	  the	  apical	  localization	  of	  this	  latter	  protein.	  
	  
Figure	  43.	  Multilumen	  cysts	  originate	  from	  IRSp53	  KO	  Caco2	  cells.	  
A	  Caco2	  cells	  WT	  or	  IRSp53	  KO	  (through	  CRISPR/Cas9	  genome	  editing)	  were	  embedded	  in	  Matrigel-­‐collagen	  matrix	  to	  form	  cysts.	  Cysts	  were	  then	  fixed,	  stained	  with	  aPKC,	  phalloidin	  and	  DAPI	  to	  detect	  nuclei	  and	  analysed	  by	  confocal	  microscopy.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  20	  μm.	  
B	  Caco2	  WT	  or	  IRSp53	  KO	  (clones	  #3	  and	  #12,	  originated	  by	  CRISPR/Cas9	  genome	  editing)	  cells	  were	  lysated	  and	  immunoblotted	  with	  the	  indicated	  antibodies.	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  To	  confirm	  that	  the	  multilumen	  phenotype	  in	  Caco2	  IRSp53	  KO	  cells	  was	  specifically	  due	  to	  the	  absence	  of	  IRSp53	  protein,	  and	  not	  to	  spurious	  effects,	  we	  infected	  Caco2	  IRSp53	  KO	  clones	  with	  lentiviral	  vectors	  encoding	  for	  GFP	  or	  mouse	  GFP-­‐IRSp53.	  In	  presence	  of	  GFP-­‐IRSp53,	  the	  multilumen	  phenotype	  of	  IRSp53	  KO	  cysts	  was	  rescued	  (24%	  of	  multilumen	  frequency),	  while	  GFP	  was	  not	  able	  to	  do	  the	  same	  (50%	  of	  multilumen	  frequency)	  (in	  Figure	  44	  A,	  images	  relatives	  to	  clone	  #12).	  	  We	  then	  decided	  to	  perform	  a	  structure-­‐function	  analysis,	  to	  understand	  which	  domain	  from	  IRSp53	  was	  required	  for	  the	  correct	  organization	  of	  Caco2	  cysts	  and	  start	  to	  get	  clues	  about	  the	  underlying	  mechanism.	  We	  infected	  IRSp53	  KO	  clones	  with	  lentiviral	  vectors	  encoding	  for	  GFP-­‐IRSp53	  carrying	  a	  point	  mutation	  in	  the	  I-­‐BAR,	  CRIB,	  SH3	  or	  PDZ-­‐binding	  domains	  and	  used	  these	  cells	  in	  our	  organoids	  assay.	  We	  observed	  a	  multilumen	  phenotype	  in	  presence	  of	  both	  IRSp53	  mutated	  in	  I-­‐BAR,	  CRIB	  and	  SH3	  domain	  (multilumen	  frequency	  of	  53%,	  55%	  and	  47%	  respectively),	  indicating	  that	  all	  of	  them	  are	  required	  for	  the	  correct	  execution	  of	  Caco2	  polarity	  program.	  Only	  PDZ-­‐binding	  domain	  is	  dispensable:	  Caco2	  IRSp53	  KO	  cells	  infected	  with	  GFP-­‐IRSp53	  PDZ	  mutant,	  in	  fact,	  formed	  cysts	  with	  a	  correct	  morphology	  (multilumen	  frequency	  reduced	  to	  25%)	  (Figure	  44	  C,	  images	  relative	  to	  clone	  #12).	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Figure	  44.	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  are	  required	  for	  the	  correct	  lumenogenesis	  of	  Caco2	  
cysts.	  
A	  Caco2	  cells	  IRSp53	  KO	  (CRISPR/Cas9	  derived	  clone	  #12)	  were	  infected	  with	  lentiviral	  vectors	  encoding	  for	  GFP	  or	  GFP-­‐IRSp53.	  Cells	  were	  then	  embedded	  in	  Matrigel-­‐collagen	  matrix	  to	  form	  cysts.	  Cysts	  were	  fixed,	  stained	  with	  phalloidin	  and	  DAPI	  to	  detect	  nuclei	  and	  analysed	  by	  confocal	  microscopy.	  Scale	  bar	  is	  20	  μm.	  
B	  Caco2	  cells	  WT	  or	  IRSp53	  KO	  (CRISPR/Cas9	  derived	  clone	  #12)	  infected	  with	  lentiviral	  vectors	  encoding	  for	  GFP	  or	  GFP-­‐IRSp53	  were	  lysated	  and	  immunoblotted	  with	  the	  indicated	  antibodies.	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Looking	  at	  the	  localization	  of	  GFP-­‐IRSp53	  mutants	  in	  Caco2	  cysts,	  we	  observed	  a	  peculiar	  localization	  of	  IRSp53	  I-­‐BAR	  and	  SH3	  mutants:	  both	  of	  them	  possessed	  a	  dotted	  localization	  in	  the	  apical	  portion,	  perfectly	  co-­‐localizing	  with	  the	  tight	  junction	  protein	  ZO-­‐1	  (Zonula	  occludens	  protein	  1)	  (Figure	  45).	  Also	  IRSp53	  WT	  and	  mutated	  in	  CRIB	  and	  PDZ-­‐binding	  domains	  partially	  co-­‐localize	  with	  ZO-­‐1,	  but	  these	  dots	  were	  connected	  by	  regions	  of	  weaker	  signal	  along	  all	  the	  apical	  surface	  of	  the	  organoid	  (Figure	  45).	  	  
	  
Figure	  45.	  IRSp53	  WT	  or	  mutated	  in	  I-­‐BAR,	  CRIB,	  SH3	  and	  PDZ-­‐binding	  domains	  co-­‐localize	  with	  
ZO-­‐1.	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multilumen	  cysts	  in	  both	  the	  cell	  lines.	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  are	  all	  required	  for	  IRSp53	  to	  exert	  its	  role	  in	  the	  correct	  establishment	  of	  a	  polarized	  cyst.	  Finally,	  both	  I-­‐BAR	  and	  SH3	  domains	  are	  necessary	  for	  the	  continuous	  apical	  localization	  of	  IRSp53.	  
IRSp53	  is	  early	  recruited	  at	  cell-­‐cell	  junctions	  in	  the	  early	  stages	  of	  MDCK	  cyst	  
formation	  The	  above	  mentioned	  results	  pointed	  out	  an	  involvement	  of	  IRSp53	  in	  pathways	  leading	  to	  polarization	  and	  acquisition	  of	  apical	  features,	  although	  the	  actual	  role	  of	  IRSp53	  in	  lumenogenesis	  remains	  elusive.	  To	  get	  insights	  into	  the	  timing	  of	  IRSp53	  involvement	  in	  the	  polarity	  program,	  we	  next	  decided	  to	  investigate	  if	  it	  was	  necessary	  in	  the	  early	  phases	  of	  MDCK	  cysts	  formation.	  We	  observed	  that	  in	  single	  cells	  IRSp53	  was	  enriched	  at	  the	  plasma	  membrane,	  while	  at	  two-­‐cells	  stages	  IRSp53	  re-­‐localized	  at	  cell-­‐cell	  contact,	  overlapping	  with	  β-­‐catenin	  (Figure	  46).	  Of	  note,	  the	  region	  in	  the	  middle	  between	  the	  two	  cells	  has	  been	  identified	  as	  the	  so	  called	  AMIS,	  in	  which	  all	  the	  apical	  proteins	  will	  be	  recruited	  to	  form	  a	  mature	  cyst	  (see	  “Introduction”).	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A	  GFP-­‐IRSp53	  localization	  in	  MDCK	  cysts	  at	  one-­‐	  or	  two-­‐cells	  stages.	  MDCK	  cells	  infected	  with	  GFP-­‐IRSp53	  were	  resuspended	  as	  single	  cells,	  plated	  on	  a	  Matrigel	  layer	  and	  fixed	  at	  6-­‐12	  hours.	  DAPI	  was	  used	  to	  detect	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  10	  μm.	  
B	  GFP-­‐IRSp53	  localization	  in	  two-­‐cells	  stage	  MDCK	  cysts.	  MDCK	  cells	  infected	  with	  GFP-­‐IRSp53	  were	  resuspended	  as	  single	  cells,	  plated	  on	  a	  Matrigel	  layer	  and	  fixed	  at	  16	  hours.	  Cysts	  were	  stained	  with	  anti-­‐β-­‐catenin,	  DAPI	  was	  used	  to	  detect	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  the	  cyst.	  Scale	  bar	  is	  10	  μm.	  	  We	  then	  performed	  a	  time-­‐course	  analysis,	  following	  GFP-­‐IRSp53	  and	  podocalyxin	  localization	  in	  the	  early	  steps	  of	  cysts	  formation.	  The	  latter	  protein	  is	  a	  known	  apical	  marker	  that	  is	  rapidly	  translocating	  from	  the	  plasma	  membrane	  to	  the	  apical	  region,	  during	  cystogenesis	  (see	  “Introduction”)	  via	  membrane	  trafficking	  [176].	  We	  observed	  GFP-­‐IRSp53	  enrichment	  at	  cell-­‐cell	  contact,	  already	  8	  hours	  after	  MDCK	  cells	  plating	  on	  Matrigel	  (Figure	  47).	  Under	  the	  same	  conditions,	  podocalyxin	  was	  still	  at	  the	  plasma	  membrane.	  We	  also	  observed	  GFP-­‐IRSp53	  partially	  localized	  into	  vesicular-­‐like	  structures,	  that	  were,	  at	  least	  in	  part,	  also	  positive	  for	  podocalyxin,	  which	  is	  known	  to	  undergo	  exocytic	  recycling	  through	  RAB8	  and	  RAB11a	  positive	  vesicles	  (see	  “Introduction”).	  At	  20h,	  both	  GFP-­‐IRSp53	  and	  podocalyxin	  accumulated	  in	  the	  AMIS	  region,	  and	  later	  on	  the	  apical	  side	  of	  the	  opening	  lumen.	  After	  6	  days	  a	  complete	  cyst	  was	  formed,	  with	  GFP-­‐IRSp53	  and	  podocalyxin	  co-­‐localizing	  in	  the	  lumen	  (Figure	  47).	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Figure	  47.	  IRSp53	  and	  podocalyxin	  localization	  during	  MDCK	  cystogenesis.	  
MDCK	  cells	  infected	  with	  GFP-­‐IRSp53	  were	  resuspended	  as	  single	  cells,	  plated	  on	  a	  Matrigel	  layer	  and	  fixed	  at	  the	  indicated	  time	  points.	  Cysts	  were	  stained	  with	  anti-­‐podocalyxin	  antibody,	  DAPI	  was	  used	  to	  
8 h
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detect	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Arrows	  highlight	  the	  areas	  of	  partial	  co-­‐localization	  between	  GFP-­‐IRSp53	  and	  podocalyxin.	  Scale	  bar	  is	  12	  μm.	  
IRSp53	  partially	  localizes	  in	  vesicles	  positive	  for	  phalloidin,	  podocalyxin,	  RAB7	  
and	  RAB11a	  To	  get	  insight	  about	  the	  intracellular	  compartments	  in	  which	  we	  observed	  GFP-­‐IRSp53	  enrichment	  during	  the	  early	  phases	  of	  cyst	  formation,	  we	  performed	  co-­‐staining	  of	  GFP-­‐IRSp53	  expressing	  MDCK	  cells	  with	  different	  markers	  (Figure	  48).	  We	  observed	  GFP-­‐IRSp53	  in	  vesicular-­‐like	  compartments,	  partially	  co-­‐localizing	  with	  phalloidin,	  podocalyxin,	  RAB7	  (which	  localizes	  in	  late	  endosomes)	  and	  RAB11a.	  We	  observed	  no	  co-­‐localization	  between	  GFP-­‐IRSp53	  and	  EEA1	  (early	  endosome	  antigen	  1,	  an	  early	  endosomes	  marker),	  LAMP1	  (lysosome-­‐associated	  membrane	  glycoprotein	  1,	  a	  late	  endosomes	  and	  lysosomes	  marker)	  nor	  Giantin	  (a	  Golgi	  marker).	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Figure	  48.	  Co-­‐localization	  analysis	  of	  GFP-­‐IRSp53	  positive	  vesicles.	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RAB11a	  construct	  was	  used.	  DAPI	  was	  used	  to	  detect	  nuclei.	  Images	  are	  sums	  projections	  of	  confocal	  sections	  containing	  GFP	  positive	  vesicles.	  Scale	  bar	  is	  6	  μm.	  	  
IRSp53	  KD	  affects	  podocalyxin	  relocalization	  in	  the	  early	  phases	  of	  MDCK	  cyst	  
formation	  As	  shown	  above,	  IRSp53	  is	  enriched	  at	  the	  cell-­‐cell	  contact	  region	  and	  at	  the	  AMIS	  during	  the	  early	  phases	  of	  MDCK	  cystogenesis.	  We	  next	  asked	  whether	  IRSp53	  removal	  affects	  cyst	  formation	  soon	  after	  cell	  plating	  on	  Matrigel,	  in	  order	  to	  investigate	  the	  possibility	  that	  IRSp53	  might	  play	  a	  role	  in	  early	  polarity	  signalling	  program.	  	  We	  observed	  that	  in	  WT	  cells,	  podocalyxin	  nicely	  accumulated	  at	  the	  AMIS	  in	  three-­‐four	  cells	  cysts,	  and	  only	  35%	  of	  them	  presented	  aberrant	  podocalyxin	  localization.	  Upon	  transient	  siRNA-­‐mediated	  IRSp53	  KD,	  podocalyxin	  was	  mislocalized	  and	  accumulated	  in	  discrete	  foci	  in	  52%	  of	  the	  analysed	  cysts.	  Podocalyxin	  distribution	  was	  reverted	  to	  its	  correct	  localization	  upon	  GFP-­‐IRSp53	  re-­‐expression	  into	  IRSp53	  KD	  cells:	  in	  this	  case,	  only	  22%	  of	  the	  cysts	  presented	  aberrant	  podocalyxin	  localization	  (Figure	  49).	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Figure	  49.	  IRSp53	  KD	  affects	  podocalyxin	  localization	  in	  three-­‐four	  cells	  cysts.	  
A	  MDCK	  cells	  WT	  or	  infected	  with	  GFP-­‐IRSp53	  were	  treated	  with	  control	  or	  IRSp53	  canine-­‐targeted	  siRNA,	  to	  knock	  down	  IRSp53.	  Cells	  were	  resuspended	  as	  single	  cells	  and	  plated	  on	  a	  Matrigel	  layer	  for	  24-­‐30	  hours.	  Cysts	  were	  then	  fixed	  and	  stained	  with	  anti-­‐β-­‐catenin	  and	  anti-­‐podocalyxin	  antibodies,	  DAPI	  was	  used	  to	  detect	  nuclei.	  Images	  are	  confocal	  section	  of	  the	  central	  region	  of	  each	  cyst.	  Scale	  bar	  is	  10	  μm.	  
B	  Percentage	  of	  cysts	  presenting	  aberrant	  podocalyxin	  localization,	  in	  the	  conditions	  tested	  in	  panel	  A.	  The	  experiment	  was	  performed	  in	  triplicate,	  analysing	  at	  least	  30	  cysts	  per	  condition.	  
C	  Level	  of	  expression	  of	  IRSp53	  in	  MDCK	  cells	  WT	  or	  infected	  with	  GFP-­‐IRSp53,	  that	  were	  treated	  with	  control	  or	  IRSp53	  canine	  targeted	  oligoes.	  	  We	  then	  performed	  a	  structure-­‐function	  analysis,	  to	  investigate	  which	  domain	  from	  IRSp53	  was	  required	  to	  correctly	  localize	  podocalyxin	  in	  the	  early	  phases	  cysts.	  We	  used	  a	  siRNA	  approach	  to	  KD	  endogenous	  IRSp53	  protein,	  in	  MDCK	  cells	  that	  have	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been	  previously	  infected	  with	  GFP-­‐IRSp53	  mutated	  in	  I-­‐BAR,	  CRIB,	  SH3	  or	  PDZ-­‐binding	  domains.	  We	  observed	  that	  both	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  mutation	  caused	  an	  aberrant	  localization	  of	  podocalyxin	  in	  cysts	  at	  24-­‐30	  hours	  after	  plating	  (in	  60%,	  59%	  and	  59%	  of	  cysts,	  respectively).	  On	  the	  contrary,	  PDZ-­‐binding	  domain	  is	  dispensable	  for	  podocalyxin	  re-­‐localization:	  in	  24-­‐30	  hours	  time-­‐frame,	  only	  43%	  of	  cysts	  presented	  an	  altered	  distribution	  of	  this	  apical	  marker	  (Figure	  50).	  
	  
Figure	  50.	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  are	  required	  for	  correct	  podocalyxin	  localization	  in	  
early	  stages	  MDCK	  cysts.	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Discussion	  and	  future	  plans	  
A	  model	  for	  filopodia	  initiation	  based	  on	  CDC42:IRSp53:VASP	  axis	  To	  summarize	  our	  findings,	  we	  showed	  that	  i)	  IRSp53	  possesses	  a	  weak	  capping	  activity,	  which	  is	  relieved	  by	  CDC42-­‐GTP	  binding.	  ii)	  A	  CDC42:IRSp53	  interaction	  is	  critical	  to	  induce	  a	  structural	  rearrangement	  of	  IRSp53	  protein	  as	  well	  as	  for	  the	  formation	  of	  a	  CDC42:IRSp53:VASP	  complex.	  iii)	  In	  vitro,	  IRSp53	  is	  able	  to	  mediate	  VASP	  clustering	  on	  functionalized	  surfaces	  and	  lipid	  bilayer,	  fostering	  VASP	  processive	  elongation	  activity.	  iv)	  The	  in	  vitro	  findings	  were	  mirrored	  by	  in	  vivo	  experiments	  in	  which	  we	  observed	  that	  IRSp53	  is	  essential	  to	  promote	  the	  formation	  of	  VASP	  foci	  along	  discrete	  areas	  on	  the	  plasma	  membrane	  and	  to	  efficiently	  promote	  filopodia	  formation.	  Based	  on	  the	  above-­‐mentioned	  results,	  we	  propose	  the	  following	  model	  for	  filopodia	  formation.	  In	  the	  initial	  state,	  IRSp53	  through	  its	  I-­‐BAR	  domain,	  localizes	  preferentially	  along	  the	  plasma	  membrane.	  At	  this	  site,	  in	  resting	  or	  signalling	  off	  conditions,	  the	  weak	  capping	  activity	  of	  IRSp53	  likely	  prevails	  and	  contributes	  to	  ensure	  that	  unfruitful,	  or	  uncontrolled,	  actin	  polymerization	  occurs.	  Actin	  polymerization	  inhibition,	  in	  this	  phase,	  might	  be	  reinforced	  by	  IRSp53	  interaction	  with	  EPS8,	  due	  to	  EPS8	  capping	  activity	  [160].	  Upon	  CDC42	  activation,	  two	  key	  biochemical	  events	  may	  take	  place.	  Firstly,	  IRSp53	  inhibition	  of	  barbed	  end	  growth	  is	  relieved.	  Secondly,	  the	  protein	  switches	  to	  its	  open	  conformation:	  open	  IRSp53	  is	  then	  able	  to	  interact	  with	  VASP.	  Indeed,	  immunoprecipitation	  experiments	  (not	  shown	  in	  this	  thesis,	  but	  included	  in	  Disanza	  et	  al.,	  2013	  [191])	  suggest	  that	  in	  the	  presence	  of	  active	  CDC42,	  IRSp53:EPS8	  interaction	  is	  competed	  out	  and	  the	  association	  with	  others	  SH3	  binders,	  and	  specifically	  VASP,	  is	  favored.	  IRSp53	  then	  induces	  localized	  VASP	  clustering,	  which	  is,	  in	  turn,	  essential	  for	  promoting	  its	  processive	  actin	  elongation	  activity.	  Long	  actin	  filaments	  are	  consequently	  produced,	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which	  cooperate	  with	  IRSp53	  membrane	  bending	  activity	  to	  promote	  and	  sustain	  filopodia	  formation,	  in	  a	  spatially	  restricted	  and	  timely	  coordinated	  manner.	  Other	  proteins	  are	  concomitantly	  recruited	  and	  required,	  for	  example,	  to	  bundle	  linear	  actin	  filaments,	  such	  as	  the	  crosslinking	  protein	  fascin,	  thereby	  increasing	  the	  stiffness	  of	  the	  inner	  cytoskeletal	  core	  of	  the	  filopodia.	  This	  is	  though	  to	  be	  necessary	  to	  oppose	  the	  counter	  forces	  exerted	  either	  by	  the	  increase	  in	  membrane	  tension	  or	  by	  the	  extracellular	  environment	  (Figure	  51).	  
Figure	  51.	  Model	  for	  filopodia	  initiation.	  	  
Here	  are	  depicted	  the	  proposed	  steps	  that	  characterize	  the	  initial	  phases	  of	  filopodia	  formation.	  Step	  1:	  in	  the	  absence	  of	  stimuli,	  IRSp53	  binds	  the	  plasma	  membrane	  and	  slows	  down	  barbed	  end	  elongation.	  Step	  2:	  following	  CDC42	  activation	  due	  to	  an	  external	  stimulus,	  CDC42	  binds	  IRSp53	  promoting	  IRSp53	  shift	  to	  its	  open	  conformation	  and	  the	  interaction	  with	  VASP,	  forming	  a	  CDC42:IRSp53:VASP	  complex.	  Step	  3:	  IRSp53	  and	  VASP	  foci	  are	  formed	  at	  the	  plasma	  membrane,	  VASP	  clustering	  allows	  processive	  actin	  filament	  elongation.	  Step	  4:	  membrane	  deforming	  activity	  of	  IRSp53	  and	  processive	  actin	  filament	  elongation	  by	  VASP	  work	  in	  concert	  to	  promote	  filopodia	  initiation,	  in	  coordinated	  time	  and	  space	  (modified	  from	  Disanza	  et	  al.,	  2013	  [191]).	  	  Our	  observations	  are	  in	  agreement	  with	  the	  recently	  proposed	  model	  of	  IRSp53	  conformational	  changes	  upon	  CDC42	  binding,	  described	  by	  Kast	  et	  al.,	  2014	  [115],	  and	  cited	  in	  the	  introduction	  of	  this	  thesis.	  Briefly,	  an	  intramolecular	  interaction	  
Figure 8
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between	  IRSp53	  CRIB	  and	  SH3	  domains	  determines	  the	  formation	  of	  a	  “close”	  conformation.	  Upon	  active	  CDC42	  binding,	  the	  intramolecular	  interaction	  is	  abrogated	  and	  IRSp53	  switches	  to	  an	  “open”	  conformation.	  Thus,	  IRSp53	  in	  the	  “close”	  conformation	  could	  exert	  capping	  activity	  over	  the	  actin	  filaments,	  while	  the	  formation	  of	  a	  complex	  between	  CDC42	  and	  “open”	  IRSp53	  will	  favor	  its	  interaction	  with	  the	  SH3	  binder	  VASP,	  and	  consequently	  promotes	  filaments	  elongation.	  Interestingly,	  an	  independent	  report	  have	  linked	  IRSp53:VASP	  interaction	  to	  podosome	  formation	  in	  NIH-­‐Src	  cells.	  Podosomes	  are	  another	  type	  of	  small	  cylindrical	  protrusion	  (1μm	  in	  diameter	  or	  less),	  rich	  in	  actin	  filaments	  and	  containing	  also	  focal	  adhesion	  molecules.	  Podosomes	  assemble	  in	  rosetta-­‐like	  structures	  and	  are	  important	  for	  cell	  migration	  and	  ECM	  invasion	  [193].	  These	  observations	  suggest	  that	  IRSp53:VASP	  interaction	  may	  be	  conserved	  and	  crucial	  for	  the	  emergence	  of	  different	  protrusive	  actin-­‐based	  cellular	  structures.	  	  It	  must	  be	  pointed	  out,	  however,	  that	  EGFP-­‐IRSp53	  in	  MVD7	  Ena/VASP	  family	  deficient	  fibroblast	  cells	  still	  localizes	  to	  the	  tips	  of	  lamellipodia	  and	  filopodia	  [194],	  implying	  that	  IRSp53	  localization	  is	  not	  affected	  by	  the	  loss	  of	  VASP,	  and,	  more	  importantly,	  that	  the	  IRSp53:VASP	  complex	  is	  not	  absolutely	  essential	  or	  uniquely	  required	  for	  filopodia	  formation.	  Additional	  mechanisms	  are	  likely	  to	  be	  operative	  in	  these	  cells	  to	  ensure	  filopodia	  formation,	  further	  pointing	  to	  the	  existence	  of	  multiple	  and	  independent	  pathways	  capable	  of	  stimulating	  filopodia	  elongation.	  This	  seems	  to	  be	  actually	  the	  case,	  as	  suggested	  by	  Goh	  et	  al.,	  2012	  [195],	  which	  showed	  that	  mDia1	  and	  WAVE2	  interaction	  with	  IRSp53	  may	  also	  participate	  in	  promoting	  filopodia	  in	  N1E-­‐115	  cells	  (mouse	  brain	  neuroblasts),	  independently	  of	  Ena/VASP	  family	  proteins.	  Of	  note,	  it	  was	  already	  known	  that	  mDia1/2	  can	  directly	  induce	  filopodia	  formation	  [196]	  [23],	  but	  filopodia	  initiated	  by	  Ena/VASP	  or	  mDia2	  proteins	  possess	  distinct	  properties,	  differing	  in	  their	  number,	  length	  and	  lifetime	  [197].	  Goh	  et	  al.,	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2012	  [195],	  however,	  observed	  that	  RFP-­‐IRSp53	  acted	  in	  synergy	  with	  GFP-­‐WAVE2	  or	  GFP-­‐mDia1	  when	  the	  proteins	  are	  coexpressed,	  while	  depletion	  of	  mDia1	  or	  WAVE2	  decreased	  the	  ability	  of	  IRSp53	  to	  induce	  filopodia	  in	  N1E-­‐115	  cells.	  Interestingly,	  mDia1	  formin	  localizes	  along	  all	  the	  length	  of	  the	  filopodia,	  while	  VASP	  is	  rigorously	  restricted	  to	  the	  filopodia	  tips.	  Similarly,	  Gertler’s	  group	  showed	  that	  the	  genetic	  removal	  of	  all	  the	  Ena/VASP	  family	  members	  in	  mice	  severely	  compromised	  filopodia	  extension	  in	  primary	  neurons,	  however,	  filopodia	  could	  still	  be	  induced	  by	  either	  plating	  cells	  on	  laminin	  or	  upon	  ectopic	  expression	  of	  mDia2	  or	  myosin	  X	  [99].	  The	  validity	  of	  the	  model	  described	  above	  finds	  further	  experimental	  and	  theoretical	  support	  in	  a	  more	  recent	  work	  by	  Prevost	  et	  al.,	  2015	  [121].	  The	  authors,	  using	  a	  variety	  of	  biochemical	  and	  in	  vitro	  reconstituted	  liposome-­‐based	  systems,	  proposed	  that	  the	  I-­‐BAR	  domain	  of	  IRSp53	  is	  present	  at	  low	  concentration	  and	  density	  along	  the	  plasma	  membrane	  at	  the	  steady	  state.	  Local	  and	  transient	  fluctuations	  of	  the	  membrane	  are	  subsequently	  stabilized	  and	  amplified	  by	  IRSp53,	  through	  a	  feed	  forward	  loop.	  At	  moderate	  protein	  density,	  I-­‐BAR	  intrinsic	  curvature	  can,	  indeed,	  favor	  negative	  curvature	  and	  the	  local	  recruitment	  of	  more	  IRSp53	  proteins.	  As	  a	  consequence	  of	  IRSp53	  accumulation,	  the	  protein	  will	  phase	  separate	  into	  coexisting	  domains	  of	  different	  curvature	  along	  the	  plasma	  membrane,	  explaining	  why	  IRSp53	  may	  be	  the	  first	  protein	  to	  mark	  the	  nascent	  filopodia	  and	  to	  be	  required	  for	  the	  initial	  formation	  of	  protrusions.	  	  
Novel	  roles	  of	  IRSp53	  in	  polarity	  determination	  As	  shown	  in	  the	  second	  part	  of	  the	  results	  section,	  we	  observed	  that	  in	  models	  of	  3-­‐D	  cells	  cysts,	  IRSp53	  is	  prominently	  enriched	  in	  the	  apical	  region,	  while	  IRSp53	  depletion	  leads	  to	  a	  multilumen	  phenotype,	  suggesting	  a	  role	  of	  IRSp53	  in	  the	  polarity	  program.	  Lumenogenesis	  is	  a	  fundamental	  step	  in	  the	  morphogenesis	  of	  many	  hollow	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epithelial	  organs;	  interestingly,	  performing	  a	  tissue	  microarray	  (TMA)	  screening,	  we	  observed	  IRSp53	  enrichment	  in	  the	  lumenal/apical	  region	  of	  different	  human	  tissues,	  as	  kidney,	  prostate	  and	  duodenum	  (Figure	  52),	  providing	  support	  to	  our	  in	  vitro	  observations	  in	  organoids.	  We	  are	  currently	  investigating	  if	  our	  IRSp53	  KO	  mice	  present	  defects	  in	  the	  structure	  and	  function	  of	  these	  tissues.	  
Figure	  52.	  Immunohistochemistry	  analysis	  of	  human	  samples	  of	  different	  origin.	  	  
Tissues	  where	  stained	  with	  anti-­‐IRSp53	  polyclonal	  antibody.	  	  We	  also	  observed	  an	  early	  enrichment	  of	  IRSp53	  in	  the	  AMIS	  region	  of	  MDCK	  cysts	  at	  two-­‐cells	  stage,	  that	  precedes	  in	  time	  podocalyxin	  enrichment	  in	  the	  same	  region.	  As	  reported	  in	  the	  introduction,	  podocalyxin	  relocalization	  to	  the	  AMIS	  region	  is	  a	  key	  event	  in	  the	  definition	  of	  polarity	  in	  MDCK	  cysts.	  Data	  presented	  here	  points	  to	  a	  role	  of	  IRSp53	  in	  podocalyxin	  relocalization,	  possibly	  through	  the	  regulation	  of	  podocalyxin	  trafficking.	  This	  latter	  hypothesis	  is	  supported	  by	  the	  observations	  of	  aberrant	  podocalyxin	  localization	  upon	  IRSp53	  loss	  in	  MDCK	  cysts	  at	  four-­‐cells	  stage	  and	  of	  GFP-­‐IRSp53	  enrichment	  in	  vesicular-­‐like	  compartments	  in	  MDCK	  cells	  plated	  on	  Matrigel.	  It	  must	  be	  pointed	  out,	  however,	  that	  the	  data	  collected	  so	  far	  are	  not	  enough	  to	  rule	  out	  a	  possible	  involvement	  of	  IRSp53	  in	  functions	  of	  the	  polarity	  program	  other	  than	  the	  trafficking	  of	  polarity	  determinants.	  A	  number	  of	  factors	  can	  cause	  multiple	  lumen	  and	  defective	  polarization	  in	  3-­‐D	  models	  of	  epithelial	  cells	  [176]:	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1-­‐	  alterated	  trafficking	  of	  apical	  proteins,	  that	  impedes	  the	  enlargement	  and	  consolidation	  of	  small	  lumens	  into	  one	  central	  lumen;	  2-­‐	  defective	  junctions	  between	  cells	  forming	  3-­‐D	  organoids;	  3-­‐	  mislocalization	  of	  pumps	  and	  channels,	  which	  generate	  the	  hydrostatic	  pressure	  that	  is	  required	  for	  lumen	  enlargement;	  4-­‐	  aberrant	  orientation	  of	  mitosis,	  that	  affects	  the	  spherical	  structure	  of	  the	  growing	  organoid.	  This	  effect	  could	  be	  due	  to	  defective	  localization	  and/or	  function	  of	  the	  proteins	  that	  regulates	  spindle	  orientation	  and	  cytokinesis,	  as	  CDC42	  [181],	  aPKC	  and	  LGN.	  IRSp53	  may	  impinge	  on	  any	  or	  all	  of	  these	  processes,	  which	  we	  are	  currently	  investigating,	  in	  order	  to	  shed	  light	  on	  the	  mechanism	  by	  which	  IRSp53	  is	  involved	  in	  the	  polarity	  program.	  	  Interestingly,	  a	  structure-­‐function	  analysis	  of	  IRSp53	  to	  define	  the	  key	  domains	  that	  are	  required	  to	  guarantee	  a	  correct	  phenotype	  in	  Caco2	  and	  in	  early	  phases	  MDCK	  cysts,	  showed	  that	  the	  I-­‐BAR,	  CRIB	  and	  SH3	  domains	  are	  all	  necessary,	  while	  the	  PDZ-­‐binding	  domain	  is	  dispensable.	  These	  observations	  can	  all	  be	  rationalized	  within	  a	  framework	  whereby:	  i)	  the	  I-­‐BAR	  domain	  recognizes	  PIP2,	  which	  is	  known	  to	  be	  enriched	  at	  the	  apical	  membrane	  [169].	  ii)	  The	  CRIB	  domain	  may	  link	  IRSp53	  to	  the	  CDC42/PAR3/PAR6	  complex,	  which	  is	  apically	  localized	  at	  the	  very	  early	  stages	  of	  lumen	  formation,	  and	  is	  involved	  in	  the	  establishment	  of	  polarity	  by	  regulating	  several	  processes	  of	  transcytosis,	  as	  well	  as	  spindle	  orientation.	  iii)	  The	  SH3	  domain	  might	  exert	  its	  role	  through	  the	  recruitment	  of	  one	  or	  more	  effectors,	  unknown	  so	  far.	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Investigation	  of	  novel	  IRSp53	  interactors	  through	  proximity	  biotinylation	  and	  
mass	  spectrometry	  analysis	  To	  investigate	  if	  novel	  IRSp53	  effectors	  are	  required	  by	  this	  protein	  to	  exert	  its	  role	  on	  polarity	  establishment,	  we	  took	  advantage	  of	  BioID	  strategy	  coupled	  to	  mass	  spectrometry	  analysis,	  as	  described	  in	  Roux	  et	  al.,	  2012	  [198].	  Briefly,	  the	  protein	  of	  interest	  is	  fused	  to	  a	  promiscous	  biotin	  protein	  ligase	  (BirA*),	  so	  that,	  after	  supplementation	  of	  cell	  culture	  medium	  with	  biotin,	  all	  the	  primary	  amine	  groups	  (predominantly	  lysines)	  around	  15-­‐20	  nm	  from	  the	  bait	  are	  biotinylated.	  Biotinylated	  proteins	  are	  then	  selectively	  isolated	  and	  analysed	  by	  mass	  spectrometry.	  	  Given	  the	  mechanism	  of	  BioID,	  biotinylated	  proteins	  can	  be	  direct	  interactors	  of	  the	  protein	  of	  interest,	  indirect	  interactors	  or	  only	  vicinal	  proteins.	  Due	  to	  the	  strong	  interaction	  between	  biotin	  and	  streptavidin,	  harsh	  condition	  can	  be	  used	  to	  lyse	  cells	  and	  in	  the	  subsequent	  passages,	  without	  compromising	  the	  efficiency	  of	  the	  in	  vitro	  binding.	  In	  particular,	  we	  used	  HeLa	  cells	  infected	  with	  lentiviral	  constructs	  encoding	  for	  BirA*-­‐IRSp53	  or	  BirA*-­‐GFP	  as	  control.	  In	  our	  experiments,	  BirA*	  approach	  was	  combined	  with	  stable	  isotope	  labelling	  with	  amino	  acids	  in	  cell	  culture	  (SILAC),	  to	  have	  a	  quantitative	  result	  of	  the	  protein	  enrichment	  in	  the	  two	  samples.	  Results	  are	  summarized	  in	  Table	  1:	  proteins	  are	  ranked	  accordingly	  to	  the	  normalized	  heavy	  to	  light	  ratio,	  please	  note	  that	  the	  first	  entry	  is	  IRSp53	  itself	  (BAIAP2).	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Table	  1.	  Summary	  of	  the	  combined	  data	  from	  two	  independent	  experiments	  using	  BirA*-­‐IRSp53	  
approach	  to	  analyse	  proximal	  proteins	  by	  SILAC	  BioID	  in	  HeLa	  cells.	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μM	  biotin	  for	  24	  hours	  and	  lysed	  in	  JS	  buffer,	  then	  biotinylated	  proteins	  were	  fished	  out	  with	  streptavidin-­‐conjugated	  magnetic	  beads	  (Thermo	  Fisher	  Scientific).	  Beads	  were	  washed	  out	  from	  aspecific	  binders	  using	  50	  mM	  Tris	  pH	  7.5,	  1%	  SDS,	  protease	  inhibitors;	  elution	  was	  performed	  using	  SDS-­‐PAGE	  Sample	  buffer	  2X,	  coupled	  with	  95°C	  boiling.	  Eluates	  were	  then	  subjected	  to	  SDS-­‐PAGE,	  after	  colloidal	  blue	  staining	  bands	  were	  processed	  for	  trypsin	  digestion	  and	  mass	  spectrometry.	  
	  Among	  the	  identified	  potential	  IRSp53	  interactors,	  we	  found	  a	  number	  of	  proteins	  related	  to	  polarity	  and	  junctions	  establishment	  (Table	  2):	  cingulin,	  ZO-­‐1,	  DLG1,	  INPPL1	  (Phosphatidylinositol	  3,4,5-­‐trisphosphate	  5-­‐phosphatase	  2),	  LIN7	  (or	  MALS),	  INADL	  (or	  PATJ)	  and	  MPP5	  (MAGUK	  p55	  subfamily	  member	  5).	  We	  are	  currently	  planning	  to	  validate	  these	  potential	  hits	  and	  to	  study	  whether	  these	  interactions	  are	  important	  in	  mediating	  IRSp53	  involvement	  in	  the	  polarity	  program	  of	  epithelial	  cells.	  	  Of	  particular	  interest	  is	  the	  presence,	  in	  this	  list,	  of	  tight	  junctions	  proteins,	  since	  we	  observed	  strong	  co-­‐localization	  of	  IRSp53	  with	  the	  tight	  junctions	  protein	  ZO-­‐1	  in	  Caco2	  cysts	  (Figure	  45),	  which	  was	  not	  abolished	  by	  mutation	  of	  any	  of	  the	  functional	  domains	  of	  IRSp53.	  Moreover,	  the	  correct	  junctional	  organization	  is	  a	  critical	  aspect	  for	  the	  proper	  morphogenesis	  of	  3-­‐D	  organoids,	  as	  discussed	  in	  the	  previous	  paragraph.	  As	  shown	  in	  Table	  2,	  the	  list	  of	  potential	  IRSp53	  interactors	  also	  comprises	  proteins	  involved	  in	  scaffolding,	  signalling	  and	  trafficking	  functions.	  We	  are	  planning	  to	  validate	  also	  these	  hits.	  As	  cited	  before,	  trafficking	  of	  polarity	  determinants	  is	  crucial	  for	  the	  correct	  polarization	  of	  epithelial	  organoids.	  As	  expected,	  various	  actin-­‐related	  proteins,	  known	  interactors	  of	  IRSp53,	  such	  as	  WASF2,	  ABI1	  and	  EPS8	  were	  also	  among	  the	  hits,	  validating	  the	  relevance	  of	  our	  proteomic	  analysis.	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IRSp53	  involvement	  in	  angiogenesis	  and	  vasculogenesis	  The	  identification	  of	  novel	  potential	  interactors	  of	  IRSp53	  should	  help	  us	  also	  to	  discover	  additional	  biological	  processes	  in	  which	  IRSp53	  may	  be	  involved.	  In	  fact,	  genetic	  and	  developmental	  analysis	  performed	  on	  Irsp53	  null	  mice	  revealed	  that	  its	  loss	  causes	  partially	  penetrant	  embryonic	  lethality	  at	  midgestation	  (with	  80%	  lethality	  at	  	  embryonic	  day	  12.5-­‐14.5).	  In	  particular,	  Irsp53	  null	  embryos	  show	  delayed	  development,	  diffuse	  edema,	  cardiac	  malformation,	  haemorrhages	  and	  defective	  angiogenesis.	  In	  Figure	  53	  images	  of	  embryo	  WT	  or	  Irsp53	  null	  are	  shown,	  in	  which	  exemplar	  cases	  of	  localized	  pericardial	  effusion	  and	  edema	  defects	  are	  highlighted.	  	  
	  
Figure	  53.	  Stereo	  microscope	  images	  from	  embryo	  WT	  or	  Irsp53	  null,	  at	  embryonic	  day	  10.5	  or	  
14.5.	  
Lower	  panels	  are	  magnifications	  of	  the	  boxed	  regions.	  	  
	  Immunohistochemistry	  analysis	  on	  whole	  embryos	  at	  embryonic	  day	  10.5,	  using	  an	  antibody	  against	  PECAM-­‐1	  (Platelet	  endothelial	  cell	  adhesion	  molecule),	  also	  known	  as	  cluster	  of	  differentiation	  31	  (CD31),	  revealed	  an	  aberrant	  architecture	  of	  the	  
IRSp53 WT                                       IRSp53 -/- IRSp53 WT                   IRSp53 -/- 
E 10.5                                                                                            E 14.5
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vessels.	  In	  Figure	  54	  the	  dorsal	  and	  lateral	  somite	  staining	  is	  highlighted:	  in	  these	  regions,	  only	  the	  bigger	  vessels	  appear	  to	  form	  correctly,	  while	  the	  smaller,	  intervessel	  ones,	  that	  give	  rise	  to	  branched	  capillary	  networks,	  show	  severe	  defects	  and	  discontinuities.	  Vascular	  defects	  were	  also	  found	  in	  the	  placenta	  from	  Irsp53	  null	  embryos	  (not	  shown),	  which	  presents	  diffuse	  hemorrhages	  and	  developmental	  abnormalities.	  In	  particular,	  we	  observed	  a	  severe	  reduction	  in	  the	  size	  of	  the	  labyrinth,	  which	  was	  also	  poorly	  vascularized	  by	  embryonic	  vessels,	  filled	  with	  large	  lacunae	  and	  lacking	  the	  spongiotrophoblasts	  layer.	  	  
	  
Figure	  54.	  PECAM-­‐1	  (CD31)	  staining	  of	  whole	  mount	  embryos	  WT	  or	  Irsp53	  null	  at	  embryonic	  
day	  10.5.	  
	  The	  lateral	  and	  dorsal	  somite	  magnification	  are	  shown.	  	  	  It	  is	  known	  that	  tip	  cells,	  at	  the	  forefront	  of	  vessel	  branches,	  extend	  numerous	  and	  long	  filopodia	  during	  sprouting	  angiogenesis.	  These	  filopodia	  are	  thought	  to	  constantly	  probe	  the	  microenvironment	  to	  guide	  the	  extension	  of	  novel	  vessels	  [199]	  [200],	  in	  a	  way	  similar	  to	  axonal	  growth	  cone	  in	  the	  nervous	  system.	  So	  Irsp53	  null	  mice	  phenotypes	  in	  angiogenesis	  and	  vasculogenesis	  could	  be,	  at	  least	  in	  part,	  due	  to	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defective	  filopodia	  extension.	  However,	  the	  dynamic	  remodelling	  of	  endothelial	  cells	  is	  also	  crucial	  for	  these	  cells	  to	  get	  organized	  into	  tubular	  structures	  that	  later	  on	  mature	  into	  a	  vascular	  network:	  again	  migration,	  cell	  division,	  polarity	  establishment,	  junctional	  stabilization,	  as	  well	  as	  membrane	  and	  cytoskeleton	  remodeling	  [199]	  are	  all	  critical	  functions	  in	  which	  IRSp53	  could	  be	  involved.	  An	  alternative	  hypothesis	  is	  that	  IRSp53	  could	  be	  primarily	  implicated	  in	  the	  formation	  of	  the	  lumen	  of	  the	  vessels,	  in	  analogy	  with	  the	  role	  or	  IRSp53	  in	  lumenogenesis	  of	  epithelial	  cells,	  as	  shown	  in	  this	  thesis.	  It	  is	  known	  that	  lumenogenesis	  in	  vessels	  recapitulates	  to	  some	  extent	  lumenogenesis	  in	  epithelial	  cells.	  For	  example,	  in	  both	  MDCK	  and	  endothelial	  cells,	  ECM-­‐integrin	  interaction	  activates	  cytoskeletal	  regulators	  (in	  particular,	  CDC42	  and	  RAC1	  are	  activated	  in	  endothelial	  cells),	  then	  apical	  determinants	  are	  delivered	  to	  the	  lumen	  initiation	  sites	  [201].	  Moreover,	  Strilic	  et	  al.,	  2009	  [185],	  proposed	  that	  two	  CD34-­‐sialomucins,	  CD34	  and	  podocalyxin,	  must	  relocalize	  to	  the	  site	  of	  lumen	  initiation	  in	  endothelial	  cells,	  with	  a	  mechanism	  dependent	  on	  VE-­‐cadherin	  adhesion,	  in	  a	  manner	  similar	  to	  what	  has	  been	  proposed	  to	  occur	  during	  kidney	  lumenogenesis.	  Sialomucins	  relocalization	  is	  crucial	  to	  generate	  the	  repulsive	  forces	  required	  to	  open	  the	  lumen,	  with	  a	  mechanism	  similar	  to	  podocalyxin	  in	  MDCK	  cysts	  (see	  “Introduction”).	  Furthermore,	  F-­‐actin	  and	  moesin	  became	  enriched	  at	  the	  future	  lumenal	  surface;	  upon	  PKC	  phosphorylation,	  moesin	  interacts	  with	  F-­‐actin	  and	  promotes	  a	  reorganization	  of	  the	  actin	  cytoskeleton.	  As	  last	  step,	  VEGF-­‐A	  and	  ROCK	  mediate	  the	  cell	  shape	  changes	  needed	  for	  lumen	  formation,	  again	  with	  mechanisms	  that	  are	  similar	  to	  the	  ones	  observed	  in	  MDCK	  cysts.	  Of	  note,	  a	  critical	  functional	  difference	  between	  epithelial	  and	  endothelial	  cells	  is	  the	  exposure	  of	  the	  latter	  cells	  to	  blood	  flow,	  high	  shear	  stress	  and	  pressures:	  these	  forces	  have	  ben	  shown	  to	  cause	  important	  changes	  in	  cell	  morphology	  and	  cell	  adhesion	  and	  to	  be	  critical	  for	  morphogenesis	  and	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lumenogenesis	  [202].	  Interestingly,	  a	  number	  of	  IRSp53	  actin	  regulatory	  partners	  have	  been	  shown	  to	  be	  specifically	  important	  for	  various	  aspects	  of	  the	  endothelial	  morphogenetic	  program.	  A	  case	  in	  point	  is	  represented	  by	  the	  endothelial	  cells-­‐specific	  genetic	  loss	  of	  RAC1	  or	  its	  effector	  WAVE2,	  which	  both	  lead	  to	  defects	  in	  vascular	  development	  in	  vivo	  [203]	  [204].	  Similarly,	  the	  formin	  formin-­‐like	  3	  (FMNL3)	  interacts	  with	  CDC42	  and	  RHOJ	  [205]	  and	  is	  required	  for	  vessel	  lumen	  formation:	  FMNL3	  is	  essential	  to	  maintain	  a	  pool	  of	  F-­‐actin	  at	  the	  endothelial	  cell	  junction,	  that	  regulates	  junctional	  stability	  [206].	  FMNL3	  is	  also	  involved	  in	  podocalyxin	  trafficking	  to	  the	  AMIS	  in	  vascular	  lumenogenesis	  [205].	  Alternatively,	  IRSp53	  could	  interact	  with	  not	  yet	  identified	  molecular	  partners	  that,	  in	  turn,	  affect	  its	  functions	  in	  angiogenesis	  and	  vasculogenesis.	  To	  this	  end,	  we	  performed	  mass	  spectrometry	  analysis	  also	  on	  HUVEC	  cells	  (human	  umbilical	  vein	  endothelial	  cells).	  These	  cells	  were	  infected	  with	  constructs	  encoding	  for	  BirA*-­‐IRSp53	  or	  BirA*-­‐GFP	  as	  control.	  The	  results	  obtained	  are	  summarized	  in	  Table	  3,	  in	  which	  we	  listed	  only	  the	  top	  ranking	  interactors	  candidates.	  Notably,	  some	  of	  these	  proteins	  were	  found	  in	  the	  previous	  analysis	  performed	  in	  HeLa	  cells,	  in	  particular	  DLG1,	  SEC16A	  and	  RAPH1	  (also	  lamellipodin),	  suggesting	  that	  they	  might	  be	  crucial	  molecular	  partners	  to	  execute	  some	  of	  the	  IRSp53	  functions.	  Our	  future	  plan	  is	  to	  validate	  these	  interactions	  in	  an	  attempt	  to	  decipher	  and	  dissect	  the	  key	  molecular	  mechanisms	  and	  players	  through	  which	  IRSp53	  affects	  such	  a	  variety	  of	  cellular	  functions,	  ranging	  from	  polarity	  to	  vasculogenesis	  and	  angiogenesis.	  To	  conclude,	  in	  this	  thesis	  novel	  roles	  of	  IRSp53	  have	  been	  presented,	  in	  particular	  in	  capping	  the	  actin	  filaments,	  in	  inducing	  filopodia	  formation	  and	  in	  the	  establishment	  of	  polarity	  program	  in	  3-­‐D	  organoids.	  However,	  a	  lot	  of	  work	  is	  still	  needed,	  judging	  from	  the	  high	  complexity	  phenotypes	  emerging	  from	  in	  vivo	  data	  in	  Irsp53	  null	  mice.	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Such	  a	  wide	  range	  of	  effects	  highlights	  the	  fact	  that	  proteins	  at	  the	  membrane-­‐actin	  interface,	  as	  IRSp53,	  can	  be	  involved	  and	  crucial	  in	  many	  different	  cellular	  events,	  also	  in	  unobvious	  ways.	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Table	  3.	  Top	  22	  IRSp53	  interactors	  in	  HUVEC	  cells,	  based	  on	  BirA*	  proximity	  ligation	  coupled	  to	  
mass	  spectrometry.	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Supplementary	  material	  
Supplementary	  methods	  
SILAC	  BioID	  in	  HeLa	  cells	  BirA*	  expressing	  vector	  was	  purchased	  from	  Addgene	  (plasmid	  #	  35700).	  BirA*	  was	  cloned	  upstream	  of	  IRSp53	  or	  GFP,	  as	  control,	  in	  lentiviral	  pLVX	  vector	  (Clonetech).	  HeLa	  cells	  were	  infected	  with	  lentiviral	  particles	  generated	  from	  pLVX	  BirA*-­‐IRSp53	  or	  pLVX-­‐BirA*-­‐GFP.	  The	  two	  populations	  have	  been	  treated	  with	  heavy	  (BirA*-­‐GFP)	  and	  light	  (BirA*-­‐IRSp53)	  labelled	  DMEM	  medium	  for	  SILAC	  (Thermo	  Fisher	  Scientific)	  (supplemented	  with	  dialyzed	  fetal	  bovine	  serum)	  for	  6	  passages;	  swap	  of	  labelling	  was	  performed	  in	  the	  replicate.	  Cells	  have	  been	  treated	  with	  50	  μM	  biotin	  for	  24	  hours	  and	  lysed	  in	  JS	  buffer,	  then	  biotinylated	  proteins	  were	  fished	  out	  with	  streptavidin-­‐conjugated	  magnetic	  beads	  (Thermo	  Fisher	  Scientific).	  Beads	  were	  washed	  out	  from	  aspecific	  binders	  using	  50	  mM	  Tris	  pH	  7.5,	  1%	  SDS	  and	  protease	  inhibitors;	  elution	  was	  performed	  using	  SDS-­‐PAGE	  Sample	  buffer	  2X,	  coupled	  with	  95°C	  boiling.	  Eluates	  were	  then	  subjected	  to	  SDS-­‐PAGE;	  after	  colloidal	  blue	  staining,	  bands	  were	  excised	  and	  reduced	  with	  10	  mM	  dithiothreitol,	  alkylated	  with	  55	  mM	  iodoacetamide	  and	  finally	  digested	  overnight	  with	  12.5	  ng/µl	  of	  trypsin	  (Roche).	  After	  acidification,	  peptide	  mixtures	  were	  concentrated	  and	  desalted,	  dried	  in	  a	  Speed-­‐	  Vac	  and	  resuspended	  in	  12-­‐15	  µL	  of	  solvent	  A	  (2%	  acetonitrile,	  0.1%	  formic	  acid).	  5µl	  of	  each	  digested	  sample	  from	  the	  forward	  and	  reverse	  experiments	  were	  loaded	  on	  a	  LC	  (liquid	  chromatography)–ESI–MS/MS	  quadrupole	  Orbitrap	  QExactive	  mass	  spectrometer	  (Thermo	  Fisher	  Scientific).	  Peptides	  were	  separated	  on	  a	  linear	  gradient	  from	  95%	  solvent	  A	  to	  40%	  solvent	  B	  (80%	  acetonitrile,	  0.1%	  formic	  acid)	  over	  30	  min	  and	  from	  40	  to	  100%	  solvent	  B	  in	  3	  min	  at	  a	  constant	  flow	  rate	  of	  0.25	  µl/min	  on	  UHPLC	  Easy-­‐nLC	  1000	  (Thermo	  Scientific),	  where	  the	  LC	  system	  was	  connected	  to	  a	  25-­‐cm	  fused-­‐silica	  emitter	  of	  75	  µm	  inner	  diameter	  (New	  Objective,	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Inc.	  Woburn,	  MA,	  USA),	  packed	  in-­‐house	  with	  ReproSil-­‐Pur	  C18-­‐AQ	  1.9	  µm	  beads	  (Dr	  Maisch	  Gmbh,	  Ammerbuch,	  Germany).	  MS	  data	  were	  acquired	  using	  a	  data-­‐dependent	  top	  12	  method	  for	  HCD	  fragmentation.	  Survey	  full	  scan	  MS	  spectra	  (300–1650	  Th)	  were	  acquired	  in	  the	  Orbitrap	  with	  70000	  resolution,	  AGC	  target	  3e6,	  IT	  60	  ms.	  For	  HCD	  spectra,	  resolution	  was	  set	  to	  17	  500	  at	  m/z	  200,	  AGC	  target	  1e5,	  IT	  120	  ms;	  Normalized	  Collision	  energy	  25%	  and	  isolation	  with	  2.0	  m/z.	  Technical	  replicates	  were	  conducted	  on	  the	  LC–MS-­‐MS	  part	  of	  the	  analysis.	  Raw	  data	  were	  processed	  with	  MaxQuant	  ver.	  1.4.1.2.	  Peptides	  were	  identified	  from	  the	  MS/MS	  spectra	  searched	  against	  the	  UniProt_Human_2014_10	  database	  using	  the	  Andromeda	  search	  engine	  in	  which	  trypsin	  specificity	  was	  set	  up	  with	  a	  maximum	  of	  two	  missed	  cleavages.	  Cysteine	  carbamidomethylation	  was	  used	  as	  fixed	  modification,	  methionine	  oxidation	  and	  protein	  N-­‐terminal	  acetylation	  as	  variable	  modifications.	  Mass	  deviation	  for	  MS/MS	  peaks	  was	  set	  at	  20	  ppm.	  The	  peptides	  and	  protein	  false	  discovery	  rates	  (FDR)	  were	  set	  to	  0.01;	  the	  minimal	  length	  required	  for	  a	  peptide	  was	  six	  amino	  acids;	  a	  minimum	  of	  two	  peptides	  and	  at	  least	  one	  unique	  peptide	  were	  required	  for	  high-­‐confidence	  protein	  identification.	  The	  lists	  of	  identified	  proteins	  were	  filtered	  to	  eliminate	  reverse	  hits	  and	  known	  contaminants.	  For	  quantitative	  analysis,	  “re-­‐quantify”	  and	  “second	  peptide”	  options	  were	  selected.	  The	  statistical	  program	  Perseus	  (ver.	  1.5.1.6)	  was	  used	  to	  quantify	  significantly	  up	  and	  down	  regulated	  proteins	  following	  the	  criteria:	  (i)	  significance	  A	  with	  a	  Benjamini-­‐Hochberg	  FDR<0.05;	  (ii)	  ratio	  normalized	  values	  concordant	  in	  both	  forward	  and	  reverse	  experiments;	  (iii)	  minimum	  H/L	  ratio	  counts	  =	  2.	  
BioID	  in	  HUVEC	  cells	  HUVEC	  cells	  have	  been	  infected	  with	  lentiviral	  constructs	  encoding	  for	  BirA*-­‐IRSp53	  or	  BirA*-­‐GFP.	  Cells	  have	  been	  treated	  with	  50	  μM	  biotin	  for	  24	  hours	  and	  lysed	  in	  JS	  buffer,	  then	  biotinylated	  proteins	  were	  fished	  out	  with	  streptavidin-­‐conjugated	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magnetic	  beads	  (Thermo	  Fisher	  Scientific).	  Beads	  were	  washed	  out	  from	  aspecific	  binders	  using	  50	  mM	  Tris	  pH	  7.5,	  1%	  SDS	  and	  protease	  inhibitors;	  elution	  was	  performed	  using	  SDS-­‐PAGE	  Sample	  buffer	  2X,	  coupled	  with	  95°C	  boiling.	  Eluates	  were	  then	  subjected	  to	  SDS-­‐PAGE;	  after	  colloidal	  blue	  staining,	  bands	  were	  excised	  and	  reduced	  with	  10	  mM	  dithiothreitol,	  alkylated	  with	  55	  mM	  iodoacetamide	  and	  finally	  digested	  overnight	  with	  12.5	  ng/µl	  of	  trypsin	  (Roche).	  After	  acidification,	  peptide	  mixtures	  were	  concentrated	  and	  desalted,	  dried	  in	  a	  Speed-­‐	  Vac	  and	  resuspended	  in	  12-­‐15	  µL	  of	  solvent	  A	  (5%	  acetonitrile,	  0.1%	  formic	  acid).	  LC-­‐ESI-­‐MS/MS	  of	  5	  µL	  of	  each	  sample	  was	  performed	  on	  a	  Fourier	  transformed-­‐LTQ	  mass	  spectrometer	  (FT-­‐LTQ,	  Thermo	  Electron,	  San	  Jose,	  CA).	  Peptides	  separation	  was	  achieved	  on	  a	  linear	  gradient	  from	  100%	  solvent	  A	  to	  20%	  solvent	  B	  (80%	  acetonitrile,	  0.1%	  formic	  acid)	  over	  30	  min	  and	  from	  20%	  to	  80%	  solvent	  B	  in	  20	  min	  at	  a	  constant	  flow	  rate	  of	  0.3	  µL/min	  on	  Agilent	  chromatographic	  separation	  system	  1100	  (Agilent	  Technologies,	  Waldbronn,	  Germany),	  where	  the	  LC	  system	  was	  connected	  to	  a	  15	  cm	  fused-­‐silica	  emitter	  of	  75	  µm	  inner	  diameter	  (New	  Objective,	  Inc.	  Woburn,	  MA	  USA),	  packed	  in-­‐house	  with	  ReproSil-­‐Pur	  C18-­‐AQ	  3	  µm	  beads	  (Dr.	  Maisch	  Gmbh,	  Ammerbuch,	  Germany),	  using	  a	  high-­‐pressure	  bomb	  loader	  (Proxeon,	  Odense,	  Denmark).	  Survey	  MS	  scans	  were	  acquired	  in	  the	  FT	  from	  m/z	  350-­‐1650	  with	  100	  000	  resolution.	  The	  five	  most	  intense	  doubly	  and	  triply	  charged	  ions	  were	  automatically	  selected	  for	  fragmentation.	  Target	  ions	  already	  selected	  for	  the	  MS/MS	  were	  dynamically	  excluded	  for	  60	  s.	  Tandem	  mass	  spectra	  were	  extracted	  by	  RAW2MSM	  ver.1.10_2007_06.14,	  converted	  into	  peaklist	  (.msm)	  and	  analyzed	  using	  Mascot	  (Matrix	  Science,	  London,	  UK;	  ver.	  2.3.02)	  searching	  against	  UniProt_CP_Human_20140709	  database.	  Searches	  were	  performed	  assuming	  the	  digestion	  enzyme	  trypsin,	  a	  fragment	  ion	  mass	  tolerance	  of	  0,50	  Da	  and	  a	  parent	  ion	  tolerance	  of	  10,0	  PPM;	  carbamidomethyl	  of	  cysteine	  was	  specified	  as	  a	  fixed	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modification,	  oxidation	  of	  methionine	  and	  acetyl	  of	  protein	  N-­‐terminus	  as	  variable	  modifications.	  Scaffold	  (ver.	  4.4.3,	  Proteome	  Software	  Inc.,	  Portland,	  OR)	  was	  used	  to	  validate	  MS/MS	  based	  peptide	  and	  protein	  identifications.	  Peptide	  identifications	  were	  accepted	  if	  they	  could	  be	  established	  at	  greater	  than	  95,0%	  probability	  by	  the	  Peptide	  Prophet	  algorithm	  with	  Scaffold	  delta-­‐mass	  correction.	  Protein	  identifications	  were	  accepted	  if	  they	  could	  be	  established	  at	  greater	  than	  99,0%	  probability	  and	  contained	  at	  least	  2	  identified	  peptides.	  Protein	  probabilities	  were	  assigned	  by	  the	  Protein	  Prophet	  algorithm.	  Proteins	  that	  contained	  similar	  peptides	  and	  could	  not	  be	  differentiated	  based	  on	  MS/MS	  analysis	  alone	  were	  grouped	  to	  satisfy	  the	  principles	  of	  parsimony.	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Filopodia explore the environment, sensing soluble and
mechanical cues during directional motility and tissue
morphogenesis. How ﬁlopodia are initiated and spatially
restricted to speciﬁc sites on the plasma membrane is still
unclear. Here, we show that the membrane deforming and
curvature sensing IRSp53 (Insulin Receptor Substrate of
53 kDa) protein slows down actin ﬁlament barbed end
growth. This inhibition is relieved by CDC42 and counter-
acted by VASP, which also binds to IRSp53. The
VASP:IRSp53 interaction is regulated by activated CDC42
and promotes high-density clustering of VASP, which is
required for processive actin ﬁlament elongation. The
interaction also mediates VASP recruitment to liposomes.
In cells, IRSp53 and VASP accumulate at discrete foci at
the leading edge, where ﬁlopodia are initiated. Genetic
removal of IRSp53 impairs the formation of VASP foci,
ﬁlopodia and chemotactic motility, while IRSp53 null
mice display defective wound healing. Thus, IRSp53 dam-
pens barbed end growth. CDC42 activation inhibits this
activity and promotes IRSp53-dependent recruitment and
clustering of VASP to drive actin assembly. These events
result in spatial restriction of VASP ﬁlament elongation for
initiation of ﬁlopodia during cell migration, invasion, and
tissue repair.
The EMBO Journal (2013) 32, 2735–2750. doi:10.1038/
emboj.2013.208; Published online 27 September 2013
Subject Categories: cell & tissue architecture
Keywords: actin dynamics; cell migration; CDC42; ﬁlopodia;
IRSp53
Introduction
Cells move and interact with the environment by forming
migratory structures composed of self-organized polymers of
actin. These protrusions can be ﬂat-sheet lamellipodia, or
elongated, ﬁnger-like ﬁlopodia. Cells use lamellipodia as
expanding membrane sheets driving cell locomotion (Wu
et al, 2012), while ﬁlopodia act as compasses navigating
cell migration (Faix et al, 2009; Yang and Svitkina, 2011a),
as well as mechanical sensors (Chan and Odde, 2008).
In lamellipodia, actin is organized in networks of branched
ﬁlaments (Svitkina et al, 2003; Yang and Svitkina, 2011b),
generated by the concerted action of the Arp2/3 complex,
capping proteins, and ﬁlament elongation factors (Svitkina
and Borisy, 1999; Wiesner et al, 2003; Akin and Mullins,
2008). Conversely, ﬁlopodia are composed of parallel actin
bundles that emanate from the cell periphery (Adams, 2004).
However, in several cell types, ﬁlopodia and lamellipodia
rapidly interchange during protrusion. Furthermore, ﬁlopodia
are frequently embedded into, or arise from, pre-existing
lamellipodia (Rottner et al, 1999; Svitkina et al, 2003). This
ﬁnding suggests that ﬁlopodia form through a reorganization
of the underlying actin network by convergent elongation of
pre-existing ﬁlaments, or by de novo actin nucleation and
elongation (Faix et al, 2009; Yang and Svitkina, 2011a).
Whatever the case, the occurrence of lamellipodia-to-
ﬁlopodia transition suggests commonalities between the
two structures. For example, while it appears that capping
proteins, including CP and EPS8, determine which actin-
based protrusive organelle dominates at the cell periphery
(Mejillano et al, 2004; Akin and Mullins, 2008; Vaggi et al,
2011), they do not function in isolation. The ENA/VASP
family of proteins (Gertler et al, 1995; Reinhard et al, 1995;
Gertler et al, 1996), which in mammals includes MENA,
VASP, and EVL, also inﬂuence the underlying actin
architecture of migratory protrusions (Bear et al, 2002).
Notably, by cellular localization alone, ENA/VASP proteins
appear to be vital to this lamellipodial–ﬁlopodial transition
since they localize to active sites of actin assembly, such as
the tips of protruding lamellipodia and ﬁlopodia (Lanier et al,
1999; Rottner et al, 1999). At the leading edge, the intensity of
GFP-VASP has been shown to increase locally in puncta that
subsequently give rise to ﬁlopodia, suggesting that higher
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order clustering of this protein may be critical for generating
linear ﬁlaments to support ﬁlopodia protrusions (Lanier et al,
1999; Rottner et al, 1999; Svitkina et al, 2003; Applewhite
et al, 2007). Biochemical studies have recently shown that
soluble VASP displays weak, processive polymerase activity
(Hansen and Mullins, 2010). High-density VASP clustering,
however, is required to enhance processive ﬁlament
elongation, even in the presence of high concentrations of
capping proteins (Breitsprecher et al, 2008, 2011). Not
surprisingly, genetic evidence in various organisms showed
that ENA/VASP proteins are essential players in ﬁlopodia
formation (Schirenbeck et al, 2006; Gates et al, 2007;
Kwiatkowski et al, 2007). Whether and how the activity
and higher order clustering of ENA/VASP family proteins is
differentially tuned to control lamellipodia-to-ﬁlopodia
transition remains, however, poorly deﬁned.
Molecules sitting at the actin:membrane interface are pre-
dicted to be important in this process, albeit their nature and
mechanisms of action remain unclear. One candidate is
IRSp53 (Insulin Receptor Substrate of 53 kDa) (also called
BAIAP2, brain angiogenic inhibitor interacting protein 2)
(Abbott et al, 1999; Oda et al, 1999; Okamura-Oho et al,
1999). IRSp53 possesses an inverted Bin-Amphiphysin-
Rvs167 (I-BAR) domain that binds to PI(4,5)P2-rich lipid
inducing negative curvatures, such as the ones required for
ﬁlopodia protrusions (Zhao et al, 2011). Consistently, IRSp53
expression is sufﬁcient to induce ﬁlopodia-like structures
(Bockmann et al, 2002; Yamagishi et al, 2004; Disanza
et al, 2006). Furthermore, IRSp53 binds activated CDC42
and, through its SH3 domain, a number of actin regulatory
proteins that are involved in ﬁlopodia protrusions (Ahmed
et al, 2010). Among them, IRSp53 was reported to bind to
MENA in vitro (Krugmann et al, 2001) and to VASP in FRET-
based and co-immunoprecipitation assays (Lim et al, 2008;
Vaggi et al, 2011). Interestingly, the interaction between VASP
and IRSp53 enhances the bundling activity of the former (Lim
et al, 2008; Vaggi et al, 2011). However, it is unknown
whether IRSp53 affects other key biochemical activities of
MENA and VASP, and what the functional consequences of
these interactions are.
Here, we show that IRSp53 alone slows down barbed end
growth. Binding to CDC42 relieves this inhibition and pro-
motes IRSp53-dependent recruitment and clustering of VASP
to the plasma membrane to initiate processive F-actin elonga-
tion. These events result in spatial restriction of VASP activity
to initiate ﬁlopodia, drive cell migration, and promote tissue
repair.
Results
Characterization of the IRSp53–VASP interaction
We initially characterized the interaction between IRSp53 and
VASP using puriﬁed proteins and various binding assays.
IRSp53 associates with VASP, as well as EVL, through its
SH3 domain (Supplementary Figure S1a–f) that contacts VASP
on proline-rich sites partially overlapping, but distinct from
the Proﬁlin binding sites (Supplementary Figure S1c and g).
Next, since VASP has recently been shown to acquire proces-
sive elongation activity upon clustering and IRSp53 can form
dimer through its I-BAR domain (Millard et al, 2005), we
tested whether in solution the two proteins can form high
order oligomer by dynamic light scattering. Puriﬁed IRSp53
produced a single major species with a hydrodynamic radius
of about 7.2nm (Figure 1A) consistent with its dimeric
structure (similar results were obtained by hydrodynamic
measurements; Supplementary Figure S2a), while the VASP
tetramer gave rise to a single species with a radius of about
14.3 nm (Figure 1A). Notably, the mixture of both proteins led
to the formation of large clusters with an average diameter of
about 200 nm (Figure 2A, left). Importantly, the VASP-DPRD
mutant, which is unable to bind to IRSp53 (Supplementary
Figure S1e), and the IRSp53 W413G mutant, which lacks
VASP binding ability (Supplementary Figure S1c), did not
form heterocomplexes (Figure 1A, right, and data not
shown). In contrast, a VASP mutant lacking the central three
GP5 motifs (VASP-DGP5), which retains IRSp53 binding abil-
ity, albeit with reduced afﬁnity (Supplementary Figure S1d
and f), was still able to hetero-oligomerize upon addition of
IRSp53 (Figure 1A, middle). Thus, IRSp53 promotes clustering
of VASP in solution, and might therefore be a decisive factor in
the regulation of VASP function in vitro and in vivo.
IRSp53-mediated inhibition of barbed end growth is
relieved by CDC42
Given the established role of VASP as an actin elongation
factor with a relatively weak ﬁlament nucleation activity
(Huttelmaier et al, 1999; Samarin et al, 2003; Barzik et al,
2005; Breitsprecher et al, 2008; Pasic et al, 2008), we next
assessed whether IRSp53 regulates VASP ﬁlament elongation
in bulk pyrenyl-actin polymerization assays. In this assay,
VASP increased the rate (up to 2.5-fold) of spectrin-actin
seeded barbed end growth from both ATP-G-actin (data not
shown) and proﬁlin-ATP-G-actin in an identical and dose-
dependent fashion, under conditions in which its nucleating
effect was negligible (Figure 1B). In contrast, IRSp53 slowed
down barbed end growth byB10-fold, in a substoichiometric
concentration range with respect to G-actin, indicating that
the interaction of IRSp53 with barbed ends, rather than with
G-actin, mediates this inhibitory effect (Figure 1C). The
interaction of VASP and IRSp53 with barbed ends also
inhibited dilution-induced depolymerization of ﬁlaments
(Figure 1D).
A structure/function analysis of IRSp53 domains mediating
barbed end growth inhibition revealed that the SH3 domain
binding activity is dispensable. Indeed, an IRSp53-W413G
mutant inhibited barbed end growth to the same extent
as wild-type (WT) IRSp53, but bound to barbed ends instan-
taneously with a Kd of 0.29 mM (Figure 1E, scheme;
Supplementary Figure S2b and c). In contrast, the isolated
I-BAR domain of IRSp53 had no effect on barbed end growth
(Figure 1E-scheme; Supplementary Figure S2b). We deter-
mined that the minimal region that mediates barbed end
growth inhibition includes the I-BAR domain and a stretch of
30 amino acids just before the SH3 domain (Figure 1E,
scheme; Supplementary Figure S2d). These results suggest
that IRSp53 uses multiple interaction surfaces for inhibiting
barbed end growth (e.g., the I-BAR domain to bind to
ﬁlaments and additional surfaces to dock onto the barbed
end protomers) or that it adopts an appropriate three-dimen-
sional conformation centred on the dimeric I-BAR domain.
Indeed, IRSp53 has recently been shown by the Dominguez
group (in a work submitted elsewhere) to fold into a closed
conformation held together by an intramolecular interaction
between the SH3 domain and a proline-rich region that is part
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of an atypical CDC42 binding interface. Mutation of these
prolines (P278DA, P281D) leads to an ‘open’ IRSp53 con-
formation, which was capable of inhibiting barbed end
growth, albeit slightly less efﬁciently than WT IRSp53
(Supplementary Figure S2d). CDC42-GTPgS abolished the
slowing down of barbed end growth by IRSp53-WT and the
proline mutant, but not by a CDC42 binding-deﬁcient mutant
(IRSp53-I267A-S268A; Figure 1E; Supplementary Figure S2e).
Importantly, only active GTP-loaded CDC42, but not the
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Figure 1 IRSp53 slows down barbed end growth: an effect relieved by CDC42. (A) IRSp53 and VASP form large clusters in solution. Intensity
weighted diameter distributions for IRSp53 and VASP showed single species for either IRSp53 (red lines) or VASP WTand mutant proteins alone
at concentrations of up to 30 mM (green lines). Aggregates formed in mixtures of 10 mM IRSp53 and 10mM VASP WTor VASPD(GP5)3, whereas
no clusters were observed with VASP-DPRD (blue lines). (B) VASP increases the association rate constant of proﬁlin-actin to barbed ends.
Barbed end growth was measured in bulk pyrenyl-actin polymerization assays using 1.25 mM MgATP-G-actin (5% pyrenyl-labelled), 5mM
proﬁlin, and VASP (V) at 0 (blue lines), 64 nM (red lines), and 169nM (green lines), in the absence (dotted lines) or in the presence (continuous
lines) of 0.16 nM spectrin-actin seeds. Inset shows cumulated data from additional assays performed with different VASP concentrations.
(C) IRSp53 slows down actin polymerization by weakly capping barbed ends. Kinetics of actin polymerization induced by spectrin-actin seeds,
measured as described in (A), in the presence of the indicated concentrations of IRSp53. (D) IRSp53 and VASP inhibit barbed end
depolymerization. Depolymerization of actin ﬁlaments (2.5mM F-actin, 50% pyrenyl-labelled) was induced by 50-fold dilution into
polymerization buffer in the presence of 0.29mM IRSp53 (red curve) or 0.34mM VASP (green curve). (E) Summary of barbed end growth
inhibition (Cap) by the indicated IRSp53 constructs and mutants (see also Supplementary Figure S2). (F) Active CDC42 relieves IRSp53 capping
activity. Kinetics of actin polymerization induced by spectrin-actin seeds was measured as described in (A) in the presence of 0.58mM IRSp53,
alone or with 10mM CDC42-GTP or CDC42-GDP. Control (CTR) sample contained no IRSp53. (G) Kinetics of actin polymerization induced by
spectrin-actin seeds was measured as described in (A) in the presence of the indicated concentrations of IRSp53 or its truncated mutant 1–375.
Right graph represents a magniﬁcation of the initial phase of elongation by seeds (inset in the left graph).
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Figure 2 IRSp53 recruits and clusters Ena/VASP proteins to drive processive actin ﬁlament elongation in the presence of capping protein.
(A) IRSp53 inhibits barbed end elongation. (Left) Polymerization of 1.0mM G-actin (20% Atto-488 labelled) in the absence or presence of 1mM
IRSp53 in 1TIRF buffer monitored by TIRF microscopy. Time is indicated in seconds in the top right corner of each frame. Scale bar, 10mm.
(Right) Quantiﬁcation of actin ﬁlament elongation rates in the absence or presence of IRSp53 as monitored by TIRF microscopy. Elongation
rates are presented as mean±s.e.m. from three independent experiments. At least 24 ﬁlaments per condition/experiment were measured.
*, Po0.05 and **, Po0.01 (T-test, compared to 1mM actin). (B) TIRF micrographs of the assembly of 1.0mM G-actin (20% Atto-488 labelled)
on uncoated (red arrowhead) or His-IRSp53-saturated Ni-NTA beads in the presence of 50nM capping protein and 200nM VASP, EVL, or hVASP
DdGAB. Blue arrowheads indicate buckling ﬁlaments (also see Supplementary Movie 1). Only ﬁlaments that were attached with their barbed
ends to the beads were observed, whereas capping protein largely abolished ﬁlament growth in solution. Time is indicated in seconds in the
upper right corner of each frame. Scale bar, 10 mm. (C) Quantiﬁcation of actin ﬁlament elongation rates from experiment shown in (B). Data are
presented as mean±s.d. of three independent experiments, in which at least 16 ﬁlaments/experiment were measured. ***, Po0.005 (T-test,
compared to His-VASP control).
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barbed end elongation (Figure 1F). Thus, IRSp53 can inhibit
barbed end growth in both the ‘closed’ and ‘open’ confor-
mation, and CDC42 relieves this inhibition presumably by
sterically hindering the IRSp53:barbed end interaction.
Notably, inhibition of barbed end elongation by IRSp53
developed slowly during ﬁlament growth (Figure 1C). This
ﬁnding is further supported by data showing that steady-state
amounts of assembled actin were unaffected by the
presence of IRSp53 and/or VASP at the concentrations tested
(Supplementary Figure S2f). Furthermore, an IRSp53 mutant
retaining the minimal surfaces for barbed end inhibition,
but lacking the entire SH3 domain (and thus presumably
adopting an open conformation) instantaneously inhibited
barbed end growth (IRSp53-1–374; Figure 1G), similarly to
IRSp53-W413G (Supplementary Figure S2b).
Finally, we monitored ﬁlament elongation in real time by
in vitro TIRF microscopy in the presence of IRSp53. Similarly
to our bulk spectrin-actin seed assays, addition of increasing
concentrations of IRSp53 signiﬁcantly slowed down barbed
growth byB30% (Figure 2A). This effect was reverted by the
addition of activated CDC42 (Supplementary Figure S2g). It
must be noted, however, that TIRF data were collected in the
early phase of ﬁlament elongation, between 0 and 400 s. In
this time frame, we also detected partial inhibition of growth
in bulk polymerization spectrin-actin seed assays. These data
provide further evidence for the slow kinetics of IRSp53
association to barbed ends. To detect more extensive barbed
end growth inhibition by TIRF, we would need to use con-
centrations of IRSp53 much higher than those we can achieve
given the relatively low Kd (B0.3 mM) of IRSp53 for barbed
ends (Supplementary Figure S2c). The low afﬁnity of IRSp53
for barbed ends could also result in short t1/2 of the
IRSp53:barbed end complex, which may allow growth of
barbed ends that are only transiently occupied by IRSp53.
Alternatively, IRSp53 may bind slowly to barbed ends be-
cause it needs to undergo a slow conformational change for
efﬁcient binding, or a slow conformational change might
follow IRSp53 binding to the sides of ﬁlaments, close to the
barbed ends, resulting in a reduction in the rate of ﬁlament
growth.
Although VASP and IRSp53 bind to each other, they have
independent and opposing effects on barbed end growth. The
addition of VASP to IRSp53-blocked barbed ends resulted in
restoration of fast ﬁlament growth to rates obtained with
VASP alone (Supplementary Figure S3a). Hence, in this assay,
the possible association of VASP and IRSp53 to barbed ends
does not change the kinetic behaviour of VASP-bound barbed
ends. Thus, the formation of a VASP::IRSp53 complex has
negligible effects on the ﬁlament elongation rate of VASP in
solution.
IRSp53 promotes VASP recruitment and clustering on
supported surfaces to drive processive ﬁlament
elongation
High-density clustering of VASP onto functionalized beads
allows processive, WH2 domain-mediated actin ﬁlament
elongation, even in the presence of high concentrations of
capping protein (Breitsprecher et al, 2008, 2011). Thus, we
assessed whether beads saturated with IRSp53 could recruit
and cluster VASP to drive processive actin assembly in the
presence of capping protein using TIRF microscopy. To
facilitate the visualization of actin ﬁlament growth, we
initially used a chimaeric VASP (VASP-DdGAB), bearing the
GAB motif of the Dictyostelium discoideum VASP homologue.
This DdGAB motif, due to its high afﬁnity for G-actin,
markedly enhances ﬁlament elongation compared to WT
mammalian VASP at the low G-actin concentration (1 mM)
used in the TIRF assay (Figure 2B and C; Supplementary
Figure S3d; Breitsprecher et al, 2011). We observed that high-
density crowding or clustering of VASP-DdGAB on IRSp53-
coated beads relieved inhibition of actin growth by capping
protein and promoted marked processive ﬁlament elongation
(Figure 2B and C; Supplementary Figure S3d). Buckling actin
ﬁlaments grew away from the bead surfaces with elongation
rates ranging from 37.1±7 to 45.4±5.5 actin subunits/s,
which is comparable to the rate obtained with VASP-DdGAB-
coated control beads (Figure 2B and C; Supplementary
Figure S3d; Supplementary Movie 1). This elongation rate
is about four times faster than the elongation rate (B10 actin
subunits/s) of spontaneously growing actin control ﬁlaments
(Breitsprecher et al, 2008, 2011). The recruitment of VASP-
DdGAB to the beads was speciﬁcally mediated by IRSp53,
since no ﬁlament growth was observed when uncoated beads
were incubated with soluble VASP (Figure 2B and C).
Likewise, no ﬁlament growth was observed when beads
were coated with IRSp53-W413G, which possesses a
defective SH3 domain (Supplementary Figure S3d). We ex-
tended these observations to human VASP (hVASP) and EVL
(hEVL). In both cases, the recruitment of the proteins to
IRSp53-coated beads in the presence of capping proteins
promoted processive ﬁlament elongation in the presence of
capping proteins (Figure 2B and C). As expected, the rate of
ﬁlament elongation in the presence of hVASP or hEVL was
3- to 4-fold slower compared to that of hVASP-DdGAB, due to
the lower afﬁnities of their GAB domains for G-actin
(Breitsprecher et al, 2011). Collectively, these results
demonstrate that bead-immobilized IRSp53 is necessary and
sufﬁcient to recruit and cluster VASP from solution, which in
turn drives processive actin ﬁlament assembly in the
presence of CP.
CDC42 favours the formation of an IRSp53–VASP
complex in vivo
IRSp53 can bind both activated RAC (Miki et al, 2000) and
CDC42 (Govind et al, 2001; Krugmann et al, 2001). MENA,
another member of the ENA/VASP family protein, has been
shown to bind to IRSp53 in a CDC42-dependent manner
in vitro (Krugmann et al, 2001). Using recombinant puriﬁed
proteins, we ﬁrst examined whether IRSp53 serves as a link
between VASP and active CDC42. Binding of IRSp53 to
GTP-CDC42 was readily detected, while VASP interacted
with GTP-CDC42 in an IRSp53-dependent manner, indi-
cating the existence of a CDC42–IRSp53–VASP complex
(Figure 3A). Furthermore, the addition of saturating amounts
of GTP-CDC42 increased the ability of IRSp53 to interact with
VASP in vitro (Figure 3B). Similar results were obtained in co-
immunoprecipitation experiments. The ectopic expression of
active CDC42, but not of a dominant-negative mutant, sig-
niﬁcantly enhanced the amount of endogeneous IRSp53 co-
immunoprecipitating with VASP (Figure 3C). The CDC42-
dependent increase in the VASP:IRSp53 association was
accompanied by a diminution of the EPS8:IRSp53 interaction
(Figure 3C). Notably, VASP and EPS8 compete for binding to
the SH3 domain of IRSp53, and in unstimulated conditions
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EPS8, which contrary to VASP acts as a capper, binds more
efﬁciently than VASP to IRSp53 (Menna et al, 2009; Vaggi
et al, 2011). Thus, CDC42 binding promotes a switch in
IRSp53-based molecular complexes that favours IRSp53
association with VASP, while reducing the interaction with
EPS8, leading to the formation of an actin assembly
promoting CDC42:IRSp53:VASP complex.
IRSp53-mediated association of VASP to PIP2-enriched
membrane is required for proper clustering of VASP at
the PM and ﬁlopodia formation
Filopodia initiation is preceded by localized accumulation of
VASP into discrete foci along the PM (Rottner et al, 1999;
Svitkina et al, 2003; Yang et al, 2007). IRSp53 also binds and
localizes at the PM, accumulating at PIP2-rich sites (Zhao
et al, 2011). Thus, IRSp53 may control and enhance VASP
activity by recruiting and spatially restricting its localization
on PIP2-rich, curved PM. We ﬁrst tested this hypothesis using
FACS-based in vitro assays that monitor the ability of
ﬂuorescently labelled (Alexa-488) proteins to bind PIP2-rich
liposomes in solution (Temmerman and Nickel, 2009).
Fluorescently labelled IRSp53 and IRSp53-W413G bound
efﬁciently to liposomes only when PIP2 was included in the
lipid mixture (Figure 4A; Supplementary Figure S4a). Alexa-
488-VASP instead did not associate with liposomes. However,
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Figure 3 CDC42 modulates the interaction between IRSp53 and VASP. (A) IRSp53 connects VASP with CDC42. Equimolar concentrations
(200nM) of IRSp53and/or VASP were incubated with 1mMGDP- or GTPgS-loaded GST-CDC42 immobilized on beads, as indicated. Inputs (10%
of total) and bound material were analysed by immunoblotting to visualize VASP or by Ponceau staining to detect IRSp53 and CDC42. (B) Equal
amounts of VASP were incubated with Ni-NTA agarose beads coating with increasing concentrations of recombinant puriﬁed His-IRSp53 (0,
100, 250, and 500nM), in the absence or presence of saturating concentrations of GTP-loaded GST-CDC42. Inputs (10% of total) and bound
material were immunoblotted with the indicated antibodies (Ponceau staining visualizes IRSp53). Right panel: Quantiﬁcation of the fraction of
VASP bound to His-IRSp53-Ni-NTA beads was determined by analysing blots with the ImageJ software. The fraction (bound/total) of VASP was
plotted against the concentrations of IRSp53 (data are the mean±s.d. of three independent experiments). (C) Lysates (2mg) of HeLa cells,
transfected with empty vector as a control (EV) or with either CDC42 dominant-negative (N17) or constitutively active (L61) mutants, were
immunoprecipitated with an anti-VASP (VASP) or control antibody (CTR). Input lysates (40mg) and immunoprecipitates (IPs) were
immunoblotted with the indicated antibodies. Right panel: The amount of IRSp53 bound to VASP was determined using the ImageJ software.
Relative binding between IRSp53 and VASP (data are the mean±s.d. of ﬁve independent experiments). Source data for this ﬁgure is available
on the online supplementary information page.
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IRSp53, Alexa-488-VASP readily bound to PIP2 lipids
(Figure 4A). This interaction was abolished when unlabelled
IRSp53-W413G was used instead of WT IRSp53 (Figure 4A),
or by the addition of an excess of unlabelled EPS8 that
competes with VASP for binding to IRSp53 (Disanza et al,
2006) (Figure 4A).
We next explored whether IRSp53 is required for the for-
mation of VASP foci at the leading edge. We took advantage of
MEF cells derived from IRSp53 null mice (Sawallisch et al,
2009; Weiss et al, 2009) stably infected with mock empty
vector, or vectors expressing IRSp53-WT or -W413G to levels
similar to the endogeneous protein (Figures 4D and 5C).
KO-pBABE
KO-pBABE-IRSp53 WT
t = 0 min t = 1 min t = 2 min t = 3 min t = 4 min t = 5 min
t = 0 min t = 1 min t = 2 min t = 3 min t = 4 min t = 5 min
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Figure 4 IRSp53 is required for VASP recruitment and clustering at the PM. (A) VASP is recruited to PIP2-containing liposomes through
IRSp53. Unlabelled or labelled (*Alexa-488) IRSp53-WT, IRSp53-W413G, EPS8, and VASP, at the indicated concentrations and combinations,
were added to 1mM of 10% PIP2 containing liposomes. Interactions were analysed by FACS and data were processed with the CellQuest Pro
software (Becton Dickinson) and expressed as mean±s.e.m. of at least three independent experiments performed in duplicate. **Indicates
Po0.01 (t-test, comparing each condition to control, buffer). (B) IRSp53 removal diminishes VASP clustering at the PM. Still images from
differential interference contrast (DIC) and ﬂuorescence time-lapse analysis of migrating cells. MEFs transfected with empty vector (KO-
pBABE), KO-pBABE-IRSp53 WT, and KO-pBABE-IRSp53 W413G were electroporated with GFP-VASP and plated on laminin (40mg/ml). Twenty-
four hours after electroporation, cells were analysed by time-lapse imaging (5min, time interval 5 s). Bar is 5mm (2 mm for the insets). Arrows
indicate VASP puncta (see also Supplementary Movies 2–5). (C) Quantiﬁcation of the number (N) of clusters (mean±s.e.m.) formed by GFP-
VASP was obtained by analysing 20 cells for each condition. (D) The expression levels of EGFP-VASP, IRSp53, and vinculin were analysed by
immunoblotting in KO-pBABE, KO-pBABE-IRSp53 WT, and KO-pBABE-IRSp53 W413G transfected MEFs.
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We analysed by time-lapse imaging the cellular dynamics
of GFP-VASP in MEFs plated on laminin (Figure 4B–D;
Supplementary Movies 2–5). In reconstituted WT IRSp53
MEFs, VASP was distributed to focal adhesions and promi-
nently enriched along lamellipodia (Figure 4B). At this
latter location, bright foci of GFP-VASP frequently moved
laterally, merged, and fused. These foci invariably preceded
the extension of ﬁlopodia that were also positive for fascin
(Figure 4B; Supplementary Figure S4b and c; Supplementary
Movies 7 and 8). Conversely, in MEFs devoid of IRSp53
or reconstituted with IRSp53-W413G mutant, the formation
of leading edge-localized GFP-VASP foci was signiﬁcantly
reduced, while VASP localization and dynamics in lamelli-
podia and focal adhesion remained unaltered (Figure 4B;
Supplementary Movies 2–5). We also tested whether IRSp53
accumulates along the leading edge in discrete foci together
with VASP by dual-colour time-lapse microscopy using GFP-
VASP and mCherry-IRSp53. Notably, both proteins accumu-
lated into bright, dynamic puncta at sites of ﬁlopodia initia-
tion (Supplementary Figure S4b; Supplementary Movie 7).
Time-resolved analysis of the accumulation of cherry-IRSp53
and GFP-VASP into foci revealed that IRSp53 preceded the
recruitment of VASP by 1.4 s on average. (Supplementary
Figure S4c; Supplementary Movie 8). Notably, mDia1, another
putative interactor of IRSp53 with ﬁlament elongation activity
that is implicated in ﬁlopodia (Goh et al, 2012), as well as
N-WASP and WAVE (data not shown), did not display any
accumulation into foci at the leading edge (Supplementary
Figure S4d). This ﬁnding suggests that these proteins are not
required in the initial phase of ﬁlopodia formation. Thus,
IRSp53 is speciﬁcally implicated in the recruitment of VASP to
PIP2-rich membrane and in its apparent clustering along
PM sites where ﬁlopodia are initiated, implying a requirement
of the IRSp53:VASP complex in the formation of these
protrusions.
To test the latter hypothesis, we monitored ﬁlopodia
induced by the expression of active CDC42 or following
the initial phases of cell spreading on extracellular matrix
(ECM) substrates (Kozma et al, 1995; Applewhite et al,
2007). A 440% reduction in CDC42-induced ﬁlopodia was
observed in MEFs devoid of IRSp53 compared with cells
reconstituted with IRSp53-WT (Figure 5A–C). Of note,
when IRSp53 is expressed, it displays a diffuse punctate
distribution throughout the cytoplasm, but also decorates
the shafts of protruding ﬁlopodia (Figure 5A–C). Similarly,
in IRSp53-WT-reconstituted MEFs, VASP, as expected, was
conﬁned to ﬁlopodia tips. Conversely, removal of IRSp53 or
re-expression of IRSp53-W413G in IRSp53 null MEFs pre-
vented the proper localization of VASP (Supplementary
Figure S5a–d). VASP localized at the tips of ﬁlopodia in
B80% of IRSp53-WT reconstituted cells, but only in 20 and
30% of empty vector and IRSp53-W314G reconstituted cells,
respectively.
Filopodia protrusions are also typically formed during cell
spreading onto ECM. Three different spreading modes have
been described for mouse ﬁbroblasts: smooth-edged, ﬁlopo-
dial or rufﬂing (Applewhite et al, 2007). ENA/VASP proteins
are known to increase the number of cells that form ﬁlo-
podia (Applewhite et al, 2007). We performed the same
analysis in IRSp53 null MEFs infected with empty vector or
IRSp53-WT shortly after plating on ﬁbronectin (Figure 5D).
We then scored cells into one of the phenotypic spreading
modes (Figure 5E). Removal of IRSp53 does not affect cell
adhesion (Figure 5E), but favours a smooth-edged/rufﬂing
mode of spreading and signiﬁcantly reduces the number of
cells forming ﬁlopodia, mimicking VASP loss-of-function
(Applewhite et al, 2007). Finally, functional interference
of CDC42 by expression of a dominant-negative mutant
signiﬁcantly reduced VASP clustering at ﬁlopodia initiation
sites and its subsequent localization at ﬁlopodia tips during
cell spreading (Supplementary Figure S5e). Thus, IRSp53 is
required for efﬁcient ﬁlopodia formation during CDC42-de-
pendent cell spreading, strengthening the notion that IRSp53
and VASP act in the same pathway.
IRSp53 drives cell directional migration and invasion,
and is required for efﬁcient epidermal wound healing
in vivo
Filopodia drive directional migration and invasion into ECM
(Vignjevic and Montagnac, 2008). Thus, we tested the
impact of IRSp53 on these processes using our genetically
modiﬁed MEFs in a battery of migration and invasion
assays (Figure 6). In wound healing assays, IRSp53 null
MEFs were defective in closing the wound when compared
with IRSp53-reconstituted cells. Defective wound closure was
due to reduced speed and impaired directional migration
(Figure 6A; Supplementary Movie 9). Importantly, IRSp53
null MEFs were impaired in extending polarized protrusions
Figure 5 IRSp53 is required for CDC42-induced ﬁlopodia formation. (A) MEF KO-pB and KO-pB-IRSp53 cells, transfected with a constitutively
active Myc-tagged CDC42 (Myc-CDC42 L61), were ﬁxed and stained with anti-Myc or anti-IRSp53 antibodies and FITC-phalloidin to detect myc-
CDC42 L61, IRSp53 (KO-pB-IRSp53), or F-actin, respectively. The right panels represent magniﬁcations of the indicated areas of each
corresponding image. Scale bar is 10mm (2.5mm for the magniﬁcations). (B) Quantiﬁcation of ﬁlopodia induced by CDC42 L61 in cells shown in
(A). Upper panel. The number of cells expressing CDC42 L61 and presenting ﬁlopodia was counted. Data are expressed as the fraction of
CDC42 L61-expressing cells presenting ﬁlopodia with respect to CDC42 L61-expressing KO-pB-IRSp53 cells (relative ﬁlopodia index). CDC42
L61 induced ﬁlopodia inB80% of transfected KO-pB-IRSp53 cells. Lower panel: The number of ﬁlopodia/cell was counted. At least 100 cells
were analysed in each experiment and three independent experiments were performed. Data are the mean±s.e.m. (C) The expression levels of
IRSp53, Myc-CDC42-L61, and vinculin were analysed by immunoblotting. There are four distinct splicing isoforms of IRSp53 (Scita et al, 2008),
which differ only in the very C-terminal region, displaying either a WH2 domain or a PDZ binding motif. The isoform we introduced into
IRSp53 KO MEFs was BAIAP2-S carrying a PDZ motif at its C-terminus. (D) IRSp53 controls the mode of cell spreading and increases the
number of ﬁlopodia forming cells. MEFs KO-pB and KO-pB-IRSp53 were seeded on ﬁbronectin-coated coverslips and ﬁxed at 5 or 10min after
seeding. Cells were stained with FITC-phalloidin (green), anti-IRSp53 antibody (red) and Dapi (blue) to detect actin ﬁlaments, IRSp53 (pB-KO-
IRSp53) and nuclei, respectively. The right panels represent magniﬁcations of the indicated areas. Scale bar is 20 mm for the upper panels, 10mm
for the lower panels, and 5 mm for magniﬁcations. (E) Upper panel: Quantiﬁcation of spreading phenotypes. Normalized data±s.e.m. of the
number of cells displaying smooth-edged/rufﬂe (S-E/Rufﬂes) and ﬁlopodia spreading phenotypes in KO-pBABE and KO-pBABE-IRSp53 MEF
cells, 5 and 10min after seeding. At least 50 cells/experiment were analysed in three independent experiments. Lower panel: Quantiﬁcation of
adhering cells. The number of adhering cells/ﬁeld±s.e.m. in KO-pBABE and KO-pBABE-IRSp53 MEF cells, 5 and 10min after seeding. At least
10 ﬁelds in each experiment were counted.
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in the wound space and moved randomly rather than
directionally (Supplementary Movie 9). Similar results were
obtained in trans-well migration and invasion assays. IRSp53
removal also impaired chemotactic migration towards serum
or PDGF (Figure 6B) and directed cell invasion in Matrigel-
coated transwells (Figure 6C) as well as into native
collagen type I chamber (Sabeh et al, 2009) (Supplementary
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Figure 6 IRSp53 removal affects directional cell migration and invasion. (A) Wound healing assay. KO-pBABE and KO-pBABE-IRSp53 MEFs,
seeded and grown to conﬂuence, were scratched with a tip and analysed by DIC time-lapse imaging (20h, 5min time interval; see
Supplementary Movie 9). Left panels: Still images taken at the indicated time points. Bar is 50 mm. White-dashed lines mark the front of
migrating cells. Right panels: Single-cell migration was analysed using the ImageJ software. The directional migration index (upper panel) and
the average speed (central panel) of cells were calculated. The directional migration index represents the ratio between the total distance
covered by cells and the distance covered longitudinally towards the centre of the wound. At least 20 cells were analysed for each condition.
Lower panel: Total wound area was measured at the indicated time points using the ImageJ software and relative wound closure was
determined as described in Materials and methods. Data are the mean±s.e.m. from n¼ 5 ﬁelds/experiment. Data are from three independent
experiments. (B) Transwell assay. KO-pBABE and KO-pBABE-IRSp53 MEFs were seeded on ﬁbronectin-coated chambers. Twenty percent serum
(left panel) or 10 ng/ml PDGF (right panel) was added in the lower chamber to generate a chemo-attractive gradient. Cells were ﬁxed after 6 h
and stained with crystal violet. Bar is 50 mm. The number of cells passing the semi-permeable membrane was counted. At least 20 different
ﬁelds were analysed for each condition. Data are the mean±s.e.m. from three independent experiments. (C) Invasion assay. KO-pBABE and
KO-pBABE-IRSp53 MEFs were seeded on Matrigel-coated chambers. PDGF was added in the lower chamber to generate a chemo-attractive
gradient. Cells were ﬁxed after 16 h and stained with Dapi to detect nuclei. Left panel: Quantiﬁcation of the number of cells passing the semi-
permeable membrane. At least 10 ﬁelds were analysed for each condition. Data are the mean±s.e.m. from three independent experiments.
Right panel: Representative images of invading cells. Bar is 10 mm.
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To assess whether IRSp53 removal also resulted in an
organismal migratory phenotype, we subjected 10-week-old
IRSp53 KO and WT littermate mice to the dermal punch
wound model of wound healing. During tissue repair
keratinocytes, endothelial cells, macrophages, and mesen-
chymal cells, such as ﬁbroblasts or myoﬁbroblasts, migrate
into the wound area (Gabbiani, 2003; Stappenbeck and
























































Figure 7 Genetic removal of IRSp53 in mice impairs wound repair. (A) Time course of wound closure. (Left panels) Microphotographs of
wounds were captured on days 0, 1, 2, 4, 5, 6, and 7 after wounding to determine the degree of wound closure in IRSp53 KO and control WT
mice. Representative images from days 0, 2, and 5 are shown. Right panel. Total wound area on days 0, 2, and 5 after wounding was measured
using the ImageJ software and relative wound closure was quantiﬁed as described in Materials and methods. Data are the mean±s.e.m. from
n¼ 6 animals/group. Scale bar is 2mm. (B) H&E analysis of back skin from IRSp53 KO and WT mice at day 7 after wounding. Black arrows
denote the wound limits. White arrowheads denote the re-epithelialization regions. Lower panels represent  5 magniﬁcations of the insets
(dashed red lines) in upper panels. C, clot; E, epithelium. Scale bar is 200 mm (higher magniﬁcations, 40 mm). (C) H&E analysis of back skin
from IRSp53 KO (left) and WT (right) mice. Lower panels represent  5 magniﬁcations of the insets (dashed red lines) in upper panels. Scale
bar is 200 mm (lower panels, 40mm). (D) IHC analysis of IRSp53 in back skin from IRSp53 KO (left) and WT (right) mice. Lower panels
represent  5 magniﬁcations of the insets (dashed red lines) in upper panels. Scale bar is 200 mm (lower panels, 40mm). (E) IRSp53 is
expressed in mouse keratinocytes, dermal ﬁbroblasts, macrophages, and endothelial cells. The expression levels of IRSp53 and vinculin were
analysed by immunoblotting in MEFs and mouse keratinocyte (C50), dermal ﬁbroblast (M Dunni, M-D) cell lines. Bone marrow macrophages
(Mf) and lung endothelial cells (EC) derived from IRSp53 KO or WT mice were also analysed. Source data for this ﬁgure is available on the
online supplementary information page.
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punched four wounds on the back skin of 10-week-old
IRSP53 KO and WT mice and monitored wound closure
over a 7-day period. Microphotographs, morphometric
quantiﬁcation, and H&E analysis of wounds revealed that
IRSp53 KO animals displayed a marked delay in wound
closure relative to control animals (Figure 7A and B).
Indeed, a thick clot was still present at 7 days after wounding
and the wound limits were larger, while the re-epithelializa-
tion process was incomplete (Figure 7B). Notably, we de-
tected no differences in the cellular composition and overall
morphology between IRSP53 KO and WT mice, indicating
that IRSp53 is dispensable for skin development, but required
for wound re-epithelialization (Figure 7C). Importantly,
IRSp53 is expressed in epidermal keratinocytes, macro-
phages, isolated dermal ﬁbroblasts, and endothelial cells
(Figure 7D and E). Removal of IRSp53 delayed wound closure
by keratinocytes in vitro (data not shown). Furthermore,
quantitative analysis of cells at wound sites revealed that
while endothelial cells were recruited in similar numbers and
generated blood vessels of similar size in IRSp53 KO and WT
mice, macrophages were instead signiﬁcantly reduced in
IRSp53 KO mice (Supplementary Figure S7). This result is
consistent with previous ﬁndings showing that IRSp53
removal impairs macrophage chemotactic cell motility
(Abou-Kheir et al, 2008). Collectively, these data suggest
that IRSp53 removal impairs the re-population of wound
sites by epithelial keratinocytes, macrophages, and dermal
ﬁbroblasts, which are the major cells involved in wound
healing in vivo.
Discussion
Our study identiﬁes a signalling and molecular mechanism
that controls, in a spatially conﬁned manner, VASP actin
regulatory activity during the initial phases of ﬁlopodia
formation from lamellipodia sheets, in response to CDC42
activation. We show that the membrane deforming I-BAR-
domain containing protein IRSp53 plays a critical role in this
process and characterize the physiological relevance of
IRSp53 regulation of ﬁlopodia in tissue repair and wound
healing in mice. While CDC42 and VASP are established
critical factors in ﬁlopodia formation, the signalling mechan-
isms regulating VASP activity and, in particular, its clustering-
dependent processive elongation function, have remained
elusive. Here, we show that the CDC42-IRSp53 axis is critical
in mediating a switch from inhibition of actin barbed end
growth (by IRSp53) to processive ﬁlament elongation follow-
ing IRSp53-mediated clustering of VASP. Moreover, this sig-
nalling axis spatially restricts VASP activity along the leading
edge of migrating cells, resulting in ﬁlopodia formation
(Figure 8).
At the molecular level, IRSp53 exerts this function through
a number of essential, biochemical, and signalling activities.
First, via the I-BAR domain, IRSP53 can bind, sense, and
promote PM deformation (Zhao et al, 2011). This property is
entirely independent from forces generated by actin
polymerization or protein:protein interactions (Zhao et al,
2011), suggesting that an initial step in the assembly of the
machinery for ﬁlopodia formation is localized membrane
evagination (Figure 8, step 1). These initial protrusions are
subsequently, or concomitantly, stabilized and extended by
actin ﬁlaments that elongate in a linear fashion (Figure 8,
step 2). Importantly, in the absence of stimuli, IRSp53 slows
down barbed end growth, thus safeguarding against un-
wanted growth of actin ﬁlaments that would occupy the
free space of outwardly curved PM, leading to unrestrained,
isotropic ﬁlopodia extensions. In this respect, it is well
established that the expression of the isolated IRSp53 I-BAR
domain, which is devoid of barbed end activity, elicits the
formation of aberrant, isometrically distributed ﬁlopodia-like
structures that are nearly devoid of F-actin (Yang et al, 2009).
Intriguingly, the weak capping activity of IRSp53 may be
reinforced by its association with EPS8 (Disanza et al, 2006),
which caps barbed ends with nanomolar afﬁnity (Disanza
et al, 2004), suggesting that an EPS8:IRSp53 complex may be
critical for proper control of ﬁlament growth at the leading
edge. The inhibition of barbed end growth by IRSp53 is
relieved by activated CDC42, which appears to compete
Figure 8 Model depicting how CDC42 switches IRSp53 from inhibition of actin assembly to ﬁlament elongation by clustering VASP during
ﬁlopodia formation. A series of distinct signalling and biochemically deﬁned steps characterize the initial phases of ﬁlopodia formation,
mediated by the membrane deforming protein IRSp53 and its interactor VASP. Step 1: in the absence of stimuli, IRSp53 binds to the PM and
slows down barbed end elongation. The constitutive association of IRSp53 with the capping protein EPS8 likely reinforces EPS8 capping
activity (not shown) (Disanza et al, 2006; Vaggi et al, 2011). Step 2: following ﬁlopodia-inducing stimuli, activated CDC42 binds to IRSp53. This
interaction relieves IRSp53-mediated inhibition of ﬁlament growth and promotes the formation of a CDC42:IRSp53:VASP complex, and
simultaneously reduces the formation of the IRSP53:EPS8 complex. Step 3: binding to CDC42 further facilitates the formation of IRSp53 and
VASP foci at the leading edge of the PM, in which VASP clustering allows processive actin ﬁlament elongation in the presence of capping
protein. Step 4: membrane deforming activity of IRSp53 and processive ﬁlament elongation by VASP work in concert to extend actin ﬁlaments
beyond the x, y plane of the membrane. During this process, the ﬁlaments become cross-linked by fascin (not shown), to resist counter
membrane tension and extracellular compression forces.
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with EPS8 for binding to IRSp53, as evidenced in co-
immunoprecipitation experiments. This latter ﬁnding is
remarkable from different points of view. At the biochemical
level, it suggests that IRSp53 adopts different conformations
controlled by CDC42 binding. In the absence of active
CDC42, IRSp53 folds into a ‘closed state’ that negatively
regulates actin polymerization. Binding of CDC42 induces a
conformational switch that not only impedes barbed end
association, but also promotes IRSp53 binding with some of
its downstream targets (see below). Structural/biochemical
evidence in this direction are provided by recent ﬁndings by
Roberto Dominguez and colleagues (manuscript submitted
elsewhere) that reveal how an SH3-CRIB-based intra-
molecular interaction is critical in mediating the switch from
a ‘closed’ to an ‘open/active’ state of IRSp53. One additional
important feature of IRSp53 is that the conformational switch
appears to be dependent on consecutive association with
EPS8 and CDC42 that eventually assemble into an open
heterohexamer. Under these conditions, the barbed capping
activity of IRSp53 is prevented by CDC42, while SH3
interactors, such as VASP, may bind to IRSp53, compete out
EPS8, and eventually switch the activity of the complex
towards ﬁlament elongation. Notably, we have previously
shown that IRSp53 may contribute to ﬁlopodia elongation
by promoting the bundling activity of a CDC42–IRSp53–VASP
complex through oligomerization (Vaggi et al, 2011). Thus, the
formation of this complex may not only be required to
promote processive ﬁlament elongation, an activity that is
essential to initiate the growth of actin ﬁlaments and of
ﬁlopodia, but also the bundling of ﬁlaments to sustain
ﬁlopodia extension. This latter activity is thought to be
primarily mediated by fascin (Vignjevic et al, 2006).
Nevertheless, bundling particularly close to the barbed ends,
where the IRSp53::VASP complex is restricted, may sub-
sequently favour tighter cross-linking by fascin. This cross-
linking may confer sufﬁcient stiffness to ﬁlopodia that then
allows them to resist counter PM tension and extracellular
forces.
The regulation of IRSp53 barbed end capping activity by
CDC42 is also important in the context of RHO family GTPase
signalling, and more generally, in the regulation of ﬁlament
barbed end growth since little is known about the mechan-
isms and signalling pathways that target this critical activity.
Indeed, blockade of barbed end growth is viewed as a ‘default
process’ that must immediately take place to avoid uncon-
trolled ﬁlament elongation that would otherwise occur on
free barbed ends, given the high concentration of G-actin (or
G-actin::proﬁlin complex) in cells (Koestler et al, 2009).
During ﬁlopodia initiation, instead, CDC42 actively and
locally inhibits IRSp53 capping, further promoting a switch
towards the formation of an active IRSP53::VASP complex
driving ﬁlopodia formation.
Our data also shed light on how VASP activity is regulated
in cells. First, we provide evidence that VASP, via IRSp53, is
directly linked to CDC42, thus deﬁning a CDC42–IRSp53–
VASP signalling relay axis for actin assembly underlying
ﬁlopodia formation. Second, we show that IRSp53 drives
VASP clustering, which is essential for promoting sustained
processive actin ﬁlament elongation of VASP at the PM in the
presence of capping proteins (Breitsprecher et al, 2008, 2011).
It has recently been shown, using single molecule TIRF
analysis, that isolated VASP is also capable of promoting
processive elongation in the presence of proﬁlin (Hansen
and Mullins, 2010). However, in solution, individual VASP
tetramers are only weakly processive (Hansen and Mullins,
2010). Clustering of VASP into dense foci appears, therefore,
to be necessary to enhance this activity for the extension of
spatially restricted and timely coordinated ﬁlopodia.
Consistently, we show that VASP is recruited to foci at the
leading edge primarily via speciﬁc IRSp53-mediated protein:
protein interactions. We cannot exclude that barbed end
binding by VASP may also contribute to localization at
the PM. However, VASP association to free barbed ends
does not explain signalling-dependent VASP clustering as
satisfactorily as IRSp53-mediated recruitment of VASP. In
this latter respect, it is worth emphasizing that the binding
of VASP to membrane-associated proteins, such as Mig-10/
RIAM/Lamellipodin or CXCR2, has previously been reported
(Krause et al, 2004; Neel et al, 2009). However, none of these
proteins localized dynamically into discrete foci at ﬁlopodia
initiation sites. Rather, they were distributed along the
entire leading edge of lamellipodia, suggesting that they
more likely contribute to the regulation of VASP activity in
these migratory protrusions. Thus, it appears likely that
distinct VASP-based protein complexes participate in the
control of its multiple activities in different migratory
structures, ultimately regulating the transition between
lamellipodia-to-ﬁlopodia. It must be also pointed out that
for this transition to be complete other activities, such as
nucleation by formin family proteins (Peng et al, 2003;
Pellegrin and Mellor, 2005; Schirenbeck et al, 2005) and
bundling by fascin (Faix et al, 2009) are likely to be
required to cooperate with the IRSp53::VASP ﬁlopodia
initiation complex. Reconstituting the interplay between
these factors will lead to a better understanding of how
cells dynamically regulate the architecture of functional
actin networks and their biological consequences.
Materials and methods
All animal experiments were conducted in accordance with national
guidelines and were approved by the ethics committee of the
Animal Welfare Ofﬁce of the Italian Work Ministry and conformed
to the legal mandates and Italian guidelines for the care and
maintenance of laboratory animals.
Expression vectors, antibodies, reagents, and cells
Cytomegalovirus (CMV)-promoter-based and elongation factor-1
(EF1)-promoter-based eukaryotic expression vectors and GST bac-
terial expression vectors were generated by recombinant PCR.
pEGFP–IRSp53 was from H Nakagawa (Austrian Academy of
Sciences, Vienna, Austria), pmCherry-Fascin was from K Rottner
(Institute of Genetics, University of Bonn, Germany) and JV Small
(Institute of Molecular Biotechnology, Vienna, Austria), pmCherry-
Eps8 (Addgene, One Kendall Sq, Cambridge, MA). All constructs
were veriﬁed by sequencing.
The antibodies used were monoclonal anti-Eps8 (Transduction
Laboratories, Lexington, KY); rabbit polyclonal anti-GST (Santa
Cruz Biotechnology, Santa Cruz, CA); anti-Myc 9E10 (Babco,
Berkeley, CA); anti-tubulin and rabbit polyclonal anti-IRSp53
(Sigma-Aldrich, St Louis, MO); rat monoclonal anti-F4/80 (AbD
Serotec, Oxford, UK); rabbit polyclonal anti-CD31 (Abcam,
Cambridge, UK). The monoclonal anti-IRSp53 was generated as
described (Disanza et al, 2006). Immortalized ﬁbroblasts from
IRSp53þ /þ and IRSp53–/– embryos were as described (Weiss
et al, 2009). pBABE control, pBABE IRSp53 WT, and pBABE
IRSp53 W413G re-expressing cells were obtained by infection of
immortalized ﬁbroblasts from IRSp53–/– embryos.
For additional detailed information on Materials and methods,
see Supplementary data.
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Actin polymerization assays
Actin polymerization was monitored by the increase in ﬂuorescence
of 10% pyrenyl-labelled actin. Seeded polymerization was induced
by addition of 0.05M KCl, 1mM MgCl2 and 0.2mM EGTA to a
solution of Ca-ATP–G-actin (1.25 mM) containing spectrin-actin
seeds, 5mM proﬁlin, and various concentrations of puriﬁed pro-
teins. Fluorescence measurements were performed at 201C in a
Safas Sfx or a Spex Fluorolog 2 spectroﬂuorimeter. Samples from
seeded-polymerization assay were pelleted for 30min at 400 000 g
in a Beckman TL-100 tabletop ultracentrifuge. Equal amounts of
starting materials, supernatants, and pellets were solubilized in
loading buffer, boiled, and resolved on an SDS-PAGE gel. Each
single assay was repeated at least ﬁve times with similar results.
Representative experiments are shown.
Dilution-induced depolymerization of pyrenyl F-actin was mon-
itored in a Spex Fluorolog 2 instrument. A 50% labelled F-actin
solution (2.5mM F-actin) was diluted 50-fold into polymerization
buffer (5mM Tris–HCl pH 7.8, 0.1mM CaCl2, 0.2mM ATP, 1mM
DTT, 0.01% NaN3, 50mM KCl, 1mM MgCl2, and 0.5mM EGTA)
containing the desired amount of IRSp53 or VASP.
TIRF microscopy for monitoring of actin polymerization and
elongation was performed with ﬂow cells, essentially as
described in Breitsprecher et al (2011) and Jegou et al (2011) (see
Supplementary Experimental Procedures for details).
Statistical analysis
All data are presented as the mean±standard errors of mean
(s.e.m.), except when speciﬁed otherwise. A Student’s t-test was
used to calculate the P-values.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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